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ABSTRACT 
 
Studies in Bioinorganic Chemistry:   
Synthesis and Reactivity of Nickel and Vanadyl NxSy Complexes. (May 2010) 
Roxanne Michelle Jenkins, B.S., University of Texas as San Antonio 
Chair of Advisory Committee: Prof. Marcetta Y. Darensbourg 
 
 As inspired by the coordination environment of nickel in NikR and NiSOD, 
imidazole ligands were incorporated into N2SNiII square planar complexes in order to 
investigate the electronic and structural features of NiII species containing both imidazole 
and thiolate ligation.   Rare examples of nickel complexes containing such ligand sets in 
continuous tetradentate (N2N’S) and discontinuous (N2S---N’) coordination were 
synthesized and characterized.  A significant finding in these studies is that the plane of 
the imidazole ligand is oriented perpendicular to the N2SNi plane.  Further investigations 
addressed the orientational preference and stereodynamic nature of flat monodentate 
ligands (L = imidazoles, pyridine and an N-heterocyclic carbene) bound to planar N2SNi 
moieties.   The solid state molecular structures of planar [N2SNiL]n+ complexes accessed  
through bridge-splitting reactions of dimeric, thiolate-S bridged [N2SNi]2  complexes, 
reveal that the plane of the added monodentate ligand orients largely orthogonal to the 
N2SNiL square plane.    Variable temperature 1H NMR characterization of dynamic 
processes and ground state isomeric ratios of imidazole complexes in their stopped 
exchange limiting spectra, readily correlate with DFT-guided interpretation of Ni-L 
rotational activation barriers.   Full DFT characterization relates the orientation mainly to 
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steric hindrance derived both from ligand and binding pocket.  In the case of the 
imidazole ligands a minor electronic contribution derives from intramolecular 
electrostatic interactions (imidazole C-2 C-Hδ+- - Sδ- interaction).    
 Our group has firmly established the versatility of the (bme-daco)2-, (bme-dach)2-, 
and (ema)4- ligands to accommodate a number of metals (M = Ni, Zn, Cu, and Fe ), and 
have demonstrated reactivity of such N2S2M complexes occurs predominately at the S-
thiolate sites.  As vanadium is of interest for its biological, pharmacological and 
spectroscopic/analytical probe abilities, vanadyl analogues were explored as mimics of 
possible chelates formed from Cys-X-Cys binding sites in vivo.  The structural and 
electronic changes from the incorporation of V=O2+ in such dianionic and tetraanionic 
N2S2 binding pockets is investigated and compared to Ni2+ and Zn2+ in similar N2S2 
environments. The nucleophilicity of the S-thiolate in these systems is explored with 
alkylating agents and W(CO)x.    Furthermore, the vanadyl interaction with the CGC 
peptide, the biological analogue of the tetraanionic N2S2 ligand, was produced and 
characterized by EPR; its W(CO)x adducts were indentified by υ(CO) infrared 
spectroscopy. 
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CHAPTER I 
INTRODUCTION 
 
Biological Functions of Nickel in Microorganisms 
 Plants, fungi, archaebacteria and eubacteria utilize nickel ions in a variety of 
essential metalloproteins which participate in Ni-sensing, uptake, trafficking, storage, 
regulation and utilization.1-2  There are nine known Ni-dependent enzymes:  urease, 
[NiFe]-hydrogenase, carbon monoxide dehydrogenase, acetyl-coenzyme A 
decarbonylase/synthase, methyl-coenzyme M reductase, Ni-superoxide dismutase, Ni-
dependent glyoxylase, acireductone dioxygenase and methylenediurease.1 Nickel can 
function as a redox cycling agent, a binding site for reactive small molecules (CH3 or 
CO) in organometallic transformations, a Lewis acid to promote hydrolysis, or as a 
regulator of vital response mechanisms.1-2  For example, nickel ions are essential to the 
physiology of microorganisms such as Helicobacter pylori and Escherichia coli. The 
survival of the bacteria relies on the nickel-containing enzyme urease (comprised of a 
dinickel active site containing four histidines) which helps maintain a neutral pH within 
the bacterial cytoplasm, and it depends on the [NiFe]-hydrogenase to supply energy to 
the cell.3-5   The pathogenic bacterium H. pylori, found in the acidic environment of the 
stomach of humans, is known to infect more than 50% of the world’s population.6-7  It 
has been associated with the onset of duodenal or gastric ulcers, gastritis and certain 
gastric cancers.8     
___________ 
This dissertation follows the style of Journal of the American Chemical Society. 
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NikR: A Nickel Regulation Protein 
 As a surplus of nickel is toxic in biological systems, the control of the 
intracellular levels of nickel is essential.9  Nickel homeostasis in H. pylori and E. coli is 
controlled by the nickel-responsive transcription factor, NikR.10-12  The molecular 
structure of the NikR protein of E. coli has been most extensively studied.2  As shown in 
Figure I-1, it is a homotetramer containing four high-affinity nickel binding sites (one 
per subunit) in the Metal Binding Domain (MBD).13   
Figure I-1.  A. NikR apoprotein highlighting the disordered α3 helix.; B.  NikR 
holoprotein.; C.  DNA-bound NikR protein. Adapted from Reference 13. 
 
 Each NiII ion is held in a square-planar arrangement consisting of the side chains 
of two histidine (His87 and His89) and one cysteine residue (Cys95) from one NikR 
monomer, and a histidine (His76) from an adjacent monomer (Figure I-2).13-14   This 
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cytoplasmic nickel sensor is responsible for repressing the transcription of the nickel 
membrane transporter, NikABCDE, when ample levels of intracellular nickel are met.10  
The  initiation of NikR binding to a 28-bp palindromic operator sequence found in  the 
promoter nikABCDE occurs following the coordination of four nickel ions to the high 
affinity sites located in the Ni-regulatory domain, i.e. the metal binding domain 
(MBD).13  
Cys95
His76'
His89
His87 H
HH
Ni
N
N
N
N
N
N S
NH
  
Figure I-2.  The nickel binding site of NikR.  Adapted from Reference 14. 
 As Figure I-1 shows, the binding of Ni2+ ions in this domain organizes the α3 
helix and initiates the protein-DNA communication.13  The exact DNA-binding response 
mechanism is still not completely understood.   A DNA-complementary surface on the 
MBD is created from the binding of nickel ions in the high affinity sites in the MBD.    
Polar interactions between the α3 loop and DNA phosphate backbone are created from 
the stable conformation of the α3 helix.  The localization of the NikR protein to the 
DNA is promoted by a short-range allosteric effect.  The ribbon-helix-helix (RHH) 
domains extend completely outwards from the MBD and the β-sheets which bind to the 
DNA major groove point in opposite directions.  When the operator base sequence is 
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recognized by the repressor, a cooperative interaction of both RHH domains ensues.  
The RHH domains rotate about the interdomain linkers and the anti-parallel β-strands 
orient to occupy the nik operator half-sites in the DNA major groove.13  
 There have been two other metal binding sites proposed in NikR, one of which 
was observed in the molecular structure of the DNA-bound NikR protein.13  Drennan 
and coworkers observed an additional metal binding site bridging the metal binding 
domain and the DNA binding domain.13  They proposed this conformation was held in 
place by a K+ ion.  Still another, a low affinity nickel binding site has been postulated, 
but not indentified by X-ray crystallography.2  Studies have established that 
stoichiometric amounts of nickel induce a nanomolar binding affinity of NikR to 
DNA.15-16  However, it has been demonstrated that excess nickel causes tighter binding 
of the protein-DNA complex.  In this case, XAS data suggests a nickel coordinated to 
N/O donors in an octahedral geometry defines this site.15    Biomimetic studies of the 
high affinity nickel(II) binding site have not been reported until now.131 
 Proteins typically bind metal ions in a highly specific manner.  Nevertheless, 
divalent transition metal ion binding studies of the high affinity metal binding site of 
NikR have demonstrated that metals such as Co2+, Cu2+, Zn2+, and Cd2+, bind with a 
similar affinity as Ni2+.15-16  Drennan and Zamble, et al., investigated the structural 
changes in the NikR protein induced by the binding of Cu2+ and Zn2+ ions to the high 
affinity metal binding domain as compared to the Ni2+ bound form.17  The results 
indicated that both Ni2+ and Cu2+ ions coordinate to the protein in a similar manner, and 
both promote the ordering of the α3 helix.   In contrast, the α3 helix remains disordered 
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on the binding of Zn2+ ions.   Competitive binding between Ni2+ and Cu2+ ions is 
however not observed in the cell, since free copper in the 2+ form is not present.17 
Overall, it is important to note that the coordination geometry about the nickel ion in 
NikR is controlled by the binding preferences of the metal and not induced by the 
protein superstructure, and this is critical to the function of the protein. 
 
Ni-dependent Superoxide Dismutase (NiSOD)  
In contrast to the structural, redox invariant function of the nickel ions found in 
NikR, a nickel-dependent enzyme in microorganisms in which the nickel ion plays a 
redox role is superoxide dismutase. Nature has designed superoxide dismutase to defend 
respiring cells from the cytotoxic effects of superoxide, catalyzing its dismutation 
reaction to molecular oxygen and peroxide. The reaction proceeds via a two step, ping 
pong mechanism wherein the metal center is first reduced by one molecule of superoxide 
producing molecular oxygen and subsequently the metal center is reoxidized by a second 
molecule of superoxide generating peroxide (Figure I-3).19-20     
Superoxide is a natural byproduct of aerobic metabolism. Superoxide and its 
derivatives damage living systems by causing oxidative damage to cellular components.  
Superoxide has the ability to abstract weakly bound protons producing organic radical 
species and it can also reduce metals leading to various Reactive Oxygen Species, 
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M3+ + O2·- + H+  →   M2+ + O2 
 
M2+ + O2·- + H+  →   M3+ + H2O2
Figure I-3.  Ping pong mechanism of superoxide dismutation. 
 
 
ROS’s.  The extremely reactive products generated from cellular reactions with 
superoxide are more deleterious to the cell than superoxide itself.  The damaging 
reactivity of ROS’s include inactivating enzymes, abstracting protons from DNA bases, 
modifying amino acids and interfering with NO-mediated signaling.  Superoxide and 
reactive oxygen species have been linked to many degenerative conditions, 
inflammatory diseases, reperfusion injury after ischemia, the process of aging, cell death 
during infections, advancement of AIDS and amyotrophic lateral sclerosis (“Lou 
Gehrig’s disease”).19-21 
SODs are classified according to their redox active metal center.  As shown in 
Figure I-4, the metal centers of the heterobimetallic Cu, Zn- and the monometallic Fe- or 
Mn- containing SODs, are coordinated to hard N or O donor atoms.  Histidine 
imidazoles, aspartate carboxylates, and water are the common ligands demonstrated to 
bind to these metal centers.22  Two simultaneous studies presented by Getzoff et al.., and 
Wuerges et al.., revealed the first protein crystal structures of the nickel-containing 
superoxide dismutase, NiSOD.23-24    The NiSOD is a relatively small protein consisting 
of a 117 amino acid sequence and is comprised of a four helix bundle hexamer structure  
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containing six Ni ions arranged in an octahedral array (Figure I-5).  The nickel(II) 
binding sites were found to incorporate both N-histidine and S-cysteine ligands creating 
a N2S2 binding motif.  This distinct SOD coordination environment involving N2S2 
ligation is a nickel binding pocket which is also observed in the acetyl coA synthase 
(ACS) metalloenzyme, where a nickel is bound by two S-thiolates and two N-amides 
from a Cys-Gly-Cys tripeptide motif.25-27     
 Molecular structures of NiSOD suggested that the redox active metal center 
undergoes conformational changes during the catalytic cycle (Figure I-5).23  The reduced 
form of the active site of NiSOD features a square planar geometry about NiII consisting 
of the N-terminus amine nitrogen, a carboxyamido N atom, two cysteine thiolates and 
2O2- + 2H+    H2O2 + O2
His
His
N
N
N
N
N N
O
M
O
O
N
N
N
N
ZnCu
N N
N
N
N
N
N
N
His
Figure I-4.  The Cu,Zn-SOD active site, the Mn-, Fe-SOD active site and the reaction 
they catalyze. 
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possibly a fifth donor ligand from an axial histidine N atom.  The molecular structure of 
the oxidized form reveals axial imidazole coordination to the Ni metal center resulting in 
a five coordinate square pyramidal geometry, Figure I-5. The imidazole plane of His1 
rotates by ~55° in the course of coordinating the His imidazolate N to the open axial site, 
achieving a Ni-N distance of ~2.63 Å (Figure 1-6).23  This is a large movement of the 
imidazole.   
 
 
Figure I-5.  Molecular structure of NiSOD. NiSOD active site. Left:  reduced form; 
Right: oxidized form.  Adapted from Reference 23. 
H
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Figure I-6.  The NiSOD active site in the reduced state (uncoordinated His) and 
the oxidized state (coordinated His) highlighting the large movement of the His1 
imidazole donor. 
 
 This work focuses mainly on the synthesis and structure of nickel coordination 
environments containing imidazole and thiolate ligation, as inspired by the NikR and 
NiSOD nickel binding sites.  Fundamental issues were discovered during the exploration 
of these bioinspired complexes, and led my work into the direction of investigating the 
factors that influence the orientation of heterocyclic monodentate ligands.  
 
Biological Relevance of Imidazole Orientation  
 Whereas the orientation of histidine donors in nickel-binding sites has not been 
addressed in structural studies of biomolecules, much effort has been directed to His-iron 
interactions, using simple imidazoles as mimics of histidine.  The axial imidazole 
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binding geometry in metalloporphrin complexes has been extensively studied by the use 
of small molecule models and theoretical computations.28-36 These works have 
demonstrated that the axial ligated imidazole geometry (orientation of the plane of the 
imidazole with respect to the Fe-Nporphyrin bond vectors, and tilt of the imidazole plane) 
can influence spectral changes,28-30,36 shifts in redox properties,30-31 coordination of 
substrates32 and changes in the spin state. 28   
A system to measure the orientation of imidazole ligands in metalloporphyrin 
complexes was developed by Hoard et al.., Figure I-7.37  The imidazole bonding 
geometry is described as the dihedral angle (ϕ) defined by the angle between the 
imidazole plane and a plane perpendicular to the N4Fe framework, which intersects a N-
atom bound to the Fe center.  When ϕ equals 0º (maximum steric repulsion), the 
imidazole plane eclipses the porphyrin nitrogen metal bonds and a ϕ value of 45º 
(minimum steric repulsion) corresponds to the imidazole bisecting the Nporphyrin-M- 
 
Fe
N
φ
N
N
N
Figure I-7.  Definition of ϕ  according to the system developed by Hoard et al. 
used to measure the orientation of imidazole ligands in metalloporphyrin 
complexes.  Adapted from Reference 37. 
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Nporphyrin angle.  An  evaluation of reported Fe heme structures by Scheidt and Chapman 
found that small ϕ angles (i.e. close to zero) were most often observed.28   These data 
implied that non-bonding interactions (steric repulsion) were not the dominating factor 
in the orientational preference of axial coordinated imidazole ligands in Fe heme 
complexes.  Structural analysis of metalloporphyrins containing two axial coordinated 
imidazoles found that longer Fe-Nimidazole bond distances were associated with imidazole 
ligands having smaller ϕ values.   
To investigate the electronic effect on ligand orientation, Scheidt and Chapman 
carried out computational studies on porphyrin type complexes that incorporated metal 
ions with various oxidation, spin states, imidazole angle.28  A stabilizing effect was 
found to be induced from an orientationally dependent small ϕ angle, which was 
determined to correspond to a bonding interaction involving a weak pπ imidazole and pπ 
metal interaction.  In all cases, with the exception of a low spin (LS) Fe(III) complex, the 
resulting conformation of the axial coordinated ligand derived from the opposing forces 
from pπ imidazole and pπ metal bonding interactions and steric factors, and  contributions 
of dπ orbitals were found to be minimal. In the LS Fe(III) system, the pπ imidazole and dπ 
metal interactions were shown to influence the value of ϕ to a greater extent.  
Furthermore, the π-bonding ability of imidazole ligands in (CN)5FeIII(1-CH3im)2- 
complexes  was examined by Asher and Abola, et al.38    These studies also found that 
weak π-bonding interactions between the Fe dπ-Im pπ orbitals of the coordinated 
imidazole ligand affect the imidazole conformation and the  M-imidazole bond distance.  
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Although a weak contribution from the π-donating properties of the imidazole 
ligand was suggested in early studies, current research has focused on other factors that 
affect the orientation of the imidazole ligand.  A recent survey of the Protein Data Base 
(PDB) crystal data base, by Knapp, et al.. found that in the majority of heme complexes 
the NH group of the axial ligated imidazole pointed in the direction of the propionic acid 
groups of porphyrin framework.34  In addition, they identified a second factor which 
influenced the orientational preference of the axial imidazole donor: the linker atoms of 
the histidine residue on the imidazole.  Both features were interpreted in terms of 
electrostatic interactions as according to their computational results, and both were 
considered to be a product of the overall protein environment.  A further theoretical 
study conducted by Knapp and coworkers examined the orientational preferences of 
axial ligated imidazoles in hemoproteins in the presence of a dielectric medium, such as 
water or protein environments, and determined that the electrostatic interaction of the 
total dipole moment of the heme-imidazole system with the solvent reaction field plays a 
significant role in the conformation of the axial imidazole ligand.35 
In addition to the stereochemical investigations of imidazole ligands in heme 
systems, imidazole orientational binding preferences have been studied in square planar 
platinum complexes and octahedral ruthenium complexes to understand the role of such 
metal complexes in biological systems, such as their mode of action as anticancer 
drugs.39-41  For example, Alessio, Marzilli and coworkers explored octahedral Ru(II) 
complexes that contained aromatic N-donor, “lopsided” ligands such as 1,5,6-
trimethylbenzimidazole, Me3Bzm, and concluded that opposing forces between steric 
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and electrostatic interactions affected ligand orientation and observed dynamic 
processes.39  The variable temperature 1H NMR spectra of cis,cis,cis-
RuCl2(DMSO)2(Me3Bzm)2 found that one Me3Bzm ligand readily flips between two 
identified species (each isomer rotated 180º from the another) while the second Me3Bzm 
ligand is immobile between -100 and +35 ºC.  The preferred, fixed orientation of the 
latter was attributed to electrostatic interactions between the C-Hδ+ of Me3Bzm and the 
two cis halides.  Other investigations by Velder, Reedijk et al. of Ru-N bound substituted 
imidazoles in dicationic Ru2+ complexes that lack coordinated halides established that 
the observed rotational behavior of the imidazole ligands about the Ru-Nimid bond is 
controlled exclusively by steric interactions.41   
The orientation and rotational fluxionality of N-heterocyclic carbene (NHC) 
ligands have also been carefully studied, concluding that rotation of NHCs about the M-
CNHC bond is also determined largely, and in most cases solely, by steric effects.43-51  For 
square planar d8 complexes the steric interference of NHC ligands with ancillary ligands 
dictates the NHC ligand plane to orient nearly perpendicular to the metal ligand 
plane.44,50-52 
A final example of the importance of imidazole orientation has been 
demonstrated in the CuA Azurin metalloprotein (Figure I-8).  Studies have established 
that the angular position of the His rings with respect to the Cu2S2 core in the active site 
of CuA Azurin modulates the interaction of the axial ligand with the copper ions, and 
thus fine tunes the structural and electronic properties of the metalloprotein.53-54 
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Figure I-8.  The active site of CuA azurin.  Adapted from Reference 53. 
 
 As a number of studies demonstrate the effects of subtle changes in imidazole 
orientation, and the fact that nature commonly employs histidine-rich sites in 
metalloproteins, further development of understanding the factors which influence the 
stereochemistry of metal bound His-imidazoles in other coordination geometries is 
important.  The main focus of this dissertation is to expand our knowledge in the 
coordination chemistry of imidazole ligands bound to nickel centers containing thiolate 
donors, and to understand the factors which influence the relative orientation of 
imidazole ligands in such systems.  Chapter III describes the electronic and structural 
effects of the incorporation of an imidazole donor into NiII square planar complexes 
containing thiolate ligation as inspired by the nickel binding sites found in NikR, a 
cytoplasmic nickel sensor protein, and NiSOD, the nickel-dependent superoxide 
dismutase.  The strikingly similar conformation of the imidazole ligand in the continuous 
tetradentate (N2N’S) and discontinuous (N2S---N’) coordination complexes encouraged 
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further investigations into the orientational preferences of various types of planar ligands 
(imidazoles, pyridine and an N-heterocyclic carbene), which is discussed in Chapter IV.   
 A final topic focuses on the coordination chemistry of vanadyl in N2S2 ligand 
sets.  Our group has utilized dianionic and tetraanionic N2S2 binding motifs to examine 
the structural and reactivity differences resulting from the incorporation of different 
metals in such sites.  Chapter V describes a synthesis and structural study of vanadyl 
held within a series of N2S2 donor environments.  The vanadyl analogues were explored 
for their reactivity with alkylating agents and W(CO)x.     
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CHAPTER II 
GENERAL EXPERIMENTAL DETAILS 
 
General Procedures    
 All solvents used were purified and degassed via a Bruker solvent system. 
Anaerobic techniques, an argon-filled glovebox and standard Schlenk techniques were 
employed for air sensitive reagents and complexes.  Reagents were purchased from 
commercial sources and used as received unless noted.   
 
General Physical Measurements 
 Electronic absorption spectra were recorded on a Hewlett-Packard 8453 diode 
array spectrometer and a Cary1E spectrophotometer using quartz cells (1.00 cm path 
length).  Mass spectrometry (ESI-MS) was performed by the Laboratory for Biological 
Mass Spectrometry at Texas A&M University.    Elemental analyses were performed by 
Atlantic Microlab, Inc., Norcross, Georgia or by Canadian Microanalytical Services, 
Ltd., Delta, British Columbia, Canada.  Infrared spectra were recorded on a Bruker 
Tensor 37 Fourier Transform infrared (FTIR) spectrometer.  Solution IR spectra were 
obtained using a CaF2 cell with a 0.1 mm path length and solid sample analysis was 
obtained using an attenuated total reflectance attachment equipped with a ZnSe crystal. 
 1H-NMR spectral measurements were carried out with a Mercury-300 FT-NMR 
spectrometer.  Variable temperature 1H-NMR spectra were acquired on an Inova500 
spectrometer operating at 500 MHz.  CD3OD or D2O were used as solvent and all 
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resonances were referenced to MeOH (CH3: 3.31 ppm) or D2O (H2O: 4.78), 
respectively, at all temperatures.  
 EPR spectra were collected on a Bruker ESP 300 spectrometer equipped with an 
Oxford ER910 cryostat operating at 10 K.  Samples were 1-2 mM in analyte and frozen 
DMF or MeCN solution.  The WinEPR Simfonia program was used to simulate the g 
and A parameters.55  
 
Electrochemistry 
 Cyclic voltammograms and differential pulse voltammograms were recorded on 
a BAS100W potentiostat under an Ar atmosphere using a three electrode cell, which 
consisted of a glassy carbon disk (0.071 cm2) working electrode, a coiled platinum wire 
counter electrode and Ag0/AgNO3 reference electrode.  Samples were measured in DMF 
with Bu4NBF4 (0.1 M) as the supporting electrolyte and at potential scan rates of 200 
mV/s.  Ferrocene was added as an internal standard and all potentials are reported 
relative to the Ag0/AgNO3 electrode using Cp2Fe/Cp2Fe+ as reference (E1/2 = 0.00 V vs. 
Ag0/AgNO3 in DMF).  The reversibility of the observed redox couples is based on the 
internal reference (Cp2Fe/Cp2Fe+).  The peak-to-peak separations (Epa – Epc) for the 
complexes studied herein are larger than the 59 mV expected for a reversible one-
electron process, but comparable with Epa – Epc for the Cp2Fe/Cp2Fe+ couple under the 
same conditions.  The ratios of the anodic and cathodic peak currents were close to unity 
for the assigned reversible systems. Bulk electrolysis was carried out using a BAS 100A 
potentiostat and BAS bulk electrolysis cell containing 30 mL of DMF which was 1.0 
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mM in 3 and 0.1 M in Bu4NBF4 under an argon atmosphere. The working electrode of 
the BAS bulk electrolysis cell was reticulated vitreous carbon. Conductance 
measurements of mmolar concentrations of analyte used an Orion 160 conductivity 
meter.   
  
X-Ray Diffraction and Analyses 
 All X-ray diffraction studies were carried out in the X-ray Diffraction Laboratory 
in the Department of Chemistry at Texas A&M University.  Structures were determined 
with the assistance of Dr. Joe H. Reibenspies.  Low-temperature (110 K) X-ray data 
were obtained on a Bruker SMART 1000 CCD based diffractometer (Mo sealed X-ray 
tube, Kα = 0.71073 Å) or on a Bruker-D8 Adv GADDS general-purpose three-circle X-
ray diffractometer  (Cu sealed X-ray tube, Kα = 1.541 84 Å).  Space groups were 
determined on the basis of systematic absences and intensity statistics.  Structures were 
solved by direct methods and refined by full-matrix least squares on F2.  H atoms were 
placed at idealized positions and refined with fixed isotropic displacement parameters 
and anisotropic displacement parameters were employed for all non-hydrogen atoms.  
The following programs were used:  data collection, SMART WNT/2000 Version 
5.63256 or FRAMBO Version 4.1.05 (GADDS);57 data reduction, SAINTPLUS Version 
6.63;58 absorption correction, SADABS;59 cell refinement SHELXTL;60 structure 
solutions, SHELXS-97 (Sheldrick);61 and structure refinement, SHELXL-97 
(Sheldrick).62 The final data presentation and structure plots were generated in X-Seed 
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Version 1.5.63  Experimental conditions and crystallographic data are listed in the 
Appendix.   
  
Computational Details 
 All computations were carried out in the Laboratory of Molecular Simulation in 
the Department of Chemistry at Texas A&M University, and performed by group 
member Michael Singleton under the direction of Dr. Lisa Perez and Prof. Michael B. 
Hall.  Initial geometries were derived from X-ray structures or deductions based on 
conformations resulting from fluxional processes in the molecules. In both cases, the 
conformational space near each of the starting geometries was sampled through 
simulated annealing calculations in the gas phase using the Cerius2 software package.64  
The simulated annealing calculations were carried out using the Open Force Field (OFF) 
module with the Universal Force Field (UFF) for 15 annealing cycles, over a 
temperature range of 300-5000 K, with ΔT = 50 K. The compounds were minimized 
after each annealing cycle resulting in 15 conformations. The initial geometry and low 
energy conformations were then optimized using Density Functional Theory, with the 
Becke three-parameter exchange functional(B3)65 and the Lee-Yang-Parr correlation 
functional(LYP) (B3LYP).66 
All theoretical calculations, including optimization, frequency and NMR, were 
performed with the Gaussian 03 suite programs.67 The Stuttgart-Dresden68 (SDD) 
effective core potential and valence basis set were used for nickel. For sulfur, the 
effective core potential and basis set of Hay and Wadt69 were used with inclusion of a 
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modified polarization function developed by Hŏllworth et al.70  For nitrogen, the 
correlation-consistent polarized valence double-ζ basis set of Dunning and coworkers71 
(cc-pVDZ) was used.  All carbon and hydrogen atoms were represented using the split 
valence double- ζ basis set of Pople and coworkers with polarization functions on heavy 
and light atoms72-74 (6-31g(d’,p’)). 
Transition state geometries were calculated using the synchronous transit-guided 
quasi-Newton (QST2) method75-76 with the final optimized geometries for both 
rotational isomers for each complex used as the initial and final geometries. Relaxed 
potential energy scans looking at rotation about the Ni – Ldonor atom were accomplished by 
freezing the S–Ni–Nimid/pyr–C2 or S–Ni–CNHC–NNHC torsion angles at 5º intervals and 
then allowing the rest of the molecule to optimize.  
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CHAPTER III 
IMIDAZOLE-CONTAINING (N3S)-NiII COMPLEXES 
RELATING TO NICKEL-CONTAINING BIOMOLECULES* 
 
Introduction 
 The reactivity of tetradentate N2S2 ligands containing nucleophilic S-sites in 
transition metal thiolate complexes has been extensively explored.  In our laboratory, 
metalation, S-oxygenations, and alkylations have been used to establish reactivity of the 
neutral (bme-daco)Ni(II) complex, bme-daco = bismercaptoethanediazacyclooctane, the 
neutral (bme-dach)Ni(II) complex, bme-dach = bismercaptoethanediazacycloheptane, as 
well as the anionic [Ni(II)(ema)]2- complex, ema = N,N’-ethylenebis-2-
mercaptoacetamide.77-81  Coupled with S-thiolates, such amine, amide, or mixed 
amine/amide N-donor ligand environments have been proposed by us and others to serve 
as biomimetics of metalloenzyme active sites.82-92 
 The preparation of histidine/cysteine mixed donor binding sites was first 
demonstrated in small peptidic complexes by Suguri, et al., as models of blue copper 
proteins.93-94  Nickel complexes of -Xaa-Xaa-His- tripeptide motifs have been studied in 
detail for their ability to influence DNA damage and cross-linking through oxidative 
processes.95-96  To explore the potential oxidative chemistry of cysteine thiolates, 
 ____________ 
*Reproduced with permission from 132.  Jenkins, R. M.; Singleton, M. L.; Almaraz, E.; 
Reibenspies, J. H.; Darensbourg, M. Y.  Inorg. Chem.  2009, 48, 7280-7293.  Copyright 
2009 American Chemical Society. 
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Burrows and coworkers synthesized the cysteine variants, -Xaa-Cys-His- and -Cys-Xaa-
His-, as possible metal binding sequences.97-98  It was found that aerobic oxidation of 
such complexes with cysteine in the second position, -Xaa-Cys-His-, led to the rapid 
formation of disulfide dimers.  In this case, other oxidized products such as 
metallosulfoxides or metallosulfones were not observed.  The dimeric disulfide-bridged 
complex was found to have no further reactivity with oxygen even though NiII peptides 
with carboxylate termini are known to spontaneously decarboxylate in air.97  In contrast, 
the NiII derivative of N-terminal -Cys-Xaa-His- resulted in the formation of a cysteine 
sulfinic acid under aerobic conditions.98  Whether the plethora of possibilities of 
oxidative products complicate or play fundamental roles in the chemistry underlying 
biological action is not well understood. 
As described in the Introduction, the molecular structures of NikR and NiSOD 
revealed nickel(II) sites which contain both N-histidine and S-cysteine ligands.23-24  
Their nickel-binding sites are reproduced in Figure III-1 as a reminder of the N/S donor 
sets needed for biomimetic studies. While biomimetic studies of the NiSOD site are 
established and on-going, the NikR binding site has received very little attention.  This is 
surprising in that histidine N-binding sites play a major role in Ni-capture both in vivo 
and in technological (His-tag) applications.1-2,99   
Considerable work has been targeted toward understanding how the NiSOD 
enzyme avoids S-oxygenation and/or S-oxidation in the presence of the products of 
SOD, O2 and H2O2.  Computational investigations have concluded that the presence of 
one or two amide donors within the N2S2 core promotes metal-based chemistry.100-101   
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There has been significant progress in the preparation of synthetic mimics of the 
NiSOD active site.  In particular, a mixed amine/amide donor set in the N2S2 core has 
resulted in a NiII complex with a ligand environment similar to the reduced state of the 
native enzyme, and this NiSOD mimic demonstrated enhanced stability toward 
oxygenation.102-103  As cis dithiolate sulfurs in NiII complexes have been shown to form 
stable S-oxygenates in both neutral and dianionic N2S2Ni complexes, we have suggested 
that kinetic control accounts for the lack of S-oxygenates in the enzyme active site of 
NiSOD.81 
Jensen and coworkers have utilized “scorpionate” ligands to mimic the nitrogen 
donors and dithiocarbamates and organoxanthate to mimic the dithiolate ligands of the 
NiSOD binding motif to obtain a five-coordinate N3S2Ni(II) complex.104  Although 
synthetic N2S2Ni complexes as NiSOD active site mimics have similar spectroscopic 
features as the native enzyme and quasi-reversible redox couples in the range of SOD 
dismutation, Shearer and Zhao’s model complexes did not produce catalytic activity for 
Figure III-1.  The metal binding site of NikR and the active site of NiSOD.  
Adapted from References 13-14 and 23-24. 
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superoxide dismutation.102-103  Neither did Jensen et al. report SOD activity.104  
Nevertheless, nickel peptide-based models mimicking the amino acid nickel-hook 
sequence found in the native NiSOD enzyme have been more successful, demonstrating 
compatible electrochemistry as well as SOD activity.105  Studies by Shearer and 
coworkers also suggest that the His imidazole remains ligated throughout SOD catalysis, 
and this is supported by computational studies of Siegbahn, et al.106-107  
Very little is known about how the electronic structure of NiII complexes 
containing both imidazole and thiolate ligation responds to oxidation and how this might 
affect SOD catalysis and response to the H2O2/O2 products.  To address this, we have 
prepared two synthetic models containing a continuous and discontinuous N2N’S donor 
set.  For this study, a dimeric dithiolate bridged NiII dication and the readily accessed 
(bme-dach)Ni(II) were used as the precursors to mixed imidazole/thiolate complexes.  
The work herein reports the synthesis, characterization and molecular structures of both 
continuous tetradentate (N2N’S) and discontinuous (N2S-N’) synthetic models 
incorporating simple imidazoles as His mimics.  Variable temperature 1H NMR studies 
in correlation with DFT calculations have been carried out to further investigate the 
orientation of the imidazole ligand.  The physical properties of the derivatives and 
precursors and SOD activity are described.  
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Experimental Details 
 General Procedures.  Isobutylene sulfide,108 (bme-dach)Ni79 and 4-
(chloromethyl)-5-methyl-1H-imidazole hydrochloride109 were prepared according to 
published procedures.   
 Synthesis of 1-(2-Mercaptoethyl)-methyl-1,4-diazacycloheptane, me-mdach.  
Similar to the preparation of the N2S2 ligand Hmmp-dach,110 under N2, N-
methylhomopiperazine (5 mL, 0.0402 mmol) was dissolved in 50 mL of dry MeCN.  
With stirring, the solution was heated to 50 °C under N2 and an excess of ethylene 
sulfide (8 mL, 0.134 mmol) was added slowly forming a white solid and a light yellow 
solution.  Heating was continued for 20 h after which the solution was anaerobically 
filtered through Celite giving a light yellow solution.  The solvent was removed in vacuo 
resulting in a yellow oil, 3.33 g, 48% yield.  C8H18N2S (MW = 174 g/mol) +ESI-MS: m/z 
= 175 [M+H]+.  1H NMR (CDCl3): δ (ppm) = 1.83 (q, 2.0 H), 2.38 (s, 2.9 H), 2.64 (m, 
4.2 H), 2.77 (m, 5.2 H), 2.86 (m, 2.6 H). 
 1-(2-Mercapto-2-methylpropyl)-methyl-1,4-diazacycloheptane, mmp-mdach, 
was prepared in a similar manner to the above using isobutylene sulfide.  A light yellow 
oil was isolated in 31 % yield.  C10H22N2S (MW = 202 g/mol)  +ESI-MS: m/z =  203 
[M+H]+. 
 Synthesis of {[1-(2-Mercaptoethyl)-methyl-1,4-diazacycloheptane]nickel(II)} 
Tetrafluoroborate, [(me-mdach)Ni]2(BF4)2, Complex 1.  Under N2, me-mdach (0.56 
g, 3.22 mmol) was dissolved in 20 mL of dry MeOH.  A solution of NaOMe (0.17 g, 
3.17 mmol) in 10 mL dry MeOH was added via cannula and the mixture was stirred at 
 26
room temperature (RT) for 1 h.  A solution of Ni(BF4)2•6 H2O (0.75 g, 3.23 mmol) in 25 
mL of MeOH was added dropwise via cannula producing a red solution.  After stirring at 
RT for 4 hours the solvent volume was reduced to ca. 5 mL.  Addition of 25 mL MeCN 
resulted in the precipitation of NaBF4 salts, which were separated from the product by 
filtration in air.  The solvent of the filtrate was removed in vacuo resulting in a tacky 
maroon residue.  The residue was dissolved in a minimum of MeOH and a maroon solid 
was obtained on addition of diethyl ether.  Alumina column chromatography was used to 
purify the crude product using MeCN as the eluent until a light yellow band was 
removed, followed by an elution mixture of MeOH/MeCN (1:25), which yielded a 
maroon band of pure [(me-mdach)Ni2](BF4)2 (0.38 g, 37%).  X-ray quality crystals were 
obtained by Et2O diffusion into a MeCN solution at 5 °C.  Elemental anal. for 
Ni2C16H34N4S2B2F8 (MW = 638 g/mol) Calcd (found): C, 30.14 (30.40); N, 8.78 (8.65); 
H, 5.37 (5.25).  Absorption spectrum (MeOH): λmax (ε, M-1 cm-1) 524 (817), 452 (775), 
354 (2503), 305 (13075), 252 (13675), 229 (21330) nm.  +ESI-MS (MeCN): m/z = 549 
[(me-mdach)2Ni2)]BF4+; 231 [(me-mdach)2Ni2]2+.  Molar conductance at 23 °C: 299 S 
cm2 mol-1 (MeCN); 310 S cm2 mol-1 (H2O). 
 Chloro-[1-(2-Mercaptoethyl)-methyl-1,4-diazacycloheptane]nickel(II), [(me-
mdach)-NiCl]2, Complex 2. Chloro-[1-(2-Mercaptoethyl)-methyl-1,4-
diazacycloheptane]nickel(II), [(me-mdach)-NiCl]2, complex 2, was prepared and 
purified in a similar manner using NiCl2•6H2O as the metal source.  The complex was 
purified by alumina column chromatography yielding pure [(me-mdach)NiCl]2 as a 
reddish brown solid (31% yield).  X-ray quality crystals were obtained by Et2O diffusion 
 27
into an MeCN solution at 5 °C.  Elemental anal. for Ni2C16H34N4S2Cl2 (MW = 535 
g/mol) Calcd (found): C, 36.0 (37.0); N, 10.5 (10.2); H, 6.41 (6.76).  Absorption 
spectrum (MeOH): λmax (ε, M-1 cm-1) 527 (967), 490 (sh), 350 (3307), 307 (7816), 247 
(17126), 211 (18002) nm.  +ESI-MS: m/z = 497 [(me-mdach)2Ni2Cl]+; 231 [(me-
mdach)2Ni2]2+.  Molar conductance at 23 °C: 124 S cm2 mol-1 (MeCN); 303 S cm2 mol-1 
(H2O). 
 Chloro-[1-(2-Mercapto-2-methylpropyl)-methyl-1,4-diazacycloheptane]-
nickel(II), [(mmp-mdach)NiCl]2, Complex 2-Me2. Chloro-[1-(2-Mercapto-2-
methylpropyl)-methyl-1,4-diazacycloheptane]nickel(II), [(mmp-mdach)NiCl]2, complex 
2-Me2, was obtained via the above method by using the mmp-mdach ligand.  Absorption 
spectrum (MeOH): λmax (ε, M-1 cm-1) 532 (904), 426 (988), 326 (6120), 283 (11940), 
244 (21300), 205 (24580) nm.  +ESI-MS mass spectral analysis for Ni2C20H42N4S2Cl2 
(MW = 591 g/mol): m/z = 553 [(mmp-mdach)2Ni2Cl]+; 259 [(mmp-mdach)Ni2]2+. Molar 
conductance at 23 °C: 104 S cm2 mol-1 (MeCN); 299 S cm2 mol-1 (H2O).  
 Synthesis of [1-(2-Mercapto-2-methylpropyl)-methyl-1,4-
diazacycloheptane]-nickel(II) Imidazole Chloride, [(mmp-mdach)Ni(Im)]Cl, 
Complex 3.  After degassing and under N2, complex 2, [(mmp-mdach)NiCl]2, (0.102 g, 
0.173 mmol) and imidazole (0.035 g, 0.514 mmol) were dissolved in 30 mL of dry 
MeOH, which immediately produced an orange solution.  After stirring overnight, the 
solution volume was reduced to a minimum under vacuum, and Et2O was added to 
precipitate the product.  The ether was decanted and the product was washed 2 x 25 mL 
Et2O to remove excess imidazole.  Pure product was isolated as an orange solid (0.092 g, 
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71% yield). X-ray quality crystals were obtained by Et2O diffusion into a MeOH 
solution at -30 °C.  NiC13H25N4SCl Elemental anal. for NiC13H25N4SCl•H2O (MW = 382 
g/mol) Calcd (found): C, 40.92 (40.88); N, 14.68 (14.45); H, 7.13 (7.07).  Absorption 
spectrum (MeOH): λmax (ε, M-1 cm-1) 467 (501), 340 (sh), 288 (10767), 211 (21461) nm.  
+ESI-MS (MeOH): m/z = 327 [(mmp-mdach)Ni(Im)]+.  Molar conductance at 23 °C: 89 
S cm2 mol-1 (MeOH); 156 S cm2 mol-1 (H2O). 
 Synthesis of [1-(5-methyl-1H-imidazol-4-yl)methylthio)ethyl-4-
mercaptoethyl-1,4-diazacycloheptane]nickel(II) Chloride, [Ni-1’(CH2-mIm)]Cl, 
Complex 4.  A 100 mL Schlenk flask was charged with (bme-dach)Ni (0.100 g, 0.361 
mmol).  The solid was degassed and suspended in 25 mL of MeCN.  A suspension of 4-
(chloromethyl)-5-methyl-1H-imidazole hydrochloride (0.060 g, 0.361 mmol) in 25 mL 
of MeCN was transferred via cannula.  As the reaction proceeded, the solids were drawn 
into solution followed by formation of a light pink precipitate.  The mixture was stirred 
overnight.  Filtration yielded a pink solid which was washed 3 x 75 mL MeCN, 
dissolved in a minimum of MeOH, and recrystallized with Et2O.  The solid was washed 
2 x 25 mL Et2O (45 mg, 31 %).  X-ray quality crystals were obtained by Et2O diffusion 
into a MeOH solution.  Elemental anal. for NiC14H25N4S2Cl·H2O (MW = 426 g/mol) 
Calcd (found): C, 39.50 (40.07); N, 13.16 (13.23); H, 6.39 (6.44).  Absorption spectrum 
(MeOH): λmax (ε, M-1 cm-1) 469 (235), 288 (6052), 211 (16983) nm.  +ESI-MS: m/z = 
371 [Ni-1’(CH2-mIm]+.  Molar conductance at 23 °C: 103 S cm2 mol-1 (MeOH); 164 S 
cm2 mol-1 (H2O). 
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 Synthesis of 1,4-Bis(3-methylimidazol-4-ylmethyl)-1,4-diazacycloheptane 
nickel(II) Tetrafloroborate, [(bmIme-dach)Ni](BF4)2, Complex 5.  Synthesis, 
purification and characterization of 1,4-bis(3-methylimidazol-4-ylmethyl)-1,4-
diazacycloheptane penta-hydrochloride hydrate (L-5HCl•H2O) was executed following 
the procedure published by Bu, et al.. with 4-(chloromethyl)-5-methyl-1H-imidazole 
hydrochloride used in the place of 4-(chloromethyl)-1H-imidazole hydrochloride.111-112  
A solution of Ni(BF4)2•6 H2O (1.328 g, 3.903 mmol) in 10 mL of MeOH was added 
dropwise to a stirring solution of L-5HCl•H2O (1.100 g, 3.814 mmol) in 15 mL of 
MeOH, resulting in immediate precipitation of yellow solid.  The reaction mixture was 
stirred overnight at 22 °C under an N2 blanket.  The ensuing green solution and yellow 
solid were separated via filtration, and the solid was washed with Et2O and dried in 
vacuo to yield 0.757 g (1.45 mmol, 38 %).  X-ray quality crystals were obtained by slow 
evaporation from a methanol solution.  Elemental anal. for NiC15H24N6B2F8 (MW = 521 
g/mol) Calcd. (found): C, 34.60 (34.07); H, 4.65 (4.70); N, 16.14 (15.62). Absorption 
spectrum (MeOH): λmax (ε, M-1 cm-1): 449 (29), 280 (sh), 233 (2232) nm.  +ESI-MS in 
MeOH: [M]2+ m/z = 173 [(bmIme-dach)Ni]2+.  Molar conductance at 23 °C: 198 S cm2 
mol-1 (MeOH); 223 S cm2 mol-1 (H2O). 
  
Synthesis and Structural Characterization 
 Synthesis and structure of N2S bridged thiolate dimers: [(me-
mdach)Ni]2(BF4)2, 1, and [(me-mdach)NiCl]2, 2.   There are many examples of N2S2Ni 
complexes in µ2S2-bridged dimers which demonstrate the diverse structural 
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arrangements encountered by µ-S-thiolate bridging.84, 87, 90,113-117 Scheme III-1 outlines 
the synthetic protocol for the N2S thiolate bridged dimeric complexes 1 and 2 explored  
Scheme III-1.
 
herein.  Both are isolated as hygroscopic, air stable solids.  Complex 1 is a deep maroon 
solid that is very soluble in MeCN and H2O and moderately soluble in MeOH.  Complex 
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 2 is isolated as a reddish-brown powder and is very soluble in MeOH and H2O and 
moderately soluble in MeCN.  The molecular structures of 1 and 2 are shown in Figure 
III-2 and a selection of metric data is given in Table III-1.  The dimeric form of complex 
1 involves edged-bridged square planes with symmetry imposed disorder relating to the 
S to N linkers.  The NiN2S2 unit is almost perfectly square planar with average standard  
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Figure III-2.  Molecular structure of complexes [(me-mdach)Ni]2(BF4)2,  1, and 
[(me-mdach)-NiCl]2, 2, shown as thermal ellipsoids at 50% probability. First 
coordination spheres shown at right. 
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Table III-1.  Metric data for complexes [(me-
mdach)Ni]2(BF4)2,  1, and [(me-mdach)-NiCl]2, 2. 
 1 2 
Ni(1)-S(1) 2.069(19) Å 2.369(17) Å 
Ni(1)-S(1A) 2.245(16) Å 2.346(18) Å 
Ni(1)-N(1) 1.923(8) Å 2.084(5) Å 
Ni(1)-N(2) 1.914(8) Å 2.144(5) Å 
Ni(1)···Ni(2) 2.837 Å 3.268 Å 
Ni(1)-Cl(1) 2.331(17) Å 
N(1)-Ni(1)-N(2) 83.6(3) º 77.3(2) º 
N(1)-Ni(1)-S(1) 96.4(5) º 86.7(14) º 
N(2)-Ni(1)-Cl(1) 92.9(14) º 
S(1)-Ni(1)-Cl(1) 96.6(6) º 
S(1)-Ni(1)-S(1A) 79.6(6) º 92.3(5) º 
Cl(1)-Ni(1)-S(1A) 114.6(6) º 
N(1)-Ni(1)-S(1A) 175.4(5) º 100.6(15) º 
N(2)-Ni(1)-S(1A) 100.5(4) º 96.8(15) º 
Ni(1)-S(1)-Ni(1A) 82.1(6) º 87.8(5) º 
 
 
deviation from plane of 0.0038 Å.  The “hinge” angle in this butterfly type complex, that 
is, the dihedral angle between the two N2S2 best planes, is 116.7º; the Ni···Ni distance is  
2.837 Å.  A similar dimer with gem dimethyl groups on the carbon α to the bridging 
sulfurs has a greater hinge angle of 135.7º and a Ni···Ni distance of 3.034 Å.110  These 
distances are compatible with other complexes containing (µ2-SR)2 bridged Ni2S2 
rhombs.84, 87, 113-117  The closest BF4- counterion in 1 has an F···Ni distance of 5.031 Å. 
In contrast to the µ-SR bridged square planar NiN2S(µ-S) of 1, the solid state 
structure of 2 finds a penta-coordinate NiII in pseudotrigonal bipyramidal, N2S(µ-S)Cl  
coordination (Figure III-2).  The equatorial plane in each tbp is comprised of one N-
donor atom of the tridentate N2S ligand, a chloro ligand and a sulfur atom from the 
adjacent (N2S)Ni moiety resulting in an Ni2S2 diamond core.  The S-donor atom and the 
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trans N-donor atom of the tridentate N2S ligand make up the axial sites.  The Ni-Saxial 
bond distance of 2 is slightly longer than Ni-Sequatorial.  As expected, the average Ni-N 
and Ni-S distances are longer in the penta-coordinate chloride derivative 2 than in 1, and 
an increase in the Ni···Ni distance, from 2.837 Å in complex 1 to 3.268 Å in complex 2 
is also observed, Table III-1.  The N-Ni-N and S-Ni-S angles in complex 1 are acute at 
83.6º and 79.6º, while the N-Ni-S angle, within the five-membered ring, is 96.4º.  In 
complex 2, the N-Ni-N angle contracts to 77.3º, the S-Ni-S opens to 92.3º, and the N-Ni-
S angle within the five-membered ring contracts to 86.7º. 
The dimeric species, [(mmp-mdach)NiCl]2, 2-Me2, is isolated as a hygroscopic, 
air stable, bright purple powder, which is very soluble in MeOH, H2O and MeCN.  Thus 
far crystals have not been obtained; however, conductivity and cyclic voltammetry 
measurements are similar in 2-Me2 and 2, suggesting similar structures.  The 2-Me2 
complex was cleaved by imidazole in the preparation of complex 3. 
 Synthesis and Structure of [(mmp-mdach)Ni(Im)]Cl, 3  The cleavage of 
dimeric µ-dithiolato NiII by monodentate ligands is a fairly common, but not a 
universally successful approach to mononuclear square planar nickel complexes.52,110,118-
120  As shown in Scheme III-1, addition of excess imidazole to [(mmp-mdach)NiCl]2 in 
MeOH results in an orange solid analyzed as complex 3 in high yield.  Complex 3 is 
hygroscopic, soluble in MeOH, H2O and DMF and crystallizes on layering a MeOH 
solution with Et2O.  The molecular structure of the imidazole-cleaved complex is shown 
in Figure III-3 and significant metric parameters are listed in the figure caption.  To our 
knowledge, 3 provides the first molecular structure of a Ni complex containing both 
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Figure III-3.  Molecular structure of the cation of [(mmp-mdach)Ni(Im)]Cl, 3, 
shown as thermal ellipsoids at 50% probability. The Cl- counter ion and MeOH 
molecule are not shown.  
 
thiolate and imidazole donor ligands.  The nickel coordination environment is largely 
square planar with very slight tetrahedral twist distortion, 7.9°, defined by the 
intersection of N(1)Ni(1)N(2) and N(3)Ni(1)S(1) planes.  The N-Ni-N angle within the 
dach donor is 81.5º while the S-Ni-Nimid angle is 91.4º; the N(2)-Ni(1)-N(3) angle is 
97.1º.  Notably, the plane of the imidazole ligand is perpendicular to the N2N’SNi plane, 
with the amine N(4) in the imidazole ring on the same side of the N2N’S coordination 
plane as is the C3 portion of the dach ring.  As in complexes 1 and 2, the NiN2C3 
metallodiazacyclohexane ring is in the chair conformation.  There is no significant 
difference in the bond distances of the Ni-Namine and the Ni-Nimid.  The Ni-S distance of 
2.149(3) Å is shorter than any Ni-S distance of complexes 1 or 2.  The extended 
structure finds a Cl- and MeOH molecule within the unit cell which appear to create a H-
bonding network as seen by the Cl···O distance of 3.568 Å and Cl···Nimid distance of 
3.119 Å (Figure III-4).  The latter is well within the summation of van der Waals' radii of 
chlorine and nitrogen.  
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Figure III-4.  Packing diagram of complex [(mmp-mdach)Ni(Im)]Cl, 3.
 
 Synthesis and Structure of [Ni-1’(CH2-mIm)]Cl, 4. Stoichiometric addition of 
4-(chloromethyl)-5-methyl-imidazole·HCl to neutral (bme-dach)Ni in MeOH results in 
solubilization of the insoluble precursors as S-alkylation occurs, Scheme III-2.  The 
acidic conditions of the reaction sacrifice a portion of the (bme-dach)Ni starting 
material; however, use of the acid-free imidazole results in poorer yields.  Purified 
complex 4 was isolated as a rose-colored solid in 30% yield.  It is hygroscopic and 
soluble in H2O, MeOH, and DMF; crystals were grown in a solution of MeOH layered  
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Scheme III-2 
(Cl-) 
1+
 
with Et2O.  The solid state structure of 4 (Figure III-5) reveals a (N2N’S)Ni square 
planar binding motif of two amine nitrogens from the dach ring, the imidazole nitrogen 
and the thiolate sulfur with a slightly larger distortion from planarity, a 13.2° Td twist, 
than was found in complex 3.  
 As given in Figure III-6, angles and bond distances in complex 4 are similar to 
those of complex 3.  The thioether-S is oriented over the N2N’S plane, however the Ni-
Sthioether distance of 3.022 Å is beyond bonding.  Although thioethers are weak donors, 
there are several square planar N2S2Ni compounds known in which the sulfur is a 
thioether within a polydentate ligand or macrocycle.121-122  In addition, S-alkylation by 
reagents that provide an additional binding site is known to maintain the tetradentate 
N2S2 bonding and expand the coordination number of N2S2Ni complexes.123-124  The 
switch of the donor atom from the thioether to the N-imidazole in 4 indicates that the 
greater binding ability of the imidazole nitrogen over the thioether sulfur overwhelms 
the favorable chelate effect for the thioether, going from a five-membered ring to a less  
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Figure III-5.  Molecular structure of the cation of [Ni-1’(CH2-mIm)]Cl, 4, shown as 
thermal ellipsoids at 50% probability. The Cl- counter ion is not shown.   
 
 
 
Figure III-6.  Ball and stick drawings of (a) [(mmp-mdach)Ni(Im)]Cl, 3, and (b) 
[Ni-1’(CH2-mIm]Cl, 4.  Counter anions are not shown.  Top: side view; Bottom: 
View ┴ to N2S plane with selected metric parameters. 
2.1
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Scheme III-3 
 
favored eight-membered ring.  Scheme III-3 outlines likely intermediates (in brackets) in 
the reaction pathway; neither of these has thus far been verified.   
As was also seen in complex 3, the orientation of the imidazole plane in 4 is 
perpendicular to the N2N’S plane.  The N(2)···S(1)···C(11) linker or imidazole tether is 
sufficiently long so as not to interfere with the optimal binding of the imidazole donor 
(vide infra).  The closest chloride ions in the crystal lattice are located 3.046 Å away 
from the N of the imidazole ligand (Figure III-7). 
 Synthesis and Structure of [(bmIme-dach)Ni](BF4)2, 5.  Complex 5, prepared 
by coworker Elky Almaraz as described in Scheme III-4, is isolated as a gold solid that 
is soluble in MeCN, MeOH, H2O and DMF.  Figure III-8 displays the thermal ellipsoid 
plot for complex 5 along with alternate views that highlight the slight staggering of the 
imidazole rings while the NiN4 plane (Td twist of 7.9°) is largely coplanar with the 
imidazole ligand planes.  The dihedral angle between the planes of the pendant 
imidazole rings is 11.4º.  An analogue of complex 5, lacking the methyl group on the  
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Scheme III-4 
Figure III-7.  Packing diagram of [Ni-1’(CH2-mIm)]Cl, 4. 
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Figure III-8.  Molecular structure of the dication of [(bmIme-dach)Ni](BF4)2, 5, 
shown as thermal ellipsoids at 50% probability.  The BF4 counter ions are not 
shown.   
 
 
imidazole and isolated as a perchlorate salt, reported by Bu, et al. has similar metric 
parameters; however, a smaller dihedral angle exists between the imidazole ring planes 
(6.1°).111-112  The extended packing structure of complex 5 shows π-π stacking between 
imidazole rings as suggested by interplanar distances of 3.432 Å (Figure III-9).  In 
contrast, the crystal structure reported by Bu et al., shows the formation of 
intermolecular hydrogen bonds between the imidazole N-H and the O atom of the ClO4- 
counterion resulting in a dimeric structure.111-112  
 Despite the differences in the imidazole orientation of the tetradentate 
(Namine)2(Nimid)2Ni, complex 5, and the complexes 3 and 4, the Ni-Nimid bond distances 
are significantly the same.  A final note on the monomeric nickel N2N’S and N2N’2 
complexes is in regards to angles within the square plane.  Figure III-6 shows minor 
differences in the free imidazole complex 3 and the long tethered imidazole complex 4.  
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In complex 5, the N(1)-Ni-N(2) angle is largely the same as in complexes 3 and 4, while 
the angle between donor atoms trans to the diazacycle donors, N(3) and S or N(3) and 
N(4), opens substantially from 91.4º and 91.6º in 3 and 4, respectively, to 104º in 
complex 5.    
Figure III-9.  Packing diagram of [(bmIme-dach)Ni](BF4)2, 5, showing π-π stacking 
between imidazole rings. 
 
 
Conductivity Measurements   
 The results of molar conductivity measurements are listed in Table III-2.  As 
expected, because of the non-coordinating BF4- counterion, complex 2 behaves as a 2:1 
electrolyte in both MeCN and H2O solutions, while the Cl- derivative, complex 1, is a 
1:1 electrolyte in MeCN and acts as a 2:1 electrolyte in H2O.125  Note that the 
conductivity of 2-Me2 follows that of complex 1 with a single Cl- dissociating in the 
polar organic solvent; both Cl- ions dissociate in H2O.  The molar conductance values for 
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the mononuclear square planar complexes, 3 and 4, are consistent with a 1:1 electrolyte 
in both MeOH and H2O solutions and complex 5 is a 2:1 electrolyte in MeOH and H2O. 
 
Table III-2.  Molar conductivities at 25ºC. 
 ΛM at 10-3 M (cm-1mol-1Ω-1) 
Compound H2O MeCN MeOH 
[(me-mdach)2Ni2](BF4)2, 1 310  299   
[(me-mdach)NiCl]2, 2 303  124   
[(mmp-mdach)NiCl]2, 2-Me2 299  104   
[(mmp-mdach)Ni(Im)](Cl), 3 156   89  
[Ni-1’(CH2·mIm)](Cl), 4 164  103  
[(bmIme-dach)Ni](BF4)2, 5 223  198 
 
 
Electronic Absorption Spectra   
 Typical square planar nickel complexes exhibit d-d transitions in the range of 
400-600 nm.  Higher energy and more intense features can be assigned as ligand-to-
metal charge transfer (LMCT) transitions.  Nickel complexes with RS- ligands show 
such intense absorbances within the 250-350 nm range, which are attributed to RS- → 
NiII charge transfer transitions.126  Table III-3 lists the electronic absorption data for 
complexes 1-5 and 2-Me2. The UV-vis absorption spectrum of [(me-mdach)Ni]2(BF4)2, 
1, in which the Ni2+ ions are held in a square planar geometry exhibit two d→d bands 
with λmax at 452 and 524 nm, in addition to high energy LMCT absorptions at 229, 252, 
305, and 354 nm (ε values > 10,000 M-1 cm-1).  In complex [(me-mdach)NiCl]2, 2, four 
intense LMCT absorptions are observed and a broad d→d band is seen at 527 nm with a 
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shoulder at 490 nm. The absorptions for 2-Me2 are similar to complex 2.  The 
absorption spectrum of the imidazole cleaved dimer, (mmp-mdach)Ni(Im)](Cl), 3, 
displays one d-d band with λmax at 467 nm and two intense ligand to metal charge 
transfer bands at 211 and 288 nm.  Similar absorptions are observed for the square 
planar complex 4.  In complex 5, all absorptions are of low intensity.  
 
Table III-3.  Summary of electronic absorption spectra. 
 UV-Vis:  λmax (nm) (ε, M-1 cm-1) 
 CT transitions d→d transitions 
[(me-mdach)2Ni2](BF4)2, 1 b 229 (21330) 252 (13765) 305 (13075) 354 (2503) 452 (775) 524 (817) 
[(me-mdach)NiCl]2, 2  211 (18000) 247 (17126) 307 (7816) 350 (3310) 490 (sh) 527 (967) 
[(mmp-mdach)NiCl]2, 2-Me2  244 (21298) 283 (11940) 426 (6115) 426 (988) 532 (904) 
(mmp-mdach)Ni(Im)](Cl), 3  211 (21460)   288 (10767) 340 (sh) 467 (501) 
[Ni-1’(CH2-mIm)](Cl), 4  211 (16980)  
 288 (6052)  469 (235) 
[(bmIme-dach)Ni](BF4)2, 5   233 (2232) 
 280 (sh)  449 (29) 
a Unless specified otherwise, all results were obtained from MeOH solutions.  b The electronic spectrum of [(me-mdach)2Ni2](BF4)2 
was measured in MeCN. 
 
  
 Electronic absorption spectroscopy was used to investigate whether donor 
switching of the N-imidazole to the S-thioether of Ni-1’(CH2-mIm)](Cl) might occur 
during incremental addition of acetic acid to a methanolic solution of 4, with the 
expectation that protonated imidazole might promote thioether binding.  No changes in 
the absorption spectrum were observed over a pH range of 8.5 to 3.4, indicating that the 
coordination environment was constant.  These results are consistent with density 
functional theory (DFT) computations which found the crystallographically observed 
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imidazole bound structure was the isomer of lower energy with an energy difference 
between the two of  3.34 kcal/mol, Figure III-10.  
 
3.34 kcal/mol
Figure III-10.  DFT optimized isomeric forms of [Ni-1’(CH2-mIm)]Cl, 4.  (top) S-
thioether bond (bottom) N-imidazole bound.  
 
Electrochemical Properties   
 A summary of electrochemical properties of complexes 1-5, 2-Me2 and (bme-
dach)Ni are given in Table III-4.  All seven complexes show an irreversible oxidation 
event, which is ascribed to thiolate oxidation in the case of complexes 3, 4, and (bme-
dach)Ni.   
 The cyclic voltammograms for the N2S µ-thiolate bridged Ni dimers, 1, 2, and 2-
Me2, are shown in Figure III-11.  Two well-defined reduction events are observed in 
each; the first reduction is reversible when the scan direction is reversed before the  
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(b) 
(c) 
(a) 
?
complex 1 
?
complex 2 
?
complex 2-Me2 
Figure III-11.  Cyclic voltammograms of a 2 mM solution of complexes (a) [(me-
mdach)Ni]2(BF4)2, 1; (b) [(me-mdach)NiCl]2, 2; (c) [(mmp-mdach)NiCl]2, 2-Me2, in DMF 
(0.1 M [nBu4N][BF4]) using a Ag/AgNO3 reference electrode, a platinum counter 
electrode and a glassy carbon working electrode standardized to Fc/Fc+. 
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Table III-4.  Electrochemical data in DMF.  
Complex Eox (V) Epa  
Ered (V) 
E1/2             Epc          
[(me-mdach)Ni]2(BF4)2, 1 +0.14   -1.30        -2.02 
[(me-mdach)NiCl]2, 2 +0.06   -1.45        -2.03 
[(mmp-mdach)NiCl]2, 2-Me2 +0.04   -1.58        -1.91 
(mmp-mdach)Ni(Im)](Cl), 3 -0.07 
                  -1.96 
                  -2.13 
                  -2.31 
[Ni-1’(CH2-mIm)](Cl), 4 -0.18   -2.50       -1.82 
[(bmIme-dach)Ni](BF4)2, 5 +0.77   -1.59       -1.21 
(bme-dach)Ni -0.14   -2.50 
Ar deaerated DMF solution (0.1 M nBu4NBF4).  All experiments 
were recorded using a glassy carbon working electrode (A = 0.071 
cm2) referenced to Fc/Fc+ and a Pt counter electrode at a scan rate of 
200 mV/s. 
 
 
 
 
 
 
 
 
 
 
2 
1 
Figure III-12.  Differential pulse voltammetry of a 2 mM solution of [(me-
mdach)Ni]2(BF4)2, 1, and  [(me-mdach)NiCl]2, 2, in DMF (0.1 M [nBu4N][BF4]) using 
a Ag/AgNO3 reference electrode, a platinum counter electrode and a glassy carbon 
working electrode standardized to Fc/Fc+. 
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Figure III-13. Cyclic voltammograms of mononuclear square planar NiII complexes in 
DMF and referenced to Fc/Fc+.  (a) [(bmIme-dach)Ni](BF4)2, 5; (b) (bme-dach)Ni; (c) 
[Ni-1’(CH2-mIm)](Cl), 4; (d) (mmp-mdach)Ni(Im)](Cl), 3. 
 second reduction, and is assigned to a NiIINiII/NiIINiI couple. The second reduction, 
presumably accessing an unstable NiINiI redox level in the intact dimers, engenders 
degradation as seen by its irreversibility and also in the differential pulse voltammetry of 
the first reduction process (Figure III-12).  All three dimers display similar 
electrochemistry in both the anodic and cathodic regimes with differences in potentials 
relating to the extent of counterion interaction or the presence of gem-dimethyl groups in 
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2-Me2.  Figure III-13 displays the cyclic voltammograms of mononuclear complexes 3-5 
and (bme-dach)Ni.  Figure III-13 (a) and (b) show fully reversible NiII/NiI reduction 
events at -1.59 and -2.50 V for complex 5 and (bme-dach)Ni, respectively.  The greater 
accessibility of the former is a result of the dicationic charge, as well as the differences 
in donor ability of the imidazole versus the thiolate ligands.  For complex 4 a 
reproducible broad feature (deconvoluting into at least 3 maxima by square wave 
voltammetry, Figure III-14) is centered at -1.82 V, and a fully reversible reduction is 
seen at -2.50 V, identical to the NiII/NiI couple of the (bme-dach)Ni dithiolate complex, 
Figure III-13 (b).  Multiple scans did not affect the form of the CV, however bulk 
electrolysis of 4 was informative.  A potential of -2.26 V was applied to a solution of 
pure, crystalline complex 4 dissolved in DMF and stopped when the total charge (Q) 
approached a calculated value of 3 electrons per molecule. The cyclic voltammogram 
obtained on this solution showed almost total loss of the broad  
 
Figure III-14.  Square wave pulse voltammetry of a 2 mM solution of [(mmp-
mdach)Ni(Im)]Cl, 3, in DMF (0.1 M [nBu4N][BF4]) using a Ag/AgNO3 reference 
electrode, a platinum counter electrode and a glassy carbon working electrode 
standardized to Fc/Fc+.  
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?
Figure III-15.  Cyclic voltammograms before (black) and after (red) bulk 
electrolysis (-2.26 V) of a 2 mM solution of [Ni-1’(CH2-mIm)]Cl, 4, in DMF (0.1 M 
[nBu4N][BF4]) using a Ag/AgNO3 reference electrode, a platinum counter electrode 
and a glassy carbon working electrode standardized to Fc/Fc+. 
 
 
feature at -1.82 V while the reversible wave at -2.50 V and the oxidation wave at -0.18 V 
remained unchanged, see Figure III-15.  The lack of current increase following bulk 
electrolysis in the -2.50 V event was of concern.  As the addition of excess (bme-
dach)Ni did not change the intensity or potential of the CV waves, it may be assumed 
that the solubility limit of (bme-dach)Ni in DMF was reached.  This was confirmed by 
control experiments with pure (bme-dach)Ni. The low intensity, broad feature centered 
at -1.82 V in complex 4 and the first two reduction waves in complex 3 (DPV shown in 
Figure III-16) are tentatively assigned to complexes of different imidazole coordination 
in number or isomeric form.  Consistent with this assignment, on addition of free 
imidazole to a solution containing complex 3 the multiple events become one broad 
intense feature centered at ca. -2.05  V (Figure III-17).   
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Figure III-16.  Square wave voltammetry of a 2 mM solution of [Ni-1’(CH2-
mIm)]Cl, 4, in DMF (0.1 M [nBu4N][BF4]) using a Ag/AgNO3 reference 
electrode, a platinum counter electrode and a glassy carbon working electrode 
standardized to Fc/Fc+.  
 
 
?
Figure III-17.  Cyclic voltammograms before (black) and after (red) bulk 
electrolysis (-2.26 V) of a 2 mM solution of [Ni-1’(CH2-mIm)]Cl, 4, in DMF (0.1 M 
[nBu4N][BF4]) using a Ag/AgNO3 reference electrode, a platinum counter electrode 
and a glassy carbon working electrode standardized to Fc/Fc+. 
 
 
 51
Computational Studies   
 DFT computational studies were carried out by group member Michael Singleton 
with a goal of determining the activation barrier to imidazole rotation about the Ni-N 
bond.  Using the X-ray crystal structures as a starting point, DFT optimized structures 
accurately reproduced the experimental coordination geometries, see Figure III-18 and 
Table III-5.  Table III-6 lists the energies and compositions of the frontier molecular 
orbitals of complexes 3 and 4; the corresponding MO contour plots are shown in Figure 
III-19. 
 
ba 
Figure III-18.  Overlay of experimental structure from X-ray diffraction with DFT 
optimized structures of (a) [(mmp-mdach)Ni(Im)]Cl, 3, and (b) [Ni-1’(CH2-
Im)]Cl, 4. 
The highest-occupied molecular orbitals (HOMO) of complexes 3 and 4 both 
display Ni dπ – Spπ antibonding orbital character, with electron density from the Ni dyz 
(12.3%) and Sthiolate pz (58.8%) orbitals of complex 3; in complex 4, the distribution is Ni 
dyz (17.1%) and Sthiolate pz (57.1%).  The S-thiolate contribution to the HOMO is slightly 
more in the untethered imidazole derivative, 3, as compared to the tethered  
 52
Table III-5. Selected experimental and optimized 
parameters for [(mmp-mdach)Ni(Im)]Cl, 3, and [Ni-
1’(CH2-Im)]Cl, 4. 
 Calculated Experimental 
Complex 3   
Ni-NImid 1.922 Å 1.888 Å 
Ni-Namine 1.998 Å 1.923 Å 
Ni-Sthiolate 2.179 Å 2.149 Å 
Complex 4   
Ni-NImid 1.930 Å 1.908 Å 
Ni-Namine 2.005 Å 1.950 Å 
Ni-Sthiolate 2.192 Å 2.168 Å 
Ni-Sthioether 3.145 Å 3.022 Å 
 
 
Table III-6. Energies and composition (%) of frontier molecular orbitals of [(mmp-mdach)Ni(Im)]Cl, 
3,  and [Ni-1’(CH2-Im)]Cl, 4, as obtained from DFT calculations. 
MO E(eV) Ni Sthiolate Sthioether Nimid N-Himid Namine Orbital composition 
Complex 3         
LUMO -4.56 51.7% 13.1%  5.73% 1.15% 14.8% Ni(x2-y2) 
HOMO -8.19 17.8% 69.0%  0.309% 0.298% 0.838% S(pz) 
HOMO-1 -9.35 76.6% 14.6%  0.286% 0.187% 1.88% Ni(z2) 
Complex 4         
LUMO -4.43 52.7% 14.0% 0.238% 5.34% 0.159% 15.3% Ni(x2-y2) 
HOMO -8.02 22.1% 62.3% 4.38% 0.144% 0.020% 0.568% S(pz) 
HOMO-1 -8.83 60.2% 4.67% 23.5% 0.452% 1.71% 0.319% Ni(z2), Sthioether(px,y,z) 
imidazole complex, 4, while the Ni orbital contribution is slightly greater in the tethered 
imidazole compound. Similarly there are small differences between the orbital makeup 
of the lowest unoccupied molecular orbitals (LUMO’s) in complexes 3 and 4, which are 
in the σ-framework of the molecules. The HOMO-LUMO gaps in complexes 3 and 4 are 
nearly identical at 3.63 eV and 3.59 eV, respectively.  
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(b) (a) 
Figure III-19.  Frontier molecular orbitals of (a) [(mmp-mdach)Ni(Im)]Cl, 3, and (b) [Ni-
1’(CH2-Im)]Cl, 4.  In each column, the orbitals descend in the order LUMO, HOMO, and 
HOMO-1. 
 
 The most significant differences in molecular orbitals are observed in the 
HOMO-1. The HOMO-1 of complex 3 is comprised largely of the overlap of the Ni 
dz2(54.0%), Ni s (15.5%) and Sthiolate py (12.4%) orbitals whereas the HOMO-1 of pπ 
complex 4 shows a large contribution from the Sthioether of 23.4% in addition to the Ni dπ–
overlap.  
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 As discussed above, the Sthiolate-Ni interaction dominates the frontier molecular 
orbitals in complexes 3 and 4.  The Nimidazole-Ni bonding interaction is seen in lower 
lying orbitals which show large contributions of Ni and the N-imidazole character for 
both the ground and the DFT derived transition state for rotation of the imidazole about 
the Ni-N bond in complex 3, vide infra.   
 
Variable Temperature 1H NMR Studies   
 As shown in Figure III-6, solid state structures find the orientation of the 
imidazole ligand plane in both [(mmp-mdach)Ni(Im)]Cl, 3, and [Ni-1’(CH2-mIm)]Cl, 4, 
to be perpendicular to the NiN2N’S plane and largely eclipsing the N-Ni-N’ vector.  In 
order to further explore the imidazole ligand orientational preference, in collaboration 
with group member Michael Singleton, the solution phase conformation of the imidazole 
ligand in complex 3 was investigated via variable temperature 1H NMR spectroscopy.  
At 23 ºC, the spectrum of 3 in CD3OD shows three sharp singlets attributed to the C-H 
hydrogens on the coordinated imidazole ligand positioned at 8.11, 7.33 and 7.12 ppm, 
Figure III-20.  The assignments given in Figure III-20 are in agreement with DFT 
computations, vide infra (Figure III-21).  Upon lowering the temperature, resonances a 
and b broaden and by -80 ºC each has split into two signals, indicating the presence of 
two isomers.  Integration shows a’ and a’’ to be in a ratio of ~1.  The resonance due to 
the proton labeled c remains sharp throughout the temperature range and the resonances 
derived from b overlap with c and an impurity.  Note that impurities are readily seen at 
room temperature.  The lower field impurity is unaffected by temperature changes.  
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However, the higher field impurity, which has not been identified, undergoes broadening 
as do the signals of interest. 
 
 
 
Ni
N
N
S
N
NH
(Cl-)
1+
a
b c
*
a b c
* *23 ºC  
*0 ºC *
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-40 ºC 
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-80 ºC 
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c 
b’’ b'a’’ a’
Figure III-20.  Variable temperature 400-MHz 1H NMR spectra of [(mmp-
mdach)Ni(Im)]Cl, 3, in MeOH. * = impurity. 
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Room Temperature Low Temperature 
Experimental 
-8.5 -8.3 -8.1 -7.9 -7.7 -7.5 -7.3 -7.1
ppm
-8.5 -8.3 -8.1 -7.9 -7.7 -7.5 -7.3 -7.1
ppm
Calculated 
-8.5 -8.3 -8.1 -7.9 -7.7 -7.5 -7.3 -7.1
PPM
-8.50 -8.30 -8.10 -7.90 -7.70 -7.50 -7.30 -7.10
ppm
Figure III-21.  Experimental 1H NMR resonances and DFT 1H NMR 
predictions for the imidazole protons of [(mmp-mdach)Ni(Im)]Cl, 3, calculated 
at room and low temperature. 
 
 
Thermodynamic (isomer ratios) and kinetic barriers associated with the fluxional 
process were obtained by using conventional equations, eqs 1 and 2. 
ΔGº = - RT ln (Keq),     Keq = [a’]/ [a’’]  (1) 
 ΔG‡ = - RT ln (kTh/ kbTcoal),     kT = (πΔν/ √2) (2) 
The ratio of the two isomers (57: 43) at -80 ºC (193 K) resulted in a ΔGº of 0.1 kcal mol-
1.  From the chemical shift difference of a’ and a’’ (164.7 Hz) and the coalescence 
temperature (213 K), eq 2 gives ΔG‡ equal to 8.9 kcal mol-1. 
 There are four possible isomers of 3 (Figure III-22).  Isomer A depicts the 
molecular structure as determined by X-ray crystallography.  Isomer B leaves the 
imidazole orientation unchanged but the NiN2C3 metallocycloheptane ring is converted  
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from chair to boat conformation.  Isomers C and D are analogous to A and B, 
respectively, but with the imidazole ring inverted.  While the lowest energy gas phase 
DFT-calculated structure is isomer C, solvent correction indicates that in MeOH isomer 
A, the experimentally found structure is of lowest energy (more stable than C by 0.68 
kcal/mol).  The stability of A in polar solvent over C is attributed to the differences in 
the dipole moments of the two complexes; the dipole moment in A is calculated to be 
6.59 and in C it is 6.11.  In both the gas phase and in solvent, the calculated difference in 
D
+ 2.49 kcal/ mol
C
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B
+ 4.18 kcal/ mol
A
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Figure III-22.  Four possible conformational isomers of [(mmp-
mdach)Ni(Im)]Cl, 3, and their DFT calculated relative energies (Gº)  Black: gas 
phase; Red: solvent correction in MeOH. 
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energy between the two complexes is relatively small.  DFT calculations were used to 
examine activation barriers to proton site equilibration due to the ring flip in the 
diazacycle backbone (A vs B or C vs D) or to rotation of the coordinated imidazole (A 
vs C or B vs D). 
 Note that the calculated ΔGº value of isomers A vs. B and C vs. D would 
correspond to an isomer ratio of ~33,000:1 and ~700:1, respectively.  At these ratios, 
only one set of signals in the NMR spectra would be observable at low temperatures.  On 
the basis on these values, the fluxional process that most likely corresponds to the 
signals seen in the NMR spectra is the rotation of the imidazole ring that equilibrates 
isomers A and C. 
 The DFT calculated barriers for the processes that interconvert the four isomers 
are given in Figure III-23.  As shown in Figure III-23(a), starting from the structure of 3 
determined crystallographically, isomer A, the DFT calculated ΔG‡ for the ring flip in 
the diazacycle backbone from the chair to the boat conformation, achieving a transition 
state where the C3 N to N linker is fairly flat, is 7.02 kcal mol-1.  Calculations carried out 
for the ring flip of the isomer with the imidazole rotated 180º as compared to the solid 
state structure, isomer B, resulted in a ΔG‡ of 6.59 kcal mol-1 (Figure III-23(b)).  The 
DFT-calculated ΔG‡ of 8.86 kcal mol-1 for the conversion of isomer A to C, that is, 
rotation of the imidazole as seen in Figure III-23(c), passing through a transition state 
where the imidazole plane is roughly within the NiN2S plane, is strikingly similar to the 
experimental value obtained from the VT NMR study.  Thus, the DFT calculations that 
aid interpretation of experimental results suggest that the separate isomers seen at low 
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Figure III-23.  DFT calculated energies (kcal mol-1): (a) Ring flip calculated with
imidazole orientation same as in solid state structure; (b) Ring flip calculated with 
imidazole orientation 180º rotated as compared to (a); (c) imidazole rotation 
calculated with NiN2C3 ring in chair conformation. 
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temperature are due to cessation of imidazole rotation about the Ni-N bond.  
Furthermore, the calculations suggest there is little difference in energy between the two 
rotational isomers of 3 (<0.2 kcal mol-1), and this is also indicated in the experimental 1H 
NMR data which by the ratio of isomers is ca. 1 at -80º C. 
 
Reactivity Studies with Small Molecules (O2-, O2 and H2O2)   
 Complexes 3-5 have been examined for superoxide reactivity using the nitroblue 
tetrazolium (NBT) assay.  This qualitative test based on the reduction of NBT by O2- is 
detected by the change of colorless NBT to the blue formazan (λmax = 580 nm, ~30 000 
M-1 cm-1; Figure III-24).127   
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Figure III-24.  Nitroblue tetrazolium (NBT) reaction with superoxide to produce 
formazan. 
 
 
 The presence of an active SOD inhibits the color formation by scavenging the 
O2
- radical.  Figure III-25 shows the results of addition of solid KO2 (100 eq. per mole of 
NBT) to a (61 µM) aqueous NBT solution (phosphate buffer, pH 7.4).  Note that the  
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Figure III-25.  Electronic spectra of (a) NBT in aqueous phosphate buffer (pH 7.4).  
(b) Blue - Addition of 100 eq of KO2; Red – 5 min after addition (formation of 
insoluble formazan decreases total intensity).  
 
limited solubility of formazan in aqueous solution causes a decrease in the absorbance 
over time. 
 Under the same conditions employed in the control experiment and in the 
presence of complex 3 (69 µM), a 40% decrease in the intensity of the band centered at 
580 nm was observed, indicating a decrease in formazan production (Figure III-26a).    
This result suggests that 3 possesses superoxide scavenging properties that prevent a  
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portion of the NBT from reacting with O2- and at a rate competitive with NBT.  In 
addition, intense bubble formation, much more than with formazan in the absence of 3, 
was observed within the first 30 seconds following KO2 addition.  It should be noted that 
there is no indication of catalytic O2- decomposition.  The addition of solid KO2 to 
concentrated solutions of  complex 3, resulted in a shift in the d-d band from 464 nm to 
471 nm and a new band appeared at 350 nm (Figure III-26b), suggesting that a new 
nickel species is formed.   
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Figure III-26.  Electronic spectra of [(mmp-mdach)Ni(Im)]Cl, 3, in phosphate buffer 
(pH 7.4) (a): Blue - Addition of 100 eq of KO2 to NBT (61 µM); Red - Addition of 
100 eq of KO2 to NBT (61 µM) /complex 3 (69 µM).  (b): Red – Complex 3 (2.75 
mM); Black – Addition of KO2 to Complex 3 (0.46 mM)/ NBT buffer solution (0.18 
mM). 
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The ability of complexes 4 and 5, and (bme-dach)Ni, as well as NiCl2, to inhibit 
NBT superoxide reactivity was screened by identical experiments.  Under both low and 
high concentrations, none inhibited the production of formazan.   
Complex 3 was screened for reactivity with the products of superoxide 
dismutation, O2 and H2O2.   Molecular oxygen was bubbled through a MeOH solution of 
complex 3. No oxygenation products were observed and only the starting material was 
recovered.  Upon addition of H2O2 (10 mM) to complex 3 dissolved in MeOH, an 
immediate color change from orange to yellow was observed.  The molecular formulas 
and predicted isotope envelopes for both the mono-oxygenated and bis-oxygenated 
derivatives of complex 3 were observed in the ESI-MS spectrum (Figure III-27). These 
results indicate that complex 3 is stable to aerobic oxidation and only strong oxidants are 
capable of oxidizing the Ni-bound  N2N’S ligand.  
 
Summary and Remarks   
  Complexes 3 and 4 presented above are, to our knowledge, the first molecular 
structures of compounds containing both an S-thiolate and N-imidazole donor atom in 
the first coordination sphere of NiII.  The use of the (bme-dach)Ni complex and the 
dimeric dithiolate bridged NiII dication as precursor reagents in the preparation of the 
Ni(N2N’S) complexes resulted in similar solid state structures for complexes containing 
both  tethered and untethered imidazole ligands.  That the diazacycloheptane N2 
backbone" plays a stabilizing role in these complexes is highly reasonable. The 
following salient points are to be noted. 
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Figure III-27.  Positive mode ESI-MS of [(mmp-mdach)Ni(Im)]Cl, 3, in MeOH 
after reaction with H2O2. 
 
 
 Imidazole Ligand Geometrical Orientation in Square Planar NiII 
Complexes. While severe ligand restrictions position the imidazole ligand coplanar with 
the N2N'2NiII plane of complex 5, the solid state structures of complexes 3 and 4 revealed 
a preferred orientation of the imidazole donor ligand perpendicular to the N2N’SNiII 
plane.  The solution phase VT 1H NMR study of complex 3 demonstrated that the 
imidazole ligand freely rotates about the Ni-Nimid bond at 22°C, with static structures 
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appearing between -60 and -80°C.  Both the experimental and the DFT computed 
barriers to rotation are found to be ~9 kcal mol-1. The lowest energy DFT-calculated gas 
phase structure also found the imidazole plane to orient perpendicular to the N2N’S 
plane, but rotated 180° with respect to the crystallographically determined structure.  
Applying solvent corrections, the DFT lowest energy structure was calculated to be the 
same orientation as observed in the solid state. Thus the built-in asymmetry of the 
diazacycloheptane ring provides subtle tuning of ligand orientation preferences. 
As discussed in the Introduction, a number of studies have demonstrated that the 
orientation of imidazole ligands found in metalloenzyme active sites influences 
structure/function relationships.28-36,53-54  Furthermore, ligand rotational properties have 
been shown to contribute to significant factors affecting antitumor properties in platinum 
and ruthenium antitumor compounds.42  The DFT computed transition state structure for 
imidazole rotation about the Ni-Nimid bond in complex 3 positions the imidazole ligand 
roughly coplanar with the NiN2S plane. In fact, elongation of the Nimidazole-Ni bond 
distance by 0.06 Å (from 1.922 in the DFT calculated ground state to 1.982 Å in the 
transition state) is accompanied by distortion (a Td twist defined by the intersection of 
the N2Ni and SNimidNi planes, of 21.2°), Figure III-28.   The preferred orientation may 
be a product of steric and/or electronic effects, which is the focus of discussion in 
Chapter IV.   
 
 66
(a) (b) 
Ni
N
N
S
NH
N
1.982
Ni
N
N
S
N
NH
1.922
Figure III-28.  (a) DFT calculated ground state structure (b) DFT calculated transition
state structure.  
  
 Superoxide Reactivity.  The nickel-imidazole complexes described above are all 
water soluble and thus their potential for superoxide reactivity could be assessed in 
aqueous buffer via the NBT assay.  Only complex 3 competed with the NBT scavenging 
of superoxide; complexes 4, 5, and (bme-dach)Ni did not and neither did simple salts 
such as NiCl2.  As the NBT assay gives little information regarding the nature of 
interference from the coordination complex, we can regard these results as preliminary. 
This data suggests the need for further examination of nickel complexes of various 
charge and redox properties such as we have in a catalog of such square planar Ni 
complexes. 
 Implications to Nickel Containing Biomolecules.  An unsuccessful attempt was 
made to synthesize a NiSOD enzyme active site model complex from alkylation of a 
thiolate within an N2S2NiII framework by chloromethylimidazole to thus incorporate a 
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dangling imidazole (His mimic) with the capability of shifting into an axial binding 
position on oxidation of NiII to NiIII.  The resulting N2N’Sthioether binding motif found for 
complex 4, which matched that of complex 3, was impressive of the good binding ability 
of imidazole nitrogen and its preference for the square plane of NiII.  In the NiSOD 
enzyme active site, the axial His binding is governed by the protein superstructure, the 
position of the His residue next to the N-terminus that provides the amine ligation, the 
coordination of the strong carboxyamido N and S donors of one cysteine unit, and a 
second distal S-cysteine donor.  This square planar coordination environment creates 
two favorable 5-membered rings, whereas the His ligand binding in the square plane in 
place of the N-terminus amine would result in one 5-membered ring and a less-favored 
7-membered ring.  
Interestingly, the (Nimid)3NiScys "plane" of NikR, Figure III-1, finds a range of 
Nimid plane orientations, canted so as to best accommodate the steric requirements.23-24  
As nickel binding or release, with concomitant long range protein structural changes, is 
an important feature of this site, specific orientations of the imidazole ligands are likely 
suspects as triggers of release and binding.  Drennan, Zamble and coworkers have 
demonstrated that other metal ions may bind in this site, however the nickel form is 
reported to be 250x more active.13, 15  Our (N2N’S)Ni complexes are suitable as first 
coordination sphere molecular models of the Ni-binding site of the NikR protein, and are 
expected to be useful for selectivity and relative binding affinity studies of 
physiologically relevant metal ions. 
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CHAPTER IV 
STUDIES OF THE ORIENTATION OF PLANAR MONODENTATE LIGANDS 
IN SQUARE PLANAR NICKEL COMPLEXES 
 
Introduction 
 The orientational binding preferences and fluxional processes of ligands in 
transition metal complexes is an area of fundamental significance relating to catalysis 
and reactivity.128-130  In the case of biologically relevant ligands such as imidazole, the 
study of these processes purports to offer insight into a vast array of biological systems 
containing metal bound histidine residues.  As discussed in Chapter I, much of the effort 
in this area has been directed toward understanding His-iron interactions through the use 
of simple imidazoles as mimics of histidine.   
Adding to the importance of Fe-Nhistidine interactions, is a wide range of 
biological metal-bound histidine complexes that could have orientational consequences, 
specifically the Ni-containing imidazole metal binding sites found in Ni superoxide 
dismutase (NiSOD), and the transcription factor, NikR.13-14,23-24   The orientation of 
histidine donors in nickel-binding sites in such systems has not thus far been emphasized 
in structural studies. 
Our work has employed diazacycles such as  diazacycloheptane (dach) as support 
for  pendant thiolate arms in development of N2S2 and N2S multi-dentate ligands.  The 
dach frame has been particularly amenable to the production of a monothiolate N2S 
ligand, which upon reaction with nickel, readily forms a dimeric, dithiolate-bridged NiII 
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dication as precursor to monomeric cyano, and as described in Chapter III, imidazole 
complexes.110, 131   The µ2(SR)2-bridged NiII dimer/ligand cleavage approach has also 
been used by Gale, Patra and Harrop to produce monomeric N2SS’Ni complexes 
designed as NiSOD analogues,132 and extensive syntheses based on cleavage reactions of 
(S-N-S)2Ni2 complexes were recently reported by Huang, Holm et al.52   
As described in Chapter III, solution phase investigations using 1H NMR 
spectroscopy demonstrated that, due to the unsymmetric dach framework, isomers of the 
(N2SN’)Ni complex A, Figure IV-1, existed at low temperatures in nearly equal ratio.131  
The observed equilibration of up/down orientations of the imidazole (with respect to the 
6-membered nickel diazacyclohexane ring), isomers A and A’, was assigned to the 
rotation of the imidazole ligand about the Ni-Nimidazole bond. The rotational barrier, ~8.9  
 
 
Figure IV-1.  Left to right:  [(mmp-mdach)Ni(Im)]+, A, DFT-calculated ground state 
structure of complex A; A‡, DFT-calculated transition state structure of complex A en 
route to isomer A’; Td twist (angle of intersection of N2Ni and N’SNi planes) of A = 
7.9 °, of A‡  = 21.2°.  Adapted from Reference 132. 
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kcal/mol, was derived from analysis of the VT 1H NMR data.  Density Functional 
Theory (DFT) analysis of the ground state and transition state structures, complexes A 
and A‡, indicated for the latter a 0.06 Å increase in the Ni-Nimid bond distance in 
addition to a significant deviation from square planarity, as shown in Figure 1.131  To 
explore the generality of this result and to provide insight into the factors contributing to 
the ground state imidazole binding orientation and to transition states of dynamic ligand 
rotational processes, a broader series of [(N2S)Ni]2 cleavage products containing planar 
ligands (imidazoles, pyridine and an N-heterocyclic carbene)  has been prepared.  As the 
π-accepting/π-donating abilities of the added ligands are insignificant in these strong σ 
donors, the orientation of the monodentate ligand is dictated largely by minimization of 
steric interactions of L with the steric constraints of N2SNi binding site.  Nevertheless, 
electronic effects are seen via DFT computations that suggest an intramolecular 
donor/acceptor interaction between the imidazole C-H and the thiolate S is operative in 
determining the stability of the ground state and transition state structures.  A structural 
survey of the solid state structures of ten square planar imidazole Ni complexes of 
tridentate ONO, ONN, ONS, and NNS Schiff base type ligands shows the importance of 
this effect in the presence of hard oxygen donors cis to the imidazole. 133-141  
 
Experimental Details 
 General Procedures.  The starting material 1,3-bis(methyl)imidazolium iodide 
was prepared according to literature procedures.142 Complexes 1, 1-H, and A were 
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prepared as described previously.110, 131  Lauren A. Leamer, an REU student, assisted 
with the preparation of complexes 3-8. 
 [(mmp-mdach)Ni]2[BF4]2, Complex 2.  To a solution of 0.050 g (0.085 mmol) 
of [(mmp-mdach)NiCl]2, complex 1,  in MeOH (20 mL)  was added 0.019 g (0.173 
mmol) of NaBF4 in MeOH (15 mL); the solution was stirred overnight.  Solvent was 
removed under vacuum, and MeCN (20 mL) was added, precipitating NaCl, and 
yielding a maroon solution of [(mmp-mdach)Ni]2[BF4]2, complex 2. The solution was 
filtered over celite, solvent was removed in vacuo, and 0.055 g (93% yield) of pure 
complex 2 was isolated as a maroon solid.  Absorption spectrum (MeOH): λmax (ε, M-1 
cm-1) 525 (354), 418 (322), 280 (4138), 244 (7247) nm. +ESI-MS (MeCN): m/z = 259 
[(me-mdach)Ni]22+.   
[(mmp-mdach)Ni(py)][Cl], Complex 3.  A mixture of 0.030 g (0.051 mmol) of 
1 in MeOH (25 mL) with 12.0 µL (0.149 mmol) of pyridine was stirred overnight, 
producing a color change from red wine to yellow-orange.   As the solvent was removed 
in vacuo, the completely dried residue on the sides of the flask turned purple, while the 
solution changed to a deep orange.  An additional 20.0 µL (0.248 mmol) of pyridine was 
added to the concentrated solution, stirred to mix the residue on the sides of flask, 
yielding a dark orange solution.  Absorption spectrum of the reaction mixture (MeOH): 
λmax 453, 350 (sh), 290, 255, 231 nm.  +ESI-MS (MeOH): m/z = 338, [(mmp-
mdach)Ni(py)]+.     
py-[(mmp-mdach)Ni]2[BF4]2, Complex 4.  A mixture of 0.050 g (0.072 mmol) 
of 2 in MeCN (30 mL) with 21.8 µL (0.253 mmol) of pyridine was stirred for 2 days, 
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producing a color change from maroon to deep yellow. The solvent was reduced to a 
minimum followed by Et2O diffusion (in the presence of a ~ 2.5 equiv excess py) to 
yield X-ray quality crystals. Pure reddish-orange crystalline product was isolated (0.031 
g, 54% yield). Elemental anal. for Ni2C25H47N5S2B2F8 (MW = 773 g/mol) Calcd (found): 
C, 38.85 (38.29); N, 9.06 (8.88); H, 6.13 (6.09).  Absorption spectrum (MeOH): λmax (ε, 
M-1 cm-1) 502 (sh), 471 (344), 334 (sh), 291 (6976), 244 (8345) nm. ESI-MS 
(CH2Cl2:MeOH): m/z = 684, py-[(mmp-mdach)Ni)]2BF4+; 338, [(mmp-mdach)Ni(py)]+;  
259, [(me-mdach)Ni]22+. 
 [(mmp-mdach)Ni(mIm)][BF4], Complex 6.  Method A: To a maroon solution 
of 2, (0.073 g, 0.105 mmol) in MeOH (30 mL) was added a colorless solution of 1-
Methylimidazole, mIm, (30 µL, 0.376 mmol, a 3.5 equiv excess) in MeOH (10 mL), 
which produced an orange solution.  After stirring overnight, the solution volume was 
reduced to a minimum under vacuum and Et2O was added to precipitate the product.  
The ether was decanted and the resulting orange product was dried in vacuo.    The solid 
was dissolved in MeCN (15 mL) and additional mIm (20 µL, 0.251 mmol, ~2 equiv 
excess mIm) was added.  The solution was filtered over celite, the filtrate reduced in 
volume, and the filtrate was layered with Et2O.   Absorption spectrum (MeOH): λmax (ε, 
M-1 cm-1) 467 (319), 341 (sh), 290 (6534), 225 (8097) nm.  +ESI-MS (MeOH): m/z = 
341 [(mmp-mdach)Ni(mIm)]+.  Diffusion of Et2O into the reaction mixture that contains 
complex 6 (with 1 equiv of excess py) that gave small yellow-orange needles initially 
and within two days changed into red-orange block crystals (12 mg, 15%) indentified 
not as 6 but rather the dinuclear (mIm-[(mmp-mdach)Ni]2[BF4]2, complex 5.   
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Method B: To a maroon solution of 2, (0.035 g, 0.050 mmol) in MeCN (25 mL) 
was added a colorless solution of mIm (41 µL, 0.514 mmol, a 10-fold molar excess) in 
MeCN (10 mL), which immediately produced an orange solution.  After stirring 
overnight, the solution volume was reduced to a minimum under vacuum and additional 
neat mIm (30 µL, 0.376 mmol) was added.  The solution was filtered and the filtrate was 
layered with Et2O to deposit orange-brown crystalline product (0.018 g, 42% yield) 
identified as the mononuclear product [(mmp-mdach)Ni(mIm)][BF4], complex 6.  
Elemental anal. for NiC14H27N4SBF4 (MW = 429 g/mol) Calcd (found): C, 39.20 
(39.21); N, 13.10 (12.97); H, 6.34 (6.34).  Absorption spectrum (MeOH): λmax (ε, M-1 
cm-1) 467 (319), 341 (sh), 290 (6534), 225 (8097) nm.  +ESI-MS (MeOH): m/z = 341 
[(mmp-mdach)Ni(mIm)]+.  1H NMR (500 MHz, CD3OD)  δ 8.04 (s, 1H), 7.26 (s, 1H), 
7.09 (s, 1H), 3.70 (s, 3H), 1.69 (s, 3H), 1.60 (s, 3H), 1.38 (s, 3H). 
[(mmp-mdach)Ni(ipIm)][BF4], Complex 7. A solution of 2-
Isopropylimidazole, ipIm, (0.029 g, 0.264 mmol) in MeCN (10 mL) was added to a 
stirring maroon solution of 2 (0.061 g, 0.088 mmol) in MeCN (25 mL), resulting in an 
immediate color change to bright orange.   After stirring overnight, the solution volume 
was reduced to a minimum under vacuum and Et2O was added to precipitate the product.  
The ether was decanted, the product was washed Et2O (3 x 25 mL) to remove excess 
ipIm, and dried in vacuo to afford the product as an orange solid (0.421 g, 53% yield).  
X-ray quality crystals were obtained by Et2O diffusion into a MeCN solution. Elemental 
anal. for NiC16H31N4SBF4•H2O (MW = 475 g/mol) Calcd (found): C, 40.46 (40.97); N, 
11.79 (11.79); H, 7.00 (6.68).  Absorption spectrum (MeOH): λmax (ε, M-1 cm-1) 468 
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(189), 335 (sh), 290 (4190), 223 (4768) nm.  +ESI-MS (MeOH): m/z = 369 [(mmp-
mdach)Ni(ipIm)]+.  1H NMR (500 MHz, CD3OD)  δ 7.33 (d, 1H), 7.23 (d, 1H), 7.04 (d, 
1H), 7.01 (d, 1H). 
 [(mmp-mdach)Ni(me2NHC)][I], Complex 8.  1,3-bis(methyl)imidazolium 
iodide (0.044 g, 0.196 mmol) and KOtBu (0.023 g, 0.205 mmol) were mixed and stirred 
in dry THF (15 mL) for 1 h.   The mixture was then added in situ to a slightly soluble 
purple suspension of complex 1 (0.040 g, 0.068 mmol) in THF (25 mL) and stirred for 
18 h. As the reaction proceeded the solution turned orange-red and an orange solid 
precipitated.  The solution was filtered and the solid was washed with hexanes (3 x 25 
mL).  X-ray quality crystals were obtained by vapor diffusion of Et2O into a MeCN 
solution.  The bright orange crystalline material was collected yielding 0.030 g (46%).  
Elemental anal. for NiC15H29N4SI•H2O (MW = 501 g/mol) Calcd (found): C, 35.95 
(35.56); N, 11.18 (11.08); H, 5.82 (6.24).  Absorption spectrum (MeOH): λmax (ε, M-1 
cm-1) 417 (104), 268 (2652), 233 (4148) nm.  +ESI-MS (MeOH): m/z = 355 [(mmp-
mdach)Ni(me2NHC)]+.  1H NMR (500 MHz, CD3OD)  δ 7.19-7.18 (dd, 2H), 4.37 (s, 
3H), 4.38 (s, 3H), 1.92 (s, 3H), 1.62 (s, 3H), 1.39 (s, 3H). 
[(mmp-dach)Ni(Im)][BF4-], Complex 9. To a solution of 1-H (0.030 g, mmol) 
in MeOH (30 mL) was added a solution of imidazole, Im, (0.011 g, mmol) in MeOH (10 
mL).  The color of the solution immediately changed from red to orange.  After stirring 
overnight, the solvent volume was reduced to a minimum and the addition of Et2O led to 
an orange precipitate, which was washed with Et2O (3 x 25 mL).  The solid was 
dissolved in CH2Cl2 and filtered over celite, dried in vacuo, yielding 22 mg (61%).  
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Absorption spectrum (MeOH): λmax (ε, M-1 cm-1) 455 (59), 370 (sh), 282 (1319), 215 
(3777) nm.  +ESI-MS (MeOH): m/z = 313 [(mmp-mdach)Ni(Im)]+.  1H NMR (500 MHz, 
CD3OD)  δ 7.86 (s, 1H), 7.09 (s, 1H), 7.04 (s, 1H), 1.61 (s, 3H), 1.43 (s, 3H).  Slow 
evaporation of a methanol solution of complex 9 resulted in orange block crystals of a 
partially cleaved dimer, Im-[(mmp-dach)Ni]2[BF4]2, complex 10, (16 mg, 48%).   
 
Scope of the Ni2(µ-SR)2 Cleavage Reactions   
 Figure IV-2 displays the overall scope of the Ni2(µ-SR)2 cleavage reactions 
reported herein along with the pKa values of the attacking ligands (as their conjugate 
acids) which vary from 5.23 to 23.143-145  The exogenous ligands are largely planar in the 
coordination environment closest to the nickel, with steric properties imposed by 
substituents that flank the donor atom, described further below.  The steric character of 
the nickel binding site is defined by a thiolate sulfur with two α-gem dimethyl groups 
and an N-donor from the diazacycloheptane frame.  Given in Figure IV-3 are space-
filling models derived from DFT computations, vide infra,  of ground state structures of 
the square planar complexes with the monodentate ligands removed so as to display the 
available binding site in complex A and in an analogue, complex 9, in which the methyl 
substituent on the dach (mdach) is replaced with hydrogen (dach).  While the methyl 
groups on the carbon α to the S-donor appear to have little steric influence on the ligands 
that dock into the available site on square planar nickel, the differences between 
complexes A and 9 are more substantial.   This was experimentally confirmed by  
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Figure IV-2.   A summary of the dimer cleavage reactions of complexes 1 and 2 which 
yield mononuclear products 3 and 6-8 and monothiolate bridged dinickel complexes 4-5.  
aNote:  With BF4- counterion,   the dinickel product forms during crystallization.  Complex 
A was reported earlier.131  Identification of ligands with respective pKa values of the 
conjugate acids: (a) pyridine (py);143 (b) imidazole (Im);143 (c) 1-Methylimidazole 
(mIm);144 (d) 2-Isopropylimidazole (ipIm);144 and (e) dimethyl N-heterocyclic carbene 
(me2NHC).145  See Experimental Section for molar excesses of added ligands and for source 
of I- in 8. 
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Figure IV-3.  Space filling models of complexes [(mmp-mdach)Ni(Im)]+, A (left, 
based on mdach) and [(mmp-dach)Ni(Im)][BF4], 9 (right, the dach derivative) in 
which the monodentate ligand has been removed, displaying the available open site 
that exists between the N- and S-donor sites.  
 
characterization of complexes 9 and 10 as prepared from dimeric complex 1-H, Scheme 
IV-1.  
 Complexes 4 -8, 10 and A in Figure IV-2 and Scheme IV-1 are represented 
according to their structures determined by X-ray crystallography.  Complexes 3 and 9 
are suggested to be analogous to other monomeric complexes consistent with their 
formulation by positive mode electrospray ionization mass spectrometry (+ESI-MS)  
Scheme IV-1 
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Table IV-1.  Summary of electronic absorption spectra.  
Complex UV-Vis:  λmax (nm) (ε, M-1 cm-1) 
[(mmp-mdach)NiCl]2, 1 244 (10161) 283 (5910) 420 (561) 532 (537) 
[(mmp-mdach)2Ni2](BF4)2, 2  244 (7247) 280 (4138) 418 (322) 525 (354) 
[(mmp-mdach)Ni(Py)]Cl, 3a 231 255 290 350 (sh) 453 
py-[(mmp-mdach)Ni]2[BF4]2, 4 244 (8345) 291 (6976) 
 
334 (sh) 
 
471 (344), 
502 (sh) 
[(mmp-mdach)Ni(mIm)] BF4, 6 225 (8097) 290 (6534) 341 (sh) 467 (319) 
[(mmp-mdach)Ni(ipIm)] BF4, 7 223 (4768) 290 (4190) 335 (sh) 468 (189) 
[(mmp-mdach)Ni(me2NHC)]I, 8 233 (3387) 268 (1238)  417 (115) 
[mmp-dach)Ni(Im)]BF4, 9 215 (3777) 282 (1319) 370 (sh) 455 (59) 
[(mmp-mdach)Ni(Im)](Cl)131 , A 211 (21460) 288 (10767) 340 (sh) 467 (501) 
  aThe molar absorptivity values are not available for complex 3. 
 
and physical properties (1H NMR  and  UV-Vis spectroscopies).  A listing of all UV-Vis 
data is given in Table IV-1.   
 
Monothiolate Bridged Dinickel Complexes: Synthesis and Structural 
Characterization 
   Syntheses.  As implied in Figure IV-2 there are complexities that relate to 
counterions in the syntheses and isolation of monomeric vs. monothiolate bridged 
dinickel complexes.  The dimer cleavage reactions of 1 with py (a) and mIm (c) were 
initially performed following an identical protocol for complex A as described in 
Chapter III.131  The addition of excess py to the wine red solution of 1 resulted in an 
immediate color change  
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Figure IV-4.  Positive mode ESI-MS of the reaction mixture of [(mmp-
mdach)Ni(py)][Cl],  3, in  MeOH. Top: Experimental spectrum.  Bottom:  
Predicted isotopic envelope.   
 
to yellow.  The +ESI-MS of the reaction mixture showed a nickel-containing isotopic 
bundle at m/z = 338 (Figure IV-4), which corresponds to the predicted pattern for a 
species having the formula C15H26NiN3S+, i.e., the mononuclear cleaved product, 
complex 3.  The electronic absorption spectra of the reaction mixture at different 
concentrations showed the disappearance of the bands that are assigned to complex 1           
(λmax =  244, 283, 420 and 532 nm) with new bands appearing at λmax = 231, 255, 290, 
350 and 453 nm.   Attempts to purify the complex by precipitation with Et2O resulted 
initially in a yellow solid which within seconds turned purple.  Likewise, on removal of 
solvent in vacuo, a purple solid was produced.  A yellow solution was regained on 
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subsequent addition of MeOH to the purple solid. That is, the removal of solvent 
promoted the reformation of complex 1.  
To avoid the competitive binding of Cl- ions to the mononuclear complex, 
subsequent cleavage reactions were carried out using the Ni2(µ-SR)2, complex 2, which 
contains  non-coordinating BF4- counter ions.  Similar to the cleavage reaction of 
complex 1 with py, the electronic absorption spectra and +ESI-MS data suggested a fully 
cleaved product, i.e., complex 3, which resulted from the treatment of complex 2 with 
excess py.  The slow diffusion of Et2O into a MeCN solution of this reaction mixture 
yielded reddish-orange crystals whose X-ray diffraction analysis (vide infra) revealed 
incomplete cleavage of complex 2 and the presence of a Ni-(µ-SR)-Ni dimer, complex 4.  
We conclude that aggregation with loss of one py ligand from complex 3 occurs during 
the crystallization process.   
The dimer cleavage reaction of complex 1 using mIm, (c) in Figure IV-2, 
proceeded with similar complexities during purification as observed when using py as 
the attacking ligand.  While color changes and spectroscopic analyses (Table IV-1 and 
Figure IV-5) of the reaction mixture from both complexes 1 and 2 suggested complete 
dimer cleavage, the X-ray quality crystals which were obtained from Et2O diffusion into 
a MeCN solution of the reaction mixture and their X-ray diffraction analysis revealed a 
second partially cleaved dimer, complex 5.    
Complex 1-H was chosen as a [(N2S)Ni]2 dimeric precursor to reduce the steric 
interference between the monodentate ligand and the dach N-donor in the mononuclear  
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product, complex 9 (Scheme IV-1).  Under the same conditions as used to produce 
complex A, complex 1-H (either as its BF4- or Cl- salt) reacted with excess Im in MeOH 
to yield an orange solid analyzed by +ESI-MS, UV/Vis spectroscopy, and 1H NMR 
spectroscopy as complex 9.  X-ray quality crystals were obtained by the slow 
evaporation of complex 9 as its BF4- salt in MeOH; however, these crystals analysed as a 
third partially cleaved dimer, complex 10.   
 Molecular Structures of Monothiolate Bridged Dinickel Complexes.  Views 
of the molecular structures of complexes 4, 5, and 10 are shown in Figure IV-6, and 
selected metric data are compared in Table IV-2.   
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Figure IV-6.  Left: Molecular structures of the dications of py-[(mmp-mdach)Ni]2[BF4]2, 4, 
(top), mIm-[(mmp-mdach)Ni]2[BF4]2, 5, (middle), and Im-[(mmp-dach)Ni]2[BF4]2, 10, 
(bottom) shown as thermal ellipsoids at 50% probability. The BF4- counter ions are not 
shown. The asymmetric unit of complex 4 contains one MeCN of crystallization.  Right: 
Ball and stick representation of 4 (top) 5 (middle), and 10 (bottom) in different orientation. 
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Table IV-2.  Metric data for complexes py-[(mmp-mdach)Ni]2[BF4]2, 
4, mIm-[(mmp-mdach)Ni]2[BF4]2, 5, and Im-[(mmp-dach)Ni]2[BF4]2, 
10 (distance, Å); angle, deg). 
 4 5 10 
Ni(1)-S(1) 2.151(19) 2.166(19) 2.187(4) 
Ni(1)-N(1) 1.900(4) 1.922(5) 1.929(11) 
Ni(1)-N(2) 1.951(5) 1.961(6) 1.884(11) 
Ni(1)-N(3) 1.918(4) 1.905(5) 1.893(12) 
Ni(2)-S(1) 2.192(2)  2.214(19)  2.178(4)   
Ni(2)-S(2) 2.133(19) 2.140(19) 2.128(4) 
Ni(2)-N(4) 1.930(6) 1.925(6) 1.918(12) 
Ni(2)-N(5) 1.944(5) 2.026(7) 1.971(13) 
Ni(1)···Ni(2) 3.379 3.339 3.534 
N(1)-Ni(1)-N(2) 82.6(19) 82.3(2) 82.6(5) 
N(1)-Ni(1)-S(1) 92.3(15) 91.2(17) 90.6(4) 
N(2)-Ni(1)-N(3) 96.2(19) 97.4(2) 93.6(5) 
S(1)-Ni(1)-N(3) 88.9(15) 89.1(18) 93.2(3) 
N(1)-Ni(1)-N(3) 173.6(2) 174.4(2) 175.8(5) 
N(2)-Ni(1)-S(1) 174.9(14) 173.5(18) 173.2(4) 
Ni(1)-S(1)-Ni(2) 102.2(7) 99.34(7) 108.1(17) 
N(4)-Ni(2)-N(5) 80.8(2) 80.7(3) 79.6(5) 
N(4)-Ni(2)-S(2) 89.9(15) 90.0(18) 91.6(4) 
N(5)-Ni(2)-S(1) 97.3(19) 96.4(2) 95.1(4) 
S(1)-Ni(2)-S(2) 91.9(8) 92.7(7) 93.7(15) 
S(1)-Ni(2)-N(4) 177.5(16) 174.4(18) 174.4(4) 
N(5)-Ni(2)-S(2) 170.4(2) 170.3 (2) 171.2(4) 
 
Complexes 4, 5, and 10 consist of a Ni(µ-SR)Ni unit, in which both nickels are in 
a regular square planar geometry.  The N2S2Ni(2) portion is nearly perfectly square 
planar with average standard deviation from the N2S2Ni plane of 0.0196 Å (maximum 
and minimum deviation are  0.0259 and 0.0037 Å by N5 and S1, respectively) for 4; 
0.0255 Å (maximum and minimum deviation are 0.0566 and 0.0027 Å by Ni1 and S2, 
respectively) for 5; and 0.0168 Å (maximum and minimum deviation are 0.0237 and 
0.0082 Å by N4 and Ni2, respectively) for 10.  The average standard deviation in the 
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N2SN’Ni(1) portion of 10 is 0.0121 Å (maximum and minimum deviation are 0.0155 
and 0.0077 Å by N1 and S1, respectively); of 4, 0.0520 Å (maximum and minimum 
deviation are 0.0675 and 0.0404 Å by N1 and Ni1, respectively); and of 5, 0.0464 Å 
(maximum and minimum deviation are 0.0603 and 0.0355 Å by N1 and Ni1, 
respectively).  The two square planes intersect with a dihedral angle of 81.4º for 4, 77.8º 
for 5, and 94.7º for 10.  Note that both 4 and 5 show the exogenous N-donor ligand plane 
is orthogonal to the NiN2N’S plane, while the imidazole ligand plane in 10 deviates from 
orthogonality by ~22º.  This feature will be discussed later when the structures of the 
complete series are compared. 
The Ni···Ni distances in 4, 5, and 10, 3.379, 3.339, and 3.354 Å, respectively, are 
significantly longer than typical  Ni···Ni distances in µ2(SR)2 butterfly complexes (2.7 to 
2.9 Å).110, 113, 131, 146  The distances within the N2N’SNi(1) plane are nearly identical for 
complexes 4, 5, and 10, while the distances about Ni(2) show more deviation both 
between complexes 4, 5, and 10, and as compared to analogous monomeric N2S2Ni 
compounds.  As in all diazacycloheptane derivatives, the N-Ni-N angles are pinched to 
ca. 80º-82º, rendering the S-Ni-S angle or S-Ni-L angle  ≥ 90 º, as seen here.  Overall, 
metric differences in the first coordination spheres of 5, 6, and 10 are minor.    
 
Mononuclear Products: Synthesis and Structural Characterization   
 Syntheses.  Isolation of single crystals of the fully cleaved mIm complex 6 in 
42% yield was achieved upon the reaction of 2 with a 10-fold excess of mIm in addition 
to growing the orange-brown X-ray quality crystals in the presence of a further 5-fold 
 85
excess of mIm in MeCN solution layered with Et2O.  A 3-fold excess of ipIm led to the 
full cleavage of complex 2, yielding 7, which was purified by precipitation with Et2O.  
Diffraction-quality orange crystals of 7 were isolated from an Et2O-layered solution of 
MeCN in 53% yield.  The reaction of complex 2 with me2NHC occurs readily in THF 
solvent and the pure product precipitated out of solution as the reaction proceeded.  
Complex 8 was isolated as an air stable, hygroscopic bright orange crystalline solid 
(46% yield) from the slow diffusion of Et2O into a MeCN solution.    
 Molecular Structures of Mononuclear Products.  Thermal ellipsoid plots of 
monocationic complexes 6, 7, and 8 are given in Figure IV-7.  Salient metric parameters 
are given within the ball and stick structures shown in Figure IV-8, and, for comparison, 
those of complex A are also given.   The Ni-Ndach and Ni-S distances, and the Ndach-Ni-
Ndach angles are largely the same in the four structures.  The most significant difference 
is in the Ni-Ndach distance trans to the monodentate donor ligand that ranges from 1.890 
to 1.947 Å, correlating with basicity of the trans ligand.  The Ni-Ccarbene distance of 
1.891 Å in 8 is the same as that reported by Huang, Holm et al. for an NS2Ni(carbene) 
complex in which the carbene donor is trans to pyridine. 52  
The critical feature for our study is the dihedral angle defined by the intersection 
of the exogenous monodentate ligand plane and the Ni complex plane, defined by the 
best N2SNiLdonor atom plane, Table IV-3.  For the monomeric complexes, the ligands of 
greatest steric bulk (ipIm, 7, and me2NHC, 8) are nearest to perpendicular while the mIm 
derivative, complex 6, is the furthest from 90º.  The torsion angle that is defined in 
Table IV-3 is required for discussion in the computational section. 
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7
8
6
Figure IV-7.  Molecular structures of [(mmp-mdach)Ni(mIm)][BF4], 6,  [(mmp-
mdach)Ni(ipIm)][BF4], 7, and [(mmp-mdach)Ni(me2NHC)][I], 8, shown as thermal 
ellipsoids at 50% probability. Counter anions are not shown: 6, BF4-; 7,  BF4-; and 8, I-. 
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 Table IV-3.  Td twist, dihedral angle between the exogenous ligand plane and the N2SNiLa  plane, and N-Ni-L-C2 torsion angle for complexes 4-8, 10, 
and A. 131 
complex 4 5 6 7 8 10 A 
Td twistb  6.4 º 5.7 4.1 6.8 4.9 1.7 7.9  
Dihedral anglec  86.6 º 85.6 76.3 84.8 87.0 68.1 87.8 
N-Ni-L-C2d  95.4 º 90.6 108.3 93.2 91.1 117.2 95.0 
aL = N donor atom in complexes 4-7, 10 and A, and L = C donor atom in 
complex 8. bTd twist defined as the intersection of the N-Ni-N and the S-Ni-
L planes. cDihedral angle is defined as the angle between the N2SNi-L  plane 
and the best ligand plane.  For complexes 4 and 8, dC2 = atom α to the donor 
atom which is on the same side as the ethylene side of the dach backbone.  N 
= nitrogen atom cis to L atom.
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Figure IV-8.  Ball and stick drawings with selected metric parameters of [(mmp-
mdach)Ni(Im)](Cl), A131;  [(mmp-mdach)Ni(mIm)]BF4, 6; [(mmp-
mdach)Ni(ipIm)]BF4, 7; [(mmp-mdach)Ni(me2NHC)](I), 8. Counter anions are not 
shown.  View ┴ to N2S plane.  Full listings of metric parameters are given in the 
Appendix. 
8 
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Defining the Steric and Electronic Contributions of the Ligands   
 Methods for describing steric and electronic properties of “flat” ligands such as 
N-heterocyclic carbenes have been well documented.49, 147 The donor properties of the 
ligands are typically compared by their effect on υ(CO) values in LNi(CO)3 systems.147  
Due to the lack of spectroscopic reporter groups in our system, as well as the 
predominately σ donor character N-donors in the N-heterocycles and the C-donor in 
NHC’s, we base the ligand donor ranking in these complexes on the pKa of the donor 
atom’s conjugate acid in each ligand, Figure IV-2. 
The steric bulk of each ligand, was evaluated from features in the experimentally 
and computationally determined structures by group member Michael Singleton.  The 
ligand width was defined as the widest point closest to the metal center, Figure IV-9.  
For example, in the ipIm ligand this is the distance between the C5 imidazole proton and 
the proton on the tertiary carbon atom of the isopropyl substituent. The width as defined 
at this point on the ligand is more relevant to the steric encumbrance of the ligand within 
the coordination sphere than the larger width from the C5 proton to the isopropyl CH3 
groups as the latter orients away from the ligand metal system decreasing their steric 
effect.  This effect is comparable to the smaller cone angle in phosphite ligands as 
defined by Tolman, et al.148  The ligand wedge angle for flat ligands is defined as the 
angle made between the atoms that define the ligand width with the vertex being the NiII 
ion (Ldonor atom-Ni avg. distance = 1.90 Å (exp’tl); 1.92 (calc’d)). This definition is 
analogous to the AL parameter described by Nolan and coworkers for comparison of 
steric properties of N-heterocyclic carbene ligands.49  Based on these parameters, listed 
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in Table IV-4, the ligands increase in steric bulk in the order:  Im ~ mIm < py < ipIm < 
me2NHC.  
Ligand Width
Wedge Angle
Figure IV-9. Illustration of ligand width and wedge angle used to define the steric 
bulk for flat ligands such as imidazoles and NHC’s.  
 
 
Table IV-4. Ligand steric parameters taken from DFT 
calculated structures; Values from the X-ray determined 
structures are given in parenthesis. 
Ligand Ligand Width (Å) Wedge Angle (º) 
Im, A 4.21 (3.94) 83.2 (78.0) 
mIm, 6 4.21 (3.98) 83.2 (79.2) 
py, 3a 4.14 (3.94) 91.3 (86.3) 
ipIm, 7 4.76 (4.69) 106.3 (101.6) 
me2NHC, 8 5.04 (5.28) 121.9 (113.6) 
aExperimental values were taken from structure of complex 5. 
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Defining the Barrier to Rotation about the Ni-L Bond: VT 1H NMR   
 The VT 1H NMR studies were carried out in collaboration with group member 
Michael L. Singleton.  As was found for complex A,131 the 1H NMR spectra of the mIm 
analogue, complex 6, change with temperature, Figure IV-10.  In the imidazole C-H 
region, three 1H resonances are observed at 22°C and assigned according to the structure 
depicted within Figure IV-10.  Resonances a and b broaden and reach coalescence on  
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Figure IV-10.  VT 500-MHz 1H NMR spectra of [(mmp-
mdach)Ni(mIm)][BF4], 6, in CD3OD. 
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lowering the temperature to -60 ºC, while resonance c remains sharp.  By – 80 ºC, 
resonances a and b reappear as four distinct signals (a’ and a’’ and b’ and b’’), 
indicating the presence of two isomers.  This behavior is almost identical to that of 
complex A and is to be expected as the added steric bulk of mIm is remote from the 
binding site.131  Free energy differences were obtained from Keq values based on the 
isomer ratios at -80 ºC and are calculated as in eqs 1 and 2. 
Keq = [a’]/[a’’] = 0.72      (1) 
ΔG = -RT ln Keq = 0.14 kcal/mol    (2) 
The activation barrier, ΔG‡, is obtained from the chemical shift difference between a’ 
and a’’ (Δν = 145 Hz) and the coalescence temperature (Tcoal = -60 ºC), eqs 3 and 4.  
kT = (πΔν/ √2)  = 304.7 s-1     (3) 
ΔG‡ = - RT ln (kTh/ kbTcoal) = 9.0 kcal/mol              (4)    
The experimental barrier to rotation of 9.0 kcal/mol is, within experimental error, 
identical to that of complex A (8.9 kcal/mol).   
 The VT 1H NMR spectra for the imidazole region of complex 7, the ipIm 
derivative, in CD3OD are shown in Figure IV-11.  Two sets of doublets indicate the 
presence of two isomers at 20 ºC, of expected structures as shown in Figure IV-11, 
which on cooling show temperature dependent chemical shifts and some broadening of 
the signals.  From the isomer ratio of a/b to a’/b’ observed at room temperature, the ΔG 
value was calculated to be 0.32 kcal/mol according to eqs 1 and 2.    The signal at 6.89 
ppm is assigned to unbound ipIm.  The increase of temperature to ~60 ºC resulted in  
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slight broadening of the signals in the imidazole region.  An NMR sample of 7 in D2O 
solution showed a similar spectrum at 20 ºC as in the CD3OD solution spectrum, with a 
more equal distribution of isomers (Figure IV-12). The pairs of singlets (a and b and a’ 
and b’) broaden and start to overlap near 100 ºC.   The unidentified signal observed at 20 
ºC at 7.06 ppm remains visible at 100 ºC, but has shifted downfield (7.70 ppm).  On 
cooling the sample back to 20 ºC the two sets of isomers, a and b and a’ and b’, 
reappear, in addition to the unbound ipIm, which is now shifted to 7.16 ppm.  Because 
the observed ‘coalescence’ temperature is at the experimental high temperature limit, it 
is unknown whether this change in the spectrum is due to intra- or intermolecular  
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Figure IV-11.  Top:  Isomers of [(mmp-mdach)Ni(ipIm)][BF4], 7; (i) is assigned 
as in the solid state by X-ray diffraction; (ii) the ipIm ligand is rotated 180º with 
respect to (i).  Bottom:  VT 500-MHz 1H NMR spectra of complex 7 in CD3OD. 
* = unbound ipIm. 
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exchange. Evidence for intermolecular exchange in complex A in the presence of free 
imidazole is presented below. 
 Complex 8, the me2NHC derivative, in CD3OD at 20 ºC shows an AB pattern 
that is centered at 7.18 ppm and assigned to C-H protons on the NHC ligand, and two 
singlets that are assigned to the NHC methyl groups at 4.37 and 4.38 ppm (Figure IV-
13).  Upon heating the sample to ~60 ºC or cooling to -80 ºC there are no changes in the 
spectra except for temperature dependent broadening and shifting (Figure IV-14).  This 
data implies that the NHC ligand does not rotate about the Ni-C bond in the tight 
confines of the square planar nickel fragment as would be expected for such a sterically 
hindered ligand of wedge angle = 122°; neither is there isomerization by 
dissociation/association.  A simple representation of the expected transition state for  
Figure IV-12.  VT 500-MHz 1H NMR spectra of [(mmp-mdach)Ni(ipIm)][BF4], 7, in 
D2O. * = unbound ipIm. 
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Figure IV-13.  500-MHz 1H NMR spectrum of [(mmp-mdach)Ni(me2NHC)][I], 8 
in CD3OD. 
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Figure IV-14.  500-MHz 1H NMR spectra of [(mmp-mdach)Ni(me2NHC)][I], 8 
in CD3OD at 20 ºC and 60 ºC.  Top:  aromatic region; Bottom:  NHC methyl 
group resonances. 
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rotation in complex 8 is shown in Figure IV-15; a more exact description is presented 
below in the computational section.  Steric repulsion between the NHC methyl group 
and the S atom as well as the NHC methyl group and the N-dach methyl group is 
expected to greatly destabilize the coplanar arrangement shown and results in a very 
high barrier to rotation.   
 
  
The 1H NMR spectrum of complex 9 at 20 ºC displays three sharp singlets at 
7.04, 7.09 and 7.86 ppm (Figure IV-16).  These resonances are assigned, consistent with 
complex A, to the C-H protons on the coordinated imidazole ligand.  At all temperatures 
explored (+60 to -80°), these signals remain sharp, but decrease in intensity with 
lowered temperatures as two additional sets of three singlets, of 1:1:1 ratios, appear.  
These completely reversible temperature-dependent spectra are shown in Figure IV-16. 
In view of the complicated dimer cleavage processes encountered during the syntheses,  
Figure IV-15.  (a) Conformation of me2NHC ligand in complex [(mmp-
mdach)Ni(me2NHC)][I], 8 as observed in the molecular structure; (b) A 90° twist 
of the me2NHC as expected for rotational transition state showing the steric 
repulsion of the NHC methyl groups with the dach-N-methyl and the S atom. 
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including monothiolate bridged materials such as those analogous to structures 4, 5 and 
10, the observation of other species is not surprising.  While assignments of the other 
species would be extremely speculative, we can confidently conclude that the primary 
species is the mononuclear imidazole complex with rapid rotation about the Ni-Nimidazole 
bond at all accessible temperatures.  Similar results were noted in the spectra of complex 
4 (Figure IV-17); an activation energy barrier was obtained from these spectra; however, 
assignment to a monomeric or binuclear species is ambiguous.    
٠٠٠* * *
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b
a
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H
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N N
N
+
H
Figure IV-16.  VT 500-MHz 1H NMR spectra of [(mmp-
dach)Ni(Im)][BF4], 9, in CD3OD. 
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Theoretical Predictions of ΔG and ΔG‡ Values   
 DFT computations were carried out by group member Michael Singleton to 
calculate the free energies of (i) and (ii) isomers of complexes 3-4 and 6-9 and to predict 
the barriers for rotation about the Ni-L bond.  Geometry optimizations were performed 
on each complex using the experimental X-ray molecular structure as the initial 
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Figure IV-17.  VT 500-MHz 1H NMR spectra of py-[(mmp-mdach)Ni]2[BF4]2, 4, in 
CD3OD. * = unassigned species. 
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geometry (defined as isomer (i)).  The metric data of the optimized structures were in 
good agreement with the experimentally determined results (Table IV-5).   A second  
Table IV-5.  Selected experimental and optimized parameters for complexes 4 and 6-8. 
 Calculated 
(Å) 
Experimental 
(Å) 
 Calculated  
(Å) 
Experimental 
(Å) 
Complex 4   Complex 7   
Ni(1)-Npy 1.938 1.918 Ni-NipIm 1.922 1.907 
Ni(1)-Namine 2.017 1.951 Ni-Namine 2.046 1.971 
Ni(1)-Namine 1.949 1.900 Ni-Namine 1.944 1.922 
Ni(1)-Sthiolate 2.240 2.151 Ni-Sthiolate 2.175 2.151 
Ni(2)-Namine 2.054 1.944    
Ni(2)-Namine 1.979 1.930    
Ni(2)-Sthiolate 2.187 2.133    
Complex 6   Complex 8   
Ni-NmIm 1.919 1.888 Ni-Cme2NHC 1.908 1.891 
Ni-Namine 2.043 1.956 Ni-Namine 2.042 1.972 
Ni-Namine 1.944 1.890 Ni-Namine 1.988 1.947 
Ni-Sthiolate 2.176 2.136 Ni-Sthiolate 2.178 2.142 
 
 
optimized structure for each complex was obtained from an initial geometry where the 
ligand is rotated 180º about the Ni-L bond vector (isomer (ii)).  No other energy minima 
resulting from ligand rotation were found.  The initial geometries of the transition state 
for each complex were located using the synchronous transit-guided quasi-Newton 
(QST2) method75-76 utilizing the geometries for isomer (i) and isomer (ii) as the starting 
points.  The transition state geometry of each complex shows the ligand plane to be 
largely perpendicular to its initial ground state orientation and roughly coplanar with the 
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N2SNi plane, Figure IV-18.  The lowest energy transition state structure in the imidazole 
derivatives finds the imidazole C2 directed towards the S atom.  To accommodate the 
transition state structure, the Ni-ligand bonds elongate and there is also a significant 
increase in the tetrahedral twist of up to 46º (for example, in complex 8, Td twist in the 
ground state structure equals 4.8º; in the transition state structure 8‡, 51º).   
 Figure IV-18 shows the computationally determined transition state structures for 
complexes 3, 4, 6-9, and A. In the transition state for complex 6‡, the mIm ligand is 
rotated ~59° from its position in ground-state 6, with C2 of the imidazole pointed 
towards the S atom. In order to obtain this orientation the ligand drops out of the N2S 
plane towards the ethylene side of the dach frame. This results in a distortion of the 
square planar geometry around the nickel giving a Td twist of 17°. This distortion is only 
slightly smaller than that found for complex A‡ (21.2º)131 and is consistent with the 
similar experimental barriers for rotation for complexes A and 6 (Table IV-6).  This 
further corroborates that the slight difference in electronic character of the mIm over the 
Im ligand has little effect on the rotational barriers.  In contrast, the decreased steric bulk 
around the Ni in the dach vs. mdach complexes, see Figure IV-3, allows the imidazole 
ligand of complex 9‡ to bind in an orientation that is only 10° from coplanar with the 
N2SNi plane, and the complex has a Td twist of only 5.8°.  In the transition state 
structures containing the bulkier ligands, complexes 7‡ and 8‡, the distortion is much 
greater:  7‡ has a N-Ni-L-C2L torsion angle of 176.5° and a Td twist of 29.1° while the 
Td twist of the NHC-containing complex 8‡ is 51.0°.  The severe distortions required to 
go through the transition state in both the ipIm and me2NHC complexes correspond well  
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ipIm, 7‡ 
Td twist = 29.1º 
mIm, 6‡ 
Td twist = 17.3º 
py, 3‡ 
Td twist = 27.5º 
me2NHC, 8
‡ 
Td twist = 51.0º 
dach Im, 9‡ 
Td twist = 5.8º 
py, A‡ 
Td twist = 21.2º 
py dimer, 4‡ 
Td twist = 23.1º 
Figure IV-18. DFT optimized structures of the transition state geometries of 
complexes 3, 4, 6-9, and A131 showing the monodentate ligand planes in their 
maximum rotation position (ca. 90º from the ground state structure).  Td twist values 
(defined as the intersection of the N-Ni-N and the S-Ni-Ldonor planes) are given below 
each structure. 
 
 101
 
Table IV-6.  Experimental and DFT calculated ΔG‡ and ΔG values for 
complexes 4, 6-9 and A based on the rotation about the Ni-L bond and 
isomer ratio observed in the 1H NMR resonances.a 
N2SLNi 
L = ligand 
 
ΔGexpt’l 
 
ΔGcalc’d 
 
ΔG‡expt’l 
 
ΔG‡calc’d 
Im(dach), 9 unknown 0.37 n.a.b 3.29 
Im(mdach), A131 0.11 0.18 8.90 8.86 
mIm, 6 0.15 0.13 8.97 8.95 
py, 3 ---- ---- ---- 14.04 
py dimer, 4 ---- ---- 11.23 17.82 
ipIm, 7 0.32 0.36 n.a.b 21.04 
me2NHC, 8 ---- ---- n.a.b 29.93 
aValues reported in kcal/mol. bExperimental ΔG‡ value was not 
determined due to the constraints of the temperature range of the 
instrument or solvent used. 
 
 
with the high experimental barriers suggested for these complexes in the VT 1H NMR 
spectra (Table IV-6). 
Because of the possibility of an equilibrium between a monothiolate bridged and 
a mononuclear species in the case of complex 4, the transition states for pyridine rotation 
were calculated for both 3‡ (Td twist = 27.5°; N-Ni-L-C2L torsion angle, where C2 = 
atom α to the donor atom, which is on the same side as the ethylene side of the dach 
backbone = 178.3°) and 4‡ (Td twist = 23.1º; N-Ni-L-C2L torsion angle, = 175.6°). 
Despite these similarities, the energy barrier for Im rotation is calculated to be 
significantly greater for the dinickel complex 4, (Table IV-6).  However, the disparities 
between the experimental barrier and the calculated barriers for either the monomer or 
the dimer indicate that the process observed by NMR spectroscopy may be more 
complicated than ligand rotation in a single complex.  
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 Table IV-6 lists the experimental and DFT-calculated ΔG and ΔG‡ values for 
complexes 4, 6-9, and A.  The predicted ΔG of 0.13 kcal/mol and ΔG‡ of 8.95 kcal/mol 
for complex 6, the mIm derivative, are consistent with the experimentally determined 
results and are nearly identical to complex A.  In complex 7, the ipIm derivative, the 
room temperature 1H NMR spectrum indicated the presence of two species.  The DFT-
calculated ΔG for the two lowest energy conformations was found to be 0.36 kcal/mol, 
which compares well with the experimental value (based on the observed distribution or 
Keq) of 0.32  kcal/mol.  The large calculated barrier to rotation of 21.04 kcal/mol is due 
to the steric repulsion that is present when the ipIm ligand is roughly coplanar with 
N2SNi plane.  Consistently, the experimental ΔG‡ value could not be determined due to 
the temperature constraints of the solvent used.  Likewise, rotation about the Ni-C bond 
was not observed in complex 8 over the temperature range studied, consistent with DFT-
calculated activation barrier of 29.9 kcal/mol.  In contrast, DFT predicts a low energy 
barrier (ΔG‡) of 3.29 kcal/mol and a ΔG of 0.37 kcal/mol for complex 9, the  derivative 
with least steric hindrance.  This barrier to rotation is substantially lower than that for 
complex A and this DFT prediction is consistent with our inability to observe separate 
rotational isomers by NMR spectroscopy at the lowest accessible temperature.  In the 
case of the pyridine complex the calculated rotational barriers for the monomer and the 
dinuclear complex were found to be higher than the experimentally determined value of 
11.2 kcal/mol by ~3.0 and ~6.5, respectively.   
  Further evidence for steric control of dynamics is seen in comparisons of 
complexes A and 9, which differ by the substituent on the terminal N donor of dach in 
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the N2SNi binding pocket, Figure IV-3.  Relaxed potential energy scans monitor the 
change in potential energy of complexes A and 9 as a function of imidazole rotation, 
Figure IV-19.  Note that two maxima result as the imidazole completes a 360° rotation. 
The first maximum, occurring as the C2C-H unit passes the thiolate S is slightly lower 
than the second, resulting from the opposite orientation of the imidazole ligand dipole.  
This phenomenon is observed for both complexes, but is more dramatic for complex 9.  
The large overall difference in the energy barriers for rotation between A and 9 is 
apparent by comparison at each energy maximum, and is consistent with the 
experimental and computational results for imidazole ligand rotation in A and 9, Table 
IV-6.   
 
 Intermolecular vs. Intramolecular Paths for Isomerization   
 The VT 1H NMR studies demonstrated that stereoisomers of these complexes 
may coexist in solution, and according to the good correlation between DFT calculations 
and the NMR data for complexes A and 6 the isomerization process observed in certain 
N2SLNi complexes is most reasonably assigned to intramolecular fluxionality, i.e., 
rotation about the Ni-L bond.  Nevertheless intermolecular isomerization processes are 
of concern, particularly in systems with high activation barriers as is the case of  the two 
complexes containing the ligands of largest wedge angle, complexes 7 and 8.   The NHC 
ligands are known to be strongly coordinated to metal ions and they show great stability 
toward thermal degradation in solution.45, 149 
 104
   
 
 As a probe of the possibility of intermolecular exchange, we have monitored the 
VT 1H NMR spectra of a well-characterized fluxional system, that of complex A in the 
presence of free imidazole.  At 20 ºC, the NMR spectrum of pure imidazole in CD3OD 
displays two sharp singlets at 7.67 and 7.04 ppm (Figure IV-20).  The addition of 1 
equiv of imidazole to a sample of complex A in CD3OD at 20 ºC resulted in broadening 
of the three singlets at 8.11, 7.33 and 7.12 ppm that are assigned to the C-H protons on 
the coordinated imidazole ligand, a, b, and c. As the temperature is raised above 20 ºC, 
Figure IV-19.  Plots of the potential energy of [(mmp-mdach)Ni(Im)]Cl, A, (R = 
CH3) and [(mmp-dach)Ni(Im)][BF4], 9, (R = H) as a function of the S-Ni-NImid-
CImid torsion angle.   Blue:  complex A;  Red:  complex 9.  The imidazole rotation 
starts from the optimized X-ray structure. 
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a, b, and c further broaden, completely flat-lining at 60-70 ºC.  A decrease in the 
temperature from 20 ºC results in the sharpening of resonances a b, and c and singlets 
for free imidazole appear at 7.07 and 7.73 ppm. 
The broad signals observed at temperatures  > 10 ºC indicate that the Ni-bound 
imidazole exchanges with the free imidazole in solution.  This intermolecular exchange 
process is slowed at temperatures below 10 ºC; for example, singlets at 7.07 (free 
imidazole) and 7.16 ppm (bound imidazole) are observed.   The activation energy  
 
  
FI FI
c b a 
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Chemical Shift (ppm)-30 ºC 
Figure IV-20.  VT 400-MHz 1H NMR spectra of the addition of free imidazole to 
[(mmp-mdach)Ni(Im)]Cl, A, in CD3OD.  FI = free imidazole. 
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parameter (ΔG‡)  for the intermolecular exchange of free imidazole with bound 
imidazole for complex A was determined to be 11.3 kcal/mol from the exchange rate 
constant at coalescence.  A comparable ΔG‡ value was determined from the line shape 
analysis in the slow exchange region (ΔG‡ = 10.8 kcal/mol).  The Eyring plots used to 
derive ΔG‡ for the exchange process are shown in Figure IV-21.   
 
ln(k) 
1/T 
Figure IV-21.  Plot of  ln(k) versus 1/T for imidazole exchange in complex  A. 
 
 
 
The VT 1H NMR data of pure complex A, i.e., without excess imidazole, shows 
no broadening of signal c at temperatures below 0 ºC.  In this previously reported VT 1H 
NMR study,131 changes were only observed in resonances  a and b, which broaden at -40 
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ºC, coalesce at -60 ºC, and reappear as two sets of singlets at -80 ºC.  In contrast, the VT 
1H NMR spectra resulting from the addition of free imidazole to complex A displays 
broadening of resonance c at the higher temperatures and begins to separate into two 
separate signals at ~10 ºC.   Comparing the VT 1H NMR parameters for intermolecular 
exchange of the coordinated imidazole ligand with free imidazole in solution to the VT 
1H NMR factors for pure complex A, we conclude that the observed fluxional process 
observed at low temperatures is intramolecular, most reasonably  due to the rotation 
about the Ni-L bond. 
 
Electrostatic Contributions to the Ground State Imidazole Binding Orientation   
 While the steric bulk of the ligands and interference with ancilliary or spectator 
ligands likely plays the largest role in the rotational barrier, there are slight deviations 
from orthogonality in the ground state orientation of the monodentate ligands in the less 
sterically bulk complexes, A, 6, and 9 that appear to be of electrostatic origin. In all, the 
C2 position of the imidazole ligands, with its electropositive C-Hδ+ tilts towards the 
thiolate S in both the experimental and DFT calculated structures. This sort of internal 
electrostatic interaction has been surmised to be important in the orientation of axial 
coordinated imidazoles in heme systems.34-35 
 Indeed, a computational S/O replacement in complexes A and 9 resulted in 
greater deviation towards coplanarity for the alkoxide analogue of the thiolate. For 
example the C2 of imidazole orients toward the alkoxide Oδ-, resulting in the case of 
computationally defined 9-(O) an N-Ni-Nimid -C2imid torsion angle of  194°, i.e., a nearly 
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coplanar imidazole/N2ONiNimid geometry, Figure IV-22.  In the case of complex A, with 
more steric hindrance built into the nickel binding pocket by virtue of the methyl group 
on the dach, the tilt of the imidazole in the N2ONiNimid is again roughly 40° away from 
the orthogonal orientation that is observed for the A-(S) derivative both experimentally 
and in the computations.  In this case the Ni-Nimid bond lengthens by ca. 0.015 Å, 
presumably to accommodate the imidazole twist.   
 
 
-10.0 58.938.4 82.8 S-Ni-Nimid-C2, °
194.1 125.9 140.8 102.5N-Ni-Nimid-C2, °
14.0 58.5 41.9 84.4 
Dihedral Anglea, 
°
1.8162.1771.8152.179Ni-S/O, Å
1.9261.9161.9381.923Ni-Nimid,Å
9-(O)9-(S)A-(O)A-(S)Complex 
Figure IV-22.  Overlays of computationally determined structures for (left) [(mmp-
mdach)Ni(Im)]+, A, as thiolate, (A-(S)), and as alkoxide, (A-(O)).  Similarly (right), 
complex 9 as thiolate, (9-(S)), and as alkoxide, (9-(O)).  In both overlays, the view 
is along the Nimid-Ni bond vector and shows tilt of the imidazole C2-H unit toward 
the chalcogen donor.  In both overlays, the imidazole is in red for the alkoxide and 
in yellow for the thiolate derivative.  Pertinent metric parameters are given in the 
table, including dihedral angle of the ligand and complex planes as defined in the 
text, and torsion angles as noted.      
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The conclusion that the shift towards coplanarity of imidazole and nickel planes in the 
N2ONiNimid virtual complexes is a result of an internal electrostatic interaction is 
consistent with the experimental structures of a set of square planar NiII complexes of 
tridentate, truncated Schiff base units that show greater variation in imidazole ligand 
orientation with respect to the tridentate ligand-metal plane.  Ten such molecular 
structures are to be found in the Cambridge Crystallographic Data base, six of which are 
shown in Figure IV-23.133-141   None were characterized for imidazole fluxionality by VT 
NMR solution studies as in our study above.  The NiII-Schiff base complexes containing 
hard O-donors cis to the unsubstituted imidazole monodentate ligand, complexes a) and 
b) in Figure 16, find coplanarity in the nickel complex plane and the plane of the 
imidazole ligand.  Intramolecular H-bonding was reported in the interaction of the C2-H 
of the imidazole with the O-donor, and intermolecular H-bonding interactions involving 
the imidazole N-H define a one dimensional assembly in the crystal lattice.  The four 
other structures of this type presented in Figure S9 are also of the co-planar type.  With a 
sterically hindered imidazole ligand, molecular structures such as c) and d) of Figure 16 
show substantial displacements of the imidazole ligand plane from the nickel complex 
square plane inducing dihedral angles of ca. 49º and 87º, respectively.  Strong 
intermolecular H-bonding is seen in the extended molecular structures of both c) and d).   
In addition, complex c) has an intramolecular C-H…πarene interaction involving the ortho 
C-H group on the phenyl ring of the monodentate ligand and the phenyl ring of the 
tridentate ligand that is suggested to produce the observed canted orientation of the 
imidazole plane with respect to the metal square plane.137 Complexes e) and f) in Figure 
 110
b) 1.980(8) Å; 9.96º 
j) 1.954(2) Å; 6.79º 
a) 1.906(2) Å; 4.25º 
Figure IV-23. A selection of tridentate Schiff base ligand complexes of nickel with 
imidazoles in the fourth site. Ni-Nimid distances and dihedral plane defined as the 
angle between the best Ni square and imidazole plane given underneath each 
structure.   a): ref. 140; b) ref. 135; c) ref. 137; d) ref. 137; e) ref. 141; f) ref. 133; g) 
ref. 138; h) ref. 139; i) ref. 134; j) ref. 136. Bond distances and angles are reported 
as averages for complexes containing more than one molecule in the asymmetric 
unit. 
e) 1.888(4) Å; 51.4º 
f) 1.888(4) Å; 51.3º 
g) 1.909(4) Å; 13.9º   
h) 1.918(2) Å; 17.0º 
d) 1.920(6) Å; 89.8º c) 1.914(2) Å; 48.4º
i) 1.904(5) Å; 20.2º 
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16 contain anionic S donors cis to the imidazole, and have intermediate metal-
plane/ligand plane dihedral angles of ca. 50° with, in addition to the intermolecular 
interactions involving H-bonding of the imidazole N-H to an adjacent complex, an 
intramolecular interaction that points the C2 of the imidazole in the direction of the S 
atom of the tridentate ligand.133, 141 
 
Summary and Conclusion 
Due to the asymmetry of the diazacycle frame in the complexes described above, 
an opportunity is presented to observe orientational preferences and dynamic rotational 
barriers that are influenced by the steric constraints of the ligand and the pocket into 
which flat ligands bind in square planar nickel complexes.  While the imidazole ligand 
has the possibility of intramolecular donor/acceptor interactions, i.e., the C2 CHδ+ with 
the thiolate Sδ-, that would result in a canting of the imidazole towards the negatively 
charged donor atom, this interaction is very weakly expressed in the structures in our 
series.  Thus we see an orientation of the imidazole plane that is largely orthogonal to the 
N2SNi plane in the monomeric complexes, determined principally by the optimization of 
minimal steric interactions while achieving maximum Ni-Nimid σ-bonding.   
The structural and dynamic results of our study, using N2S binding sites, coupled 
with analysis of literature structures of various square planar nickel imidazole complexes 
in largely hard donor environment may be correlated as follows: 
1)  In the Schiff base adducts consisting of N-, O-donor atoms the ground state 
imidazole binding orientation both reduced steric repulsion in the binding 
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pocket that flanks the imidazole and significant intramolecular electrostatic 
interactions between O and the imidazole C2 CHδ+  overwhelm the minimal 
steric restrictions resulting in coplanarity.  In the case of the N2SNi 
complexes in the current study, increased steric bulk on either the binding 
pocket (the secondary and tertiary amines in the N2S pocket) or on the planar 
monodentate ligand lead to a nearly perpendicular orientation of the 
imidazole plane, as intramolecular donor/acceptor interactions that would 
encourage canting of the imidazole ring towards coplanarity are minimal.  
2) While two isomers of the N2SNi-Nimid complexes are seen at room and even 
higher temperatures for imidazoles with steric hindrance at the C2 site, 
dynamic interconversions of non-hindered analogues occur with activation 
barriers experimentally accessible by VT NMR studies.  The barriers 
obtained experimentally and through DFT studies show a correlation between 
increasing activation barrier and increasing steric hindrance, indicating that 
the mobility of the monodentate ligands about the Ni-L bond is controlled by 
the ligand size (width and wedge angle) and the access to nickel as controlled 
by the ancillary donors. 
3) The exchange of free and bound imidazole in complex A, occurs with a 
barrier of ~ 11 kcal/mol and ceases close to 0 ºC, further supporting that the 
exchange process observed for pure complex A at lower temperatures is a 
result of intramolecular dynamic processes.  
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4) DFT optimized transition state structures for the interconversion of isomers 
of N2SNi-Nimid find a lengthening of the Ni-Nimid bond as rotation about the 
Ni-Nimid bond pushes the imidazole into coplanarity with the nickel complex 
plane; distortion from strictly square planar further accommodates the 
increase in steric repulsion.   
The orientation of His-imidazole in biological systems is influenced by many 
factors.  This study has shown two such factors, steric bulk and internal electrostatic 
interactions, determine the ground state binding orientation and dynamic behavior of N-
heterocyclic ligands bound to square planar N2S nickel sites, such as is found in the 
nickel responsive transcription factor, NikR.13-14 The binding of four Ni2+ ions, each 
held in a square planar N3SNi coordination environment, within the metal binding 
domain causes conformational changes in the protein superstructure, which initiates the 
interaction of the protein with DNA.13 Fundamental model studies such as this one 
contribute to a delineation of the possible factors that may influence these protein 
structural and dynamic changes. 
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CHAPTER V 
 TETRADENTATE N2S2 VANADYL(IV) COORDINATION COMPLEXES:  
SYNTHESIS, CHARACTERIZATION AND REACTIVITY STUDIES 
 Introduction 
 Brief History of Vanadium in Biology.  Vanadium chemistry plays a 
fundamental role in biological systems and industrial applications.  Biochemical 
processes of vanadium span from simple organisms to humans.  Vanadium was first 
recognized as an essential element in living systems in the early 1900’s when 
extraordinary quantities of vanadium were indentified in the blood cells of tunicates 
(ascidains or sea squirts).150-151  To date, the functional role of the vanadium in these 
marine organisms is not well defined, and research in this area has primarily focused on 
the mechanism of the reduction of the V5+ ion from sea water, the oxidation state within 
the cells, and the transport/storage of vanadium ions.152-154  In 1931, high concentrations 
of vanadium were discovered in mushrooms (toadstool), and this vanadium-containing 
natural product (amavadin) was finally isolated in 1972.155-156  Although amavadin has 
been shown to serve as an electron-transfer mediator, the precise mode of action of 
vanadium in this system is also still unclear, and research is ongoing.152-154   
 The importance of vanadium in biochemistry continues to grow.  In 1977, the 
vanadate ion was indentified as an efficient inhibitor of Na+, K+ ATP-ases, and in the 
1980’s vanadium was established as a biometal in two classes of enzymatic systems, 
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vanadium-dependent haloperoxidases and vanadium-dependent nitrogenases.157-160  The 
discovery of vanadium-containing active sites sparked myriad model compounds and 
investigations into understanding the coordination chemistry and mode of action of 
vanadium in biological systems.152-154 
 In humans, vanadium is defined as an ultra trace element (uptake 10-60 
µg/day).161  A clear biochemical function for vanadium in humans has not been 
identified but the likelihood that it has an essential role is considerable.  In fact, 
vanadium and its aggregates were shown to inhibit many phosphate metabolizing 
enzymes, even in low concentrations.154 This inhibition effect is a result of similar 
structural characteristics between the vanadate, VO43-, and the phosphate, PO43-, ion 
which leads to analogous binding in biological environments.152-154 
 Beginning in the early 1980’s, much effort has focused on developing and 
understanding the therapeutic affects of vanadium for treatment of diabetes.  The insulin-
enhancing properties of vanadium complexes were first discovered by the use of simple 
inorganic salts of vanadium, such as [(V=O)SO4].154 Since then, many vanadium 
compounds in both V4+ and V5+ states have been synthesized, characterized, and 
screened for insulin-enhancing properties.162-163  Numerous studies have established that 
the oral administration of certain vanadium compounds has positive affects on glucose 
homeostasis (Figure V-1).  In particular, peroxovanadium(V) complexes and 
vanadium(IV) complexes containing variations of the maltolato ligand have 
demonstrated the highest insulin-enhancing activity.  In fact, BEOV (bis(2-ethyl-3-
hydroxy-4-pyronato)oxovanadium(IV)) recently entered phase IIa clinical trials.164 
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Figure V-1.  Structures of vanadium complexes with insulin-enhancing 
properties.162-163  (a) bis(acetylaceonato)oxovanadium(IV), (V=O)(acac)2; (b) 
bis(picolinato)oxovanadium(IV), VO(pic)2 or VPA; (c) 1: bis(maltolato)-
oxovanadium(IV), BMOV; 2: bis(ethylmaltolato)-oxovandium(IV), BEOV.  
(a) 
(c) 
(b) 
 
 Considering the complexity of the insulin signaling system, it is not surprising 
that the precise mode of action of vanadium containing complexes is not completely 
understood.  In the insulin cascade, the binding of insulin to the insulin receptor 
stimulates tyrosine kinase activity.  The resulting autophosphorylation initiates a variety 
of intracellular signaling pathways, which function in a synergistic manner to regulate 
glucose metabolism.  Studies have demonstrated that the oxovanadium or vanadate 
insulin-enhancing activity results from the inhibition of phosphotyrosine phosphatase 
1B, an enzyme responsible for specifically dephosphorylating the phosphorylated 
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tyrosine residue on the insulin receptor.  It is also important to note that other receptors 
in the insulin cascade have been shown to be activated by vanadium compounds.154  
 The intact vanadium complex used for the treatment of diabetes is not considered 
to be the active species in these processes.  Recent investigations of BEOV 
pharmocokinetics in rats established that the vanadyl complexes dissociate after 
administration, leaving the “free” vanadyl ion to be absorbed and transported by 
circulatory proteins in the blood.165-166  Studies established that vanadyl ions bind to both 
serum albumin and transferrin, and transferrin is accepted as the principal vanadium 
chaperone.167  The dissociation of the ligands from orally administered vanadium 
compounds opens up the possibility of “free” vanadyl ion binding to sites in various 
proteins and small peptides within the cell.   
 Vanadium-Sulfur Interactions in Biological Systems.  The interaction of 
vanadium with cysteinyl groups in biological systems is well recognized.154 For instance, 
V-S bonding is seen in the active site of vanadium-dependent nitrogenases,  and it is 
known that vanadate inhibits certain phosphate-metabolizing enzymes through binding 
to cysteinyl residues.154  Furthermore, the enzyme inhibition properties of vanadium in 
vivo has led to the investigation of oxovanadium(IV) complexes containing S-donor 
atoms as insulin-enhancing agents.168  Finally, redox transformations of vanadate to 
vanadyl occur in the cell through the thiol functional group of glutathione, a tripeptide 
which can dimerize via oxidative disulfide formation.167  In fact, several reports suggest 
complex formation between glutathione and oxovanadium(IV) ions.169-170  Studies of 
oxovanadium(IV)-glutathione model compounds demonstrated that two glutathione 
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coordination modes are observed at different pH ranges, one of which proposes V-Sthiolate 
binding (Figure V-2).170 
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Figure V-2.  Proposed structures of VIVO2+ bound to glutathione at pH = 5-7 (a) 
and pH = 7-10 (b).170  
 
  
 N2S2(VIV=O) Coordination Complexes.  In order to understand the coordination 
chemistry of vanadium in biological systems, simple ligands are commonly used to 
mimic possible binding sites in biomolecules.  The occurrence of thiolates and their 
interactions with vanadium in nature has encouraged the synthesis and investigation of a 
manifold of thiolate-bound vanadium coordination complexes in combination with 
various N,O chelates.  In particular, several examples of mononuclear square pyramidal 
N2S2(VIV=O) complexes involving bidentate or tetradentate ligand sets have been 
examined and only four have been structurally characterized by X-ray diffraction 
studies.  These structurally characterized (VIV=O) complexes featuring N2S2 
coordination spheres include bidentate ligands in trans conformations, and tetradentate 
N2S2 ligand sets (Figure V-3).171-174  These complexes reveal the versatility of the 
vanadyl ion to accommodate both hard and soft donor atoms, and that such ligand fields 
can result in stable (VIV=O) complexes.   
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 (VIV=O)-amide Coordination Complexes.  Chelation through the 
carboxyamido nitrogen of the peptide backbone, although not a common coordination 
mode, is observed in certain proteins and enzymes, such as serum albumin, nitrile 
hydratase, and acetyl coA synthase.25, 175-177  Vanadium-catalyzed photocleavage has 
been utilized as a probe to characterize complex protein systems, and there are several 
examples that suggest the involvement of amide ligands in the photoinduced peptide 
cleavage process of phosphate binding proteins.178 A recent survey of the Cambridge 
data base finds seven square pyramidal (VIV=O) complexes featuring N-amidate binding 
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Figure V-3.  Examples of mononuclear square pyramidal VIVO complexes 
containing thiolate ligation. (a) 1, VO[cyclo-C5H8=N-NC(-S-)(SCH3)]2; 3, 
VO[cyclo-C6H10=N-NC(-S-)(SCH3)]2;172 5, VO[4-(CH3)2N-C6H4CH=N-NC(-S-
)(SCH3)]2 (b) vanadyl(IV)-cysteine methyl ester;171 (c) [VO(C8H18N2S2)];173 (d) 
VIVO(tsalen).174 
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(Figure V-4).179-182 Much work in this area has  employed pseudo-peptide complexes 
utilizing Schiff base adducts  or aryl-rich tetradentate ligands to examine the potential 
for vanadium coordination to deprotonated amide ligands in largely N,O chelate 
systems. There is only one report of a thiolate donor within the binding pocket.   
 
  
 Notably, each of these examples involves amide bond(s) extended from aromatic 
backbones.  The incorporation of the amide donor(s) provides a strong σ donating ligand 
environment resulting in stabilized VIV=O2+ complexes.  The effect of the amide donor 
on the ligand field has been noted to lower EPR Ax and Ay parameters relative to amine 
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Figure V-4.  Examples of mononuclear square pyramidal VIVO complexes 
containing amide ligation. (a) 1, [VO(pycac)], 2, [VO(pycbac)];179 (b) 
VIVO(PAIS);180 (c) {K2[VO(depa-H)]}·1.5CH3CN·H2O;181 (d) [VIVO(thipca)];182 (e) 
Na[VIVO(hypyb)]·2CH3CN;182 (f) Na2[VIVO(hybeb)] ·2CH3OH;182.  Note for (e) the 
Na ions bind to the carboxyamido oxygen and phenolate oxygen atom, and in (f) the 
Na ion binds to the carboxyamido oxygen atoms. 
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donors, and to significantly shift the VO stretching frequency, which ranges from 980-
991 cm-1 for one coordinated amide and 942-955 cm-1 for two ligated amides.179-182    
 Our group has studied a series of metals bound within a dianionic N2S2 ligand set 
utilizing the dach and daco diazacycle frameworks functionalized with ethylene thiolate 
linkers.183-185  Furthermore, we recently investigated Cu(II) binding to Holm’s 
tetraanionic N2S2 ligand (referred to earlier as ema4-), which contains two aliphatic 
amide bonds.82  These studies have now been extended to include vanadyl ions.  The 
work herein examines the structural and electronic changes from the incorporation of 
V=O2+ in such dianionic and tetraanionic N2S2 binding pockets (Chart V-1).   In 
addition, the vanadyl interaction with the CGC peptide, the biological analogue of the 
tetraanionic N2S2 ligand, has been explored (Chart V-1).  As these types of chelating 
environments are found in nature, the study of V=O2+ coordination and reactivity of such 
sites are of much interest.   
 
Experimental Details 
 Materials.  The starting material N,N’-bis(2-mercaptoethyl)-1,5-
diazacyclooctane, (H2-bmedaco),186 N,N’-bis(2-mercaptoethyl)-1,5-diazacycloheptane, 
(H2-bmedach),187 N,N’-ethylenebis(2-mercaptoacetamide), (ema),82 and  cis-
[(piperdine)2W(CO)4]188 were prepared according to literature procedures.  Fmoc 
protected peptides and TentaGel S-RAM® beads were purchased from Advanced Chem 
Tech.  The synthesis of CGC was followed using standard solid-phase peptide 
techniques.   
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 N,N’-bis(2-mercaptoethyl)-1,5-diazacyclooctane oxovanadium(IV), [(bme-
daco)(V=O)], Complex 1.  As previously prepared by a former group member, Michelle 
Hatley, the H2-bmedaco ligand (0.842 g, 3.6 mmol) was dissolved in MeOH (30 mL), 
and a solution of (V=O)(acac)2 (0.868 g, 3.3 mmol) in MeOH (50 mL) was added 
dropwise.189 The colorless solution immediately turned green, and upon stirring 
overnight a green precipitate formed.  The mixture was filtered in air, the solid was 
washed with 30 mL portions of Et2O, and allowed to dry in air. An analytically pure 
sample was obtained by recrystallization from warm CH2Cl2 to obtain 0.247 mg (25%) 
of product.  Diffusion of Et2O into a saturated solution of the complex in CH2Cl2 
produced X-ray quality green needle-like crystals.  Elemental anal. for C10H20N2S2VO 
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(MW = 299 g/mol) Calcd (found): C, 40.12 (40.12); N, 9.36 (9.25); H, 6.73 (6.55). 
ATR-FTIR: υ(V=O), 979 cm-1.  +ESI-MS (CH2Cl2): m/z = 300 [(bme-daco)VO]+.   
 N,N’-bis(2-mercaptoethyl)-1,5-diazacycloheptane oxovanadium(IV), [(bme-
dach)(V=O)], Complex 2.  To a light yellow solution of the H2-bmedach ligand  (0.785 
g, 3.56 mmol) in MeOH (20 mL), a solution of (V=O)(acac)2 (0.951 g, 3.59 mmol) in 
MeOH (50 mL) was added dropwise. The solution turned green and a light purple solid 
precipitated.  The reaction was stirred at room temperature for 20 h, the green filtrate 
was separated from the purple solid.  The purple solid was washed with MeOH (3 x 30 
mL), then with Et2O (3 x 30 mL), and dried in air to afford a light purple solid (0.752 g, 
74% yield).  X-ray quality crystals were obtained from the slow evaporation of the green 
filtrate under anaerobic conditions. The purple crystalline material was collected 
yielding 0.031 g (3%) giving total yield of 0.783 g (77%).  C9H18N2S2VO Elemental 
anal. for C9H18N2S2VO (MW = 285 g/mol) Calcd (found): C, 37.89 (37.91); N, 9.82 
(9.72); H, 6.36 (6.41). ATR-FTIR: υ(V=O), 976 cm-1.  +ESI-MS (CH2Cl2): m/z = 286 
[(bme-dach)(V=O)]+.   
 Tetraethylammonium [N,N’-ethylenebis(2-mercaptoacetamide) 
oxovanadium(IV)], [Et4N]2[(V=O)(ema)], Complex 3. Under anaerobic conditions, the 
N,N’-ethylenebis(2-mercaptoacetamide) ligand (0.100 g, 0.344 mmol), KOH ( 0.079 g, 
1.41 mmol) and Et4NCl (0.114 g, 0.688 mmol) were mixed in MeOH (20 mL) for 30 
min resulting in a light yellow solution.  A suspension of (V=O)(SO)4 (0.051 g, 0.313 
mmol) in MeOH (30 mL) was added to the ligand mixture using a plastic cannula.  The 
reaction mixture was heated to 60-65 ºC for 20 hrs yielding a teal blue solution 
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containing a white precipitate (K2SO4).  The solution was cooled to RT, filtered over 
celite, and the solvent was removed in vacuo.   MeCN (25 mL) was added to extract the 
product as a blue solution.  The solution was filtered over celite and the solvent reduced 
to minimum. X-ray quality crystals were obtained by vapor diffusion of Et2O into the 
MeCN solution. The blue-purple crystalline material was collected yielding 0.057 g 
(34%). Compound is extremely hygroscopic.  Elemental anal. for C22H48N4S2VO3·2.5 
H2O (MW = 577 g/mol) Calcd (found): C, 37.89 (37.91); N, 9.82 (9.72); H, 6.36 (6.41). 
ATR-FTIR: υ(V=O), 941 cm-1.  -ESI-MS (MeCN): m/z = 401 (Et4N)[(V=O)(ema)]-.   
 Potassium [(Cysteinyl-glycyl-cysteinecarboxamide) oxovandium (IV)], 
K2[(V=O)(CGC)], Complex 4. Method A: The H4CGC ligand (0.032 g, 0.099 mmol) 
and KOH (0.011 g, 0.196 mmol) were mixed in DMF (10 mL) and stirred for 30 
minutes.  A light green solution of (V=O)(acac)2 (0.024 g, 0.091 mmol) in DMF (15 mL) 
was added dropwise.  The reaction was stirred for 16 hrs and a light blue-green solid was 
obtained after precipitation with Et2O, yielding 28.1 mg (67 % yield).   ATR-FTIR: 
υ(V=O), 945 cm-1.   
 [(V=O)(ema.(CH2)3)], Complex 5. To a blue solution of [Et4N]2[(V=O)(ema)] ( 
0.031 g, 0.058 mmol) in MeCN (10 mL) was added neat 1,3-dibromopropane (4 µL, 
0.039 mmol) resulting in a grey-blue solution with the formation of a white precipitate.  
After stirring for 30 min, the resulting solution was filtered over celite, the solvent was 
reduced and layered with Et2O.  Reddish-blue crystals were isolated.  ATR-FTIR: 
υ(V=O), 986 cm-1.   
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 Tetraethylammonium [N,N’-ethylenebis-(2-mercaptoacetamide)- 
oxovanadium (IV) tungsten tetracarbonyl], [Et4N]2[(V=O)(ema)W(CO)4], Complex 
6.  A solution of (pip)2W(CO)4 (0.018 g, 0.039 mmol) in DMF (10 mL) was heated to 40 
°C for 10 min under a N2 atmosphere. To this was added dropwise a blue solution of 3 
(0.020 g, 0.038 mmol) in DMF (10 mL).  The solution was heated at 40 °C for an 
additional 20 min producing an amber color.  The solution was stirred for 30 min at 
room temperature. IR in υ(CO) region of the reaction mixture (DMF, cm-1): υ(CO) 
1996(w), 1919(w), 1872(s), 1849(m), 1802(m).   
 Potassium [(CGC)oxovanadium(IV) tungsten tetracarbonyl], 
[K]2[(V=O)(CGC)W(CO)4], Complex 7.  In a similar manner for 6, a light green DMF 
solution of K2[(V=O)(CGC)] (0.022 g, 0.047 mmol) was added slowly to a DMF 
solution of warm (pip)2W(CO)4 (0.022 g, 0.047 mmol).  IR in υ(CO) region of the 
reaction mixture (DMF, cm-1): υ(CO) 1995(w), 1916(w), 1866(s), 1849(m), 1805(m). 
 
Synthesis and Structural Characterization 
 Syntheses of neutral [(bme-daco)(V=O)] and [(bme-dach)(V=O)], Complexes 
1 and 2.  As was earlier performed by a former group member, Michelle Hatley, for the 
neutral [(bme-daco)(V=O)], the neutral [(bme-dach)(V=O)] was also prepared by ligand 
displacement on reaction of (V=O)(acac)2 with the H2-bmedaco or H2-bmedach ligand in 
methanol solutions at room temperature (Scheme V-1).189  The resulting green 
precipitate (complex 1) and purple precipitate (complex 2) were isolated and purified  to  
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give 25% and 77% yield for 1 and 2, respectively. These neutral N2S2 VIV=O complexes 
are resistant to aerobic oxidation in the solid state but, slowly (days) decompose in 
solution, presumably to yield Vv species.  The neutral complexes are soluble in DMF, 
H2O, CH2Cl2, and slightly soluble in warm MeOH, where complex 2 was of lower 
solubility than 1.  
 Syntheses of dianionic (Et4N)2[(V=O)(ema)], Complex 3.  The preparation of 
the dianionic vanadyl complex was accomplished by the addition of (V=O)SO4 to the 
deprotonated form of the ligand in methanol solutions while heating (60 ºC) as outlined 
in Scheme V-2.  The tetraanionic ema ligand was chosen to increase the solubility of the 
vanadyl-bound complex, and was expected to stabilize the highly oxidized metal center. 
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In addition, the N2S2 binding pocket of the ema ligand is good synthetic mimic of the 
CysGlyCys tripeptide motif (vide infra).190  Raymond and coworkers found that 
dianionic N2O2(V=O)2- complexes containing deprotonated amide donors were stable in 
 air in the solid state and in solution.181  In contrast, the amide-containing dianionic 
N2S2(V=O)2-, complex 3, is highly susceptible to oxidation in air in the solid state form 
and in solution.  The exposure of MeCN solutions of complex 3 to air results in a color 
change from blue to red.  X-ray quality crystals obtained by the slow diffusion of Et2O 
into a red MeCN solution revealed the commonly observed solution oxidation product, 
the decavanadate ion V10O286-.154  Complex 3 is soluble in a wide range of solvents 
(H2O, MeOH, MeCN, and CH2Cl2).   
 Synthesis of K2[(V=O)(CGC)], Complex 4.  The CysGlyCys (CGC) tripeptide 
has been complexed with Ni(II) and Cu(II) as metalloenzyme binding site mimics and 
shown to bind through deprotonated carboxyamido nitrogens and thiolates, producing a 
tetradentate N2S2 coordination environment.87,183,190  Similar to the Ni(CGC)2- complex, 
the CysGlyCys peptide derivative of vanadyl was prepared from the displacement of 
acacH from (VIV=O)(acac)2 by the presence of  two equivalents of KOH in DMF 
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solvent.  A second method used to prepare by 4 was accomplished by the addition of 
(V=O)SO4 to the deprotonated form of the ligand.   Both syntheses yielded a light green 
solid in ca. 70% yield.  Comparable to its synthetic analogue, complex 4 is extremely 
oxygen sensitive in both the solid and solution state; the light green color changes to red 
in the presence of oxygen. The dianionic vanadyl peptide complex is soluble in DMF 
and H2O.  The N2S2 coordination environment proposed for the CGC ligand bound to the 
vanadyl(IV) moiety is based on the comparison of its spectroscopic characterization and 
reactivity to the synthetic analogue complex 3. 
 Description of Molecular Structures of Complexes 1, 2 and 3.  Complexes 1–
3 were characterized by X-ray diffraction analysis and their molecular structures are 
presented in Figures V-5 and V-6 as thermal ellipsoid plots and salient metric parameters 
are shown in Table V-1.  Full structural reports are given in the Appendix.  The crystals 
of complex 3 exhibit pleochroism (blue/purple).  In all complexes, the expected square 
pyramidal coordination geometry is observed with the N2S2 donor set arranged around 
the basal plane with the vanadyl oxygen at the apex.  The vanadium atom is displaced 
from the basal plane toward the apical oxygen by 0.6525 (1), 0.6521 (2), and 0.7125 Å 
(3).  The N2S2 planes are quite regular with average deviation for 1 of 0.0341 Å 
(maximum and minimum deviation of 0.0365 Å by N2 and 0.0318 Å by S1), for 2 of 
0.0481 Å (maximum and minimum deviation of 0.0561 Å by N2 and 0.0402 Å by S1), 
and for 3 of 0.0674 Å (maximum and minimum deviation of 0.0775 Å by N2 and 0.0572 
Å by S1). The V-O bond distances are 1.600(3), 1.605(3), and 1.623(19) Å for 
complexes 1, 2, and 3, respectively.  A distance ranging between 1.56-1.60 is commonly 
 129
Figure V-5.  Molecular structures of the neutral VIV=O complexes [(bme-
daco)(V=O)], 1, (top), and [(bme-dach)(V=O)], 2, (bottom) shown as thermal 
ellipsoids at 50% probability. 
 
Figure V-6.  Molecular structure of the dianionic VIV=O complex  
[Et4N]2[(V=O)(ema)], 3, shown as thermal ellipsoids at 50% probability in 
different views. Left: side on as presented for [(bme-daco)(V=O)], 1, and [(bme-
dach)(V=O)], 2.  Right: bisecting the <S-V-S and <N-V-N angles.  The EtN4+ 
counter ions are not shown. The asymmetric unit contains one H2O of 
crystallization.    
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Table V-1.  Metric data for [(bme-daco)(V=O)], 1, [(bme-
dach)(V=O)], 2, and [Et4N]2[(V=O)(ema)], 3, (distance, Å; angle, 
deg). 
 1 2 3 
V(1)-O(1) 1.600(3) 1.605(3) 1.623(19) 
V(1)-N(1) 2.154(3) 2.122(3) 2.028(2) 
V(1)-N(2) 2.159(3) 2.111(3) 2.028(2) 
V(1)-S(1) 2.362(17) 2.341(12) 2.369(17) 
V(1)-S(2) 2.348(13) 2.346(12) 2.363(15) 
N(1)-V(1)-N(2) 84.14(12) 74.35(11) 78.41(10) 
S(1)-V(1)-S(1) 88.82(5) 98.20(5) 93.91(6) 
N(1)-V(1)-S(1) 84.23(10) 84.50(8) 82.33(8) 
N(2)-V(1)-S(2) 83.62(10) 83.34(9) 81.27(8) 
N(1)-V(1)-S(2) 144.33(9) 141.09(9) 137.28(7) 
N(2)-V(1)-S(1) 148.14(9) 146.39(9) 145.04(7) 
 
 
reported for the VO distance of vanadyl complexes in square pyramidal geometry; 
however, longer bond distances (>1.60) have been observed in vanadyl complexes 
bound in tetra anionic ligand sets.  In this series, the longer bond distance observed in 
complex 3 correlates with the IR data (vide infra).   
 The V-S distances are comparable to reported square pyramidal vanadyl(IV) 
complexes and likewise, the  V-Namine and V-Namide distances are within the normal 
range of V-N distances.  The N-V-N angle in complex 2 is pinched slightly more than 
that observed for the N2S2Ni analogue and this observed constraint is compensated by an 
increase in the S-V-S angle.  Similarly, a restriction in the N-V-N angle resulting in an 
opening in the S-V-S angle is observed in complex 3.   A molecule of water in the 
asymmetric unit links two adjacent complexes through hydrogen bonding interactions to 
the carboxamide oxygens producing a dimer through a closed loop.  To our knowledge, 
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complex 3 represents the first example of square pyramidal vanadyl(IV) complex bound 
to cis-dithiolates and aliphatic diamidates in the basal plane.  
 In complexes 1, 2 and 3 the N to S ethylene linkers are eclipsed across the N2S2 
plane.  In 1, the vanadium diazacyclohexane rings are in chair and boat configurations 
with the boat opposite to the oxygen side of the vanadyl.  In 2, the single vanadium 
diazacyclohexane ring is in the chair conformation and opposite to the oxygen side.  In 
this case, the vanadium diazacyclopentane ring is oriented toward the oxo side of the 
vanadyl. 
 
Infrared Analysis   
 Complexes 1 and 2 characteristically display a υ(V=O) band in the IR spectrum 
at ca. 978 cm-1, which is within the range reported for oxovanadium complexes (935-
1035 cm-1).168, 191-195  The most characteristic difference between the IR spectrum of 
neutral and dianionic vanadyl N2S2 complexes is that the vanadyl stretch in the latter is 
at a lower frequency, ca. 942 cm-1.  This significantly lower VO stretching frequency is 
consistent with the longer V=O bond distance as compared to the neutral N2S2(V=O) 
complexes.  Although the lengthening of the V-O bond distance seems to correlate with 
an increase of sigma donation from the electron rich basal plane ligands, it has been 
noted by Christou, et al. that a direct relationship between the ligand field in the basal 
plane and the V-O bond distance cannot be made.193  In fact, Christou et al. points out 
that dianionic complexes with electron-rich equatorial planes have similar V-O bond 
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distances to their neutral ligand sets (<1.6 Å), suggesting the V-O bond distance is 
influenced by other factors. 
  
Electron Paramagnetic Resonance (EPR) Spectroscopy   
 Vanadyl complexes are well suited for EPR spectral detection because of the 
VIV=O d1 ground state configuration.  This spectroscopic tool can provide information 
on the number and orientations of ligands bound to the vanadyl center.  For square 
pyramidal vanadyl complexes, the unpaired electron is found mainly in a dxy orbital, and 
complexes of this type exhibit spin Hamiltonian values with  gz < gx,y and Az > Ax,y.  The 
most abundant naturally occurring isotope of vanadium is 51V (> 99%), which has a 
unique nuclear spin, I, of 7/2.  The interaction of the unpaired electron with the nuclear 
spin of vanadium results in a signature eight line hyperfine splitting pattern (2I+1 = 8 
lines).   
 The frozen solution X-band EPR spectra of the neutral N2S2(V=O) derivatives, 
complexes 1 and 2, were recorded in DMF at 10 K (Figure V-7).  The spectra show the 
distinctive eight line pattern expected for a d1 V(IV) system.  The EPR parameters for  
the oxovanadium N2S2 complexes were determined by computer simulation of the 
experimental spectra (Table V-2). For comparison, Table V-2 includes EPR parameters 
reported for complexes with related donor sets.174, 179-180, 168, 194-195  Overall the g and A 
values are similar to other square pyramidal VIV=O2+ complexes.  Complexes 1 and 2 
display larger gx, gy, and Az values as compared to other N2S2 chromophores containing 
N-imine donors.  The spin Hamiltonian parameters of 1 and 2 better match the values  
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Figure V-7.  Frozen solution EPR spectra of  neutral N2S2(VIV=O) complexes in 
DMF: (a) [(bme-daco)(V=O)], 1; (b) [(bme-dach)(V=O)], 2.  Top: experimental 
spectrum.  Bottom: computer simulated spectrum. 
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Table V-2. EPR parameters for oxovanadium(IV) complexes.a 
Complex Donor set gZ gx gy Az Ax Ay 
[(bme-daco)(V=O)], 1 N2S2 1.968 1.991 1.9945 157.40 52.60 42.95 
[(bme-dach)(V=O)], 2 N2S2 1.967 1.9915 1.995 153.27 53.67 38 
(Et4N)2[(V=O)(ema)], 3 N2S2 1.970 2.001 2.001 153.27 60 33 
(K)2[(V=O)(CGC)], 4 N2S2 1.9695 1.999 1.999 156.41 51.60 42 
[(V=O)(ema)·(CH2)3], 5b N2S2 1.977 2.000 2.000 153.12 49 33 
VO(tsalen) c N2S2 1.978 1.986 1.986 148 51 51 
[VO(tsatln)] c N2S2 1.966 1.975 1.975 140 37 37 
[VO(tsalphen)] c N2S2 1.967 1.987 1.987 145 51 51 
[VO(mp)2]2- d,e O2S2 1.975 2.007 1.999 150 40 40 
[VO(mmppt)] 2 f,g O2S2 1.958 1.985 1.981 151 42 52 
[VO(salen)]h N2O2 1.955 1.986 1.989 166 56 55 
[VO(pycac)]i,j  N3O 1.9558 1.9777 1.9811 151.43 53.29 42.46 
VO(PAIS)k,l N3O 1.961 1.986 1.982 154 45 54 
aIn frozen DMF.  bIn frozen MeCN.  cReference 174.  dMeasured in frozen CH2Cl2/DMF.   eReference 194.  
fMeasured in frozen CH2Cl2/DMF.  gReference 168. hReference 195.  iReference 179. jMeasured in 
chloroform at 120 K.   kMeasured in frozen DMF/EtOH.  lReference 180. 
 
 
reported for O2S2 vanadyl complexes.  In MeCN, the dianionic (Et4N)2[(V=O)(ema)], 
complex 3, displays the eight line EPR spectra but the signals are very broad (Figure V-
8).  Identical results are obtained from frozen DMF solutions.  The ligand set in complex 
3 has a greater ability to delocalize electron density away from the vanadyl center, which 
may explain the broadened lines in the EPR spectrum.  The g-values are quite similar to 
the neutral N2S2 derivative, while the Ax value is slightly larger and the Ay is smaller.   
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 The EPR spectra of  (K)2[(V=O)(CGC)], complex 5,  in DMF shows the typical 
hyperfine splitting and anisotropic line shapes for a VIV=O2+ center (Figure V-8). Slight 
differences in the EPR spectral parameters are observed between 5 and its analogue, 
complex 4.  The largest difference is seen in the smaller Ax value and larger Ay value in  
5 as compared to 4.  In both complexes containing amide donors, the g-values are 
slightly larger than the complexes with amine donors. From a comparison of the EPR 
parameters of complex 5 to others in Table V-2, it is clear that 5 contains a V=O2+ held 
in a N2S2 coordination sphere. 
 Overall, the tetradentate square pyramidal VIV=O complexes presented herein fit 
into the trends observed for square pyramidal oxovanadium(IV) complexes.  These 
general trends show higher g-values and lower A values for basal plane S-donors as 
compared to their O,N analogues, and higher g-values for dianionic complexes as 
compared to their neutral counterparts.    The most notable difference between the 
present complexes and others of similar coordination environment is the larger Az, gx 
and gy parameters.   
 
Reactivity of (V=O)-bound Thiolates  
 The reactivity of nickel-bound thiolates in neutral and dianionic N2S2 complexes 
has been extensively explored. In fact, reactivity studies of numbers of metal N2S2 
complexes with M = Ni, Zn, Cu, and Fe have established that the sulfurs are readily 
alkylated, metallated, or oxygenated.131, 183-185   The incorporation of the vanadyl ion in 
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the N2S2 donor environment permits the examination of how the electron withdrawing 
vanadyl unit affects the nucleophilicity of the thiolate donors.  
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 Reactivity with 1,3-dibromopropane.  Reaction of neutral N2S2(V=O) 
complexes 1 and 2 with 1,3-dibromopropane did not lead to S-alkylated products, even 
under reflux conditions.  However, according to Scheme 4, the addition of neat 1,3-
dibromopropane to a blue MeCN solution of complex 3, VO(ema)2-, results in the 
formation of a white precipitate and  a grayish blue solution within 15 minutes.  Neutral 
complex 5, [(V=O)(ema)·(CH2)3], was isolated as X-ray quality crystals following 
filtration and slow diffusion of Et2O into a MeCN solution.   The υ(V=O) frequency in 
the ATR-FTIR spectrum displays a band at 986 cm-1, which is shifted positively by 41 
cm-1 compared to the dianionic vanadyl precursor, complex 3.  This shift is consistent 
with a decrease of electron density in the basal plane.  The EPR spectrum of 
[(V=O)((ema)·(CH2)3)] in frozen MeCN shows that the complex contains a paramagnetic 
VIV=O species (Figure V-9).  The spectrum differs from the precursor, complex 3, in that  
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Figure V-9.  Frozen solution EPR spectra of neutral complex  
[(V=O)((ema)·(CH2)3)],  5, in MeCN. Top: experimental spectrum.  Bottom: 
computer simulated spectrum. 
 
 
distinctive sharp hyperfine lines are observed, the gz value increases, and the Ax 
parameter decreases.   The most significant difference in the EPR parameters of complex 
5 as compared to the other complexes in this series is that complex 5 has a larger gz 
value.   
 Reactivity with cis-[(piperdine)2W(CO)4].  The tungsten tetracarbonyl 
derivatives of N2S2M (M = Ni or Zn, as ZnCl+) complexes have been used to establish 
the electron donating ability of the N2S2M unit as reported by the CO stretching 
frequencies.184-185, 190, 196-198  We carried out analogous studies with the N2S2(V=O) 
derivatives to determine if the S-thiolates were reactive towards W(CO)4 and to gain 
information regarding  their  electronic character.  While the neutral N2S2(V=O) 
 139
complexes 1 and 2 showed no tendency to form adducts when exposed to the typical 
precursor to W(CO)4 derivatives, the dianionic complexes 3 and 4  behaved similarly to 
the N2S2Ni analogues.  The preparation of dianionic vanadyl-W derivatives was 
accomplished via displacement of the labile piperdine ligands from the cis-
[(piperdine)2W(CO)4] complex as shown in Schemes 5 and 6.  The addition of a DMF 
solution of 3 (blue) or  4 (green) to cis-[(piperdine)2W(CO)4] in warm DMF  
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resulted in a color change to greenish-brown.  The reactants were stirred at 40 ºC for 15 
min and then stirred at room temperature for an additional 10 min. As shown in Figure 
V-10, the υ(CO) IR bands indicated quantitative conversion to a new species. 
1805 
1849 
1866 
1802 
1848 
1872 
*
1995 
177518251875192519752025
*
1995 
177518251875192519752025
Figure V-10.  IR spectra of the υ(VO) region in a DMF solution.  Top: 
[Et4N]2[(V=O)(ema)W(CO)4], 5.  Bottom: [K]2[(V=O)(CGC)W(CO)4], 6.  * = 
Band at ca. 1919 cm-1 indicates the formation of a (V=O)(N2S2)-W(CO)5 adduct. 
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 The carbonyl vibrational stretching frequencies are listed in Table V-3; Ni(II) 
and Zn(II) analogues are included for comparison.  For L2M(CO)4 complexes, four IR 
bands are observed (assigned to the two A1, B1, and B2 vibrational modes) for idealized 
C2v symmetry, and three absorptions are expected for LW(CO)5 complexes (assigned to 
the two A1 and E vibrational modes) for idealized C4v symmetry.199  According to the 
absorptions observed for both complexes 3 and 4, the formation of a mixture of the tetra- 
and pentacarbonyl products is a likely conclusion, with the tetracarbonyl adduct as the 
major species. The presence of the W(CO)5 species has been noted in Ni-W derivatives, 
and postulated to occur via a CO-scavenging process from the release of a CO from the 
W(CO)4 precursor or the initial Ni-W adduct, resulting in the thermodynamically stable 
pentacarbonyl Ni-W product.184, 190, 196  Scheme 5 and 6 displays the possible (V=O)-
W(CO)x (x = 4 or 5) products. While the single X-ray structures of complexes 6 and 7 
have not been determined, the vanadyl-W adducts depicted in Schemes 5 and 6 are based 
on the molecular structure of the pentacoordinate Zn-W analogue.184   
 Previous work in our group established that the Ni(ema)2- and Ni(CGC)2- 
complexes exhibit similar S-based donor ability as  determined by the  υ(CO) values of  
the W(CO)4 adducts of each complex.190  The position of the infrared υ(CO) bands for 
the W(CO)4 derivatives of [(V=O)(ema)]2- and  [(V=O)(CGC)]2- show that these two 
complexes are equal in S-based donor ability. 
 As compared to the dianionic N2S2Ni and (CGC)Ni analogue bound to W(CO)4, 
the υ(CO) values of the [N2S2(V=O)]W(CO)4 analogues are shifted positively by ca. 10-
20 cm-1.  This might be expected due to the electron-withdrawing nature of the vanadyl  
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Table V-3.  CO stretching frequencies (cm-1) and vibrational mode 
assignmentsa for W(CO)4 and W(CO)5 derivatives of (V=O)2+, Ni2+ and 
Zn2+ N2S2 complexes.b 
 
L2W(CO)4 A11  B1 A12 B2 
[VO(ema)] 2- 1995 1919c 1872 1848 1802 
[VO(CGC)] 2- 1995 1916c 1866 1849 1805 
[Ni(ema)]2-d 1986  1853 1837 1791 
[Ni(CGC)]2- 1988  1863 1845 1793 
[Zn-1’Cl]-e 1988  1861 1836 1801 
(Ni-1’)f 1996  1873 1852 1817 
(Ni-1*)f 1996  1871 1857 1816 
piperdine 
 
2000  1863 1852 1809 
LW(CO)5 A11 E  A12  
[Ni(ema)]2-g 2060 
(1967sh) 
1918  1868  
[Ni(CGC)]2-g 2061 
(1974sh) 
1917  1869  
[Zn-1’Cl]- 2063 1920  1869  
(Ni-1*) 2061 1920  1874  
 
aAssignments are based under pseudo-C2v and pseudo-C4v symmetry.  
bUnless otherwise noted, spectra were recorded in DMF solutions.  
cFormation of a N2S2(V=O)-W(CO)5 species.  dReference 190.  
eReference 184; 1’ = [N,N’-bis(2-mercaptoethyl)-N,N’-diazacycloheptane]. 
fReference 196; 1* = [N,N’-bis(2-mercaptoethyl)-N,N’-diazacyclooctane]. 
gReference 190;   Recorded in THF solutions. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
center, preventing less electron density to be transferred to the W(CO)4 unit.  Notably, 
the υ(CO) values of monoanionic [(Zn-1’Cl)W(CO)4]- are lower that those of the 
dianionic  [V=O(ema)W(CO)4]2-  and [V=O(CGC)W(CO)4]2- complexes.184    Despite 
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the dianionic character of the N2S2(V=O) moieties, the  υ(CO) stretching frequencies are 
most similar to the values reported for the W(CO)4 derivatives containing neutral N2S2Ni 
units.196  As mentioned earlier, the neutral N2S2(V=O) complexes 1 and 2 do not show 
any reactivity at the coordinated thiolate atoms, whereas  the dianionic complexes 3 and 
4 demonstrate that the electron withdrawing properties of the vanadyl ion do not quench 
the nucleophilic nature of the metal-bound thiolate(s). 
 
Conclusions 
 The synthesis and characterization of five N2S2(VIV=O) complexes, which 
incorporate either amine/thiolate, amide/thiolate or amide/thioether donor sets, have 
been described.  The neutral N2S2(VIV=O) species show stability to aerobic oxidation in 
the solid state, while the dianionic N2S2(VIV=O) species complexes are air sensitive.  
Amide donors in previously reported VIV=O complexes are linked to aromatic 
backbones, whereas the amido nitrogen donors presented herein extend from aliphatic 
chains, better mimicking amino acid binding sites. Three of the complexes were 
structurally characterized by X-ray diffraction analysis, the neutral complexes 1 and 2, 
and the dianionic complex 3. In each case, the complexes are five coordinate with square 
pyramidal geometry, and the V=O moiety is significantly displaced from the basal plane. 
 The suggested structure for the product of V=O2+ ion bound to the deprotonated 
CGC peptide is based on (1) the presence of a strong IR band at 940 cm-1, indicative of a 
V=O group, and (2) EPR parameters that parallel the complexes within this N2S2 series.  
Although dianionic [O2S2(VIV=O)] complexes have been shown to display similar V=O 
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stretching frequencies, the EPR parameters for the [(V=O)(CGC)]2- complex more 
closely resemble those from V=O2+ in a N2S2 ligand field.194  From these similar 
spectroscopic results, we conclude that the vanadyl ion is bound to an N2S2 coordination 
environment within the CGC peptide. This is consistent with the known N2S2 binding of 
CGC complexes with Cu2+ and Ni2+.  
 The EPR spectra indicate the presence of paramagnetic VIV=O species in all of 
the complexes presented herein.  The g and Az values are within ranges typical for N2S2 
donor sets bound to a oxovanadium centers. The EPR parameters are indicative of strong 
σ-donation from the basal plane ligands (g-values 1.91-2.0).181   The replacement of the 
amine donors with amides results in slightly higher gx and gy values, which suggests a 
slight increase in σ-donation in the basal plane.  Specifically, complex 3 displays very 
broad signals in its EPR spectrum.  The absence of sharp hyperfine splitting in complex 
3 may be due to the delocalization of the unpaired electron away from the metal center, 
thus reducing the unpaired electron coupling with the vanadium nucleus.  In contrast, the 
S-alkylated complex 5 displays sharp hyperfine signals in its EPR spectrum.  As the 
electron density on the S-thiolates was shifted from S:→Ni to covalent bond formation 
with carbon atoms, the electron density becomes localized on the amido donors. This 
assumption is based on previous NBO analysis and electrostatic potential maps of the 
Ni2+ analogues of complexes 3 and 5.190  In the Ni2+ systems, the computational results 
indicated that the electron density is delocalized over the dianionic [Ni(ema)]2- complex 
(largely on the thiolate S-lone pairs and amido N-lone pairs).  The principal resonance 
structure determined from NBO analysis found covalent bond character in the Ni-S bond 
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and dative bond character in Ni-N bond.  The NBO analysis of the [Ni(ema)]·(CH2)3 
complex derived from alkylation shows that the electron distribution becomes localized 
on the amido nitrogens resulting in Ni-S dative bond character and Ni-N covalent 
character.  Furthermore, the significantly lower V=O stretching frequencies observed for 
the dianionic complexes, 3 and 4, may be a result of the increase in electron richness 
about the VIV=O center, and upon alkylating 3 to yield 5, the υ(V=O) band shifts to 986 
cm-1. Together these results support our hypothesis that the electronic distribution of 
complex 3 is delocalized, which in turn affects the interaction of the unpaired electron 
with the vanadium nucleus.   A detailed analysis of the EPR parameters in terms of MO 
properties in correlation with electronic absorption spectroscopy data would further aid 
in the interpretation of the affects of the N2S2 ligand field on the vanadyl center.   In 
addition, DFT studies (NBO and electrostatic potential analysis) would be beneficial in 
probing the electron distribution in these N2S2(VIV=O) complexes. 
 There was no evidence of reactivity of the thiolates in the neutral N2S2(VIV=O) 
complexes.  However, S-site modification of complexes 3 an 4 was accomplished by the 
formation of W(CO)x derivatives.  Regardless of the electron richness of the  N2S2 
ligand field in complexes 3 and 4, the S-based donor ability as  determined by the  
υ(CO) values of  the W(CO)4 adducts showed that the S-donors bound to the V=O 
moiety produce a ligand field that is similar to the donor ability of N2S2Ni in neutral 
N2S2Ni-W(CO)4 adducts.   
 The biological relevance of thiolates and amide binding in proteins has been 
noted in the Introduction.  This work adds to the chemistry of oxovanadium  binding to 
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N-amides from aliphatic linkages and S-thiolates, and demonstrates that stable VIV=O 
complexes can be formed with binding sites that consist of such donors. 
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CHAPTER VI 
CONCLUSIONS 
 
 
Summary and Perspectives  
 Much of bioinorganic chemistry is inspired by metal binding sites that involve 
nitrogen and sulfur-rich coordination environments derived from the amino acid side 
chains of histidine, methionine and cysteine, as well as the N-terminal amine and the 
deprotonated carboxyamido nitrogen of the peptide bond.  Such NxSy binding sites in 
biomolecules are found in acetyl coA synthase, nitrile hydratase, NikR, and the nickel-
dependent superoxide dismutase.1, 25, 177 Approaches to synthetic analogues of such 
ligation to transition metals have included a wide variety of ligand sets, but with little 
emphasis on thiolate/imidazole combinations. Inspired by the metal binding sites in 
NiSOD and NikR, small molecule models designed to explore the structural and 
electronic effects of both thiolate and imidazole donors bound to a nickel center were 
discussed in the first part of this dissertation.  
Commonly used as histidine biomimetics are multidentate imidazole type ligands 
held in rigid settings.200  For N3 donor sets that mimic the tri-histidine motif in 
metalloprotein metal binding sites, the scorpionate ligands, tris(pyrazoyl)borate, (Tp-), 
and tris(pyrazol-1-yl)methane, (Tpm), are frequently used (Figure VI-1).  These ligand 
systems are easily synthesized and functionalized.  The center boron or carbon anchor 
can be substituted by another atom or group, and the tripodal arms can be derivatized to 
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include a variety of different ligand donors.    In all such ligand systems, the orientation 
of the histidine mimic pyrazoyl or imidazole N-donor ligand is controlled by the tripodal 
arm linker torsion angles.  While biomimetics that use such C3 ligands have most 
certainly advanced metallobiochemistry, monodentate ligands, such as imidazoles, are 
expected to more accurately model the flexibility in polypeptide chains and to be more 
appropriate for square planar coordination geometries. 
 In my work, simple imidazoles were incorporated into nickel-thiolate complexes 
to produce N,S coordination environments related to those observed in NiSOD and 
NikR.  During my endeavors, other small molecule models of the NiSOD active site 
were reported, and these complexes are shown in Figure VI-2.81, 90, 102-103, 104, 200-201  
Research in the area of N2S2Ni chemistry has firmly established that electrophilic and 
oxidative reactivity occurs at the S-thiolates.202  As predicted by computational studies, 
the first generation synthetic analogues concentrated on incorporating a mixed 
amine/amide set into the N2S2 coordination sphere in order to suppress reactivity at the 
nickel bound thiolates and promote nickel-based chemistry.100-101   The first biomimetic 
Tp- 
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Tpm 
Figure VI-1. Basic tripodal ligand systems: Tp- and Tpm. 
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to incorporate a mixed amine/amide donor set was presented by Shearer et al. (Figure 
VI-2a).102-103  This complex exhibited enhanced stability toward oxygenation, but did not 
show SOD activity.  In addition, an amine/amide mixed donor set with an N2S2Ni 
coordination sphere was accessed via dimer cleavage by Harrop et al. (Figure VI-2b).90 
This complex displayed similar spectroscopic properties as did the model by Shearer et 
al., but also did not exhibit NiSOD chemistry.   
 Our group investigated thiolate modification by alkylation or S-oxygenation of 
the Ni(ema)2- complex, which contains two amide and two thiolate donors.81  In line 
with our previous studies, we found that such sulfur protection directs reactivity to the 
nickel.  In addition to demonstrating that stable S-oxygenates can be produced from 
dianionic N2S2Ni complexes (Figure VI-2e), we came to the conclusion that the absence 
of such reactivity in the NiSOD active site was most reasonably due to kinetic control.  
Subsequent to our reports, Jenson and coworkers presented NiSOD model complexes 
utilizing the tripodal ligand, hydrotris(3-phenyl-5-methylpyrazolyl)borate ligand 
(TpPh,Me), and organoxanthate or dithiocarbamates ligands to produce N2S2Ni square-
planar and N3S2Ni pyramidal complexes (Figure VI-2c and d).104  As shown for the other 
model complexes, spectroscopic features were similar to the native active site, but SOD 
activity was not reported.  The synthetic N3SNi mimic by Grapperhaus et al. shown as f 
in Figure VI-2 will be discussed below.201  A final note on NiSOD biomimetics, is that 
the only functional SOD models that have been reported to date contain nickel centers 
coordinated within peptidic coordination environments.203-204  Such constructs have been 
reported by Shearer and coworkers in which they demonstrated NiSOD catalytic activity  
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for a nickel(II) ion coordinated to a 12-mer peptide, and by Laurence et al. who has 
prepared a functional model utilizing a asparagine-cysteine-cysteine tripeptide bound to 
a nickel(II) center.203-204 
 My original synthetic vision for an ideal NiSOD enzyme active site model 
complex accessible from known square planar N2S2 nickel complexes was to have a 
dangling imidazole attached from a thiolate or from a thioether sulfur with capability to 
coordinate in the axial site on oxidation of NiII to NiIII, see Chapter III.   Both plans were 
reasonable based on prior work.  Our group had previously demonstrated that N2S 
thiolate bridged nickel dimers could be cleaved with nucleophiles, and we had 
established that tetradentate N2S2 bonding is maintained after S-alkylation by reagents 
that provide an additional binding site.109, 122-125  The first plan to include an imidazole 
linker from a thiolate ligand was to be accomplished by the following reaction: 
 
Confirmation of the mononuclear formulation was provided by +ESI-MS analysis (m/z = 
357) and elemental analysis, and the N2S2 coordination was proposed consistent with 
UV-vis spectral data (λmax = 450, 352, 284, 212 nm).  However, the electrochemistry in 
MeCN did not show a reversible oxidation event in a range that would imply nickel- 
based chemistry, which would have promoted the axial imidazole binding.  Only one 
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irreversible oxidation event was observed at +24 mV vs. Fc+/Fc and that was assigned to 
S-oxidation.  Attempts to obtain X-ray quality crystals of this complex were 
unsuccessful, and further study was less promising than other lines of research.   
 A second plan was carried out to incorporate a dangling imidazole ligand via the 
alkylation of the thiolate using 4-(chloromethyl)-5-methyl-imidazole·HCl, as shown in 
Chapter III.  In this case, X-ray quality crystals were obtained; however, the molecular 
structure revealed a preference for N-imidazole binding in the square plane of NiII over 
that of the S-thioether donor.   Although DFT computations found a difference of only 
3.34 kcal/mol between the N-imidazole-bound versus the S-thioether-bound complex, a 
switch of the donor from the N-imidazole to the S-thioether binding could not be 
achieved via the protonation of the imidazole ligand.  These results demonstrated the 
strong binding of the imidazole nitrogen.  The chain length connecting the imidazole to 
the diazacycle backbone was the perfect length to promote the imidazole binding in its 
favored orientation, that is, orthogonal to the NiL4 square plane.   
 While the original intent of this work to obtain a NiSOD model with a hemilabile 
axial imidazole ligand was not achieved, the study of imidazole/thiolate donor 
combination bound to nickel became, in our opinion, a more significant focus.   A 
second nickel-imidazole complex was designed as a first coordination sphere molecular 
model of the Ni-binding site of the Nik-R protein and accessed through dimer cleavage 
reactions using imidazole.   This complex differed from the NiSOD model complex in 
that the N-imidazole ligand was not tethered to the N2S framework, producing a 
tridentate and monodentate N2N’S ligand set.  Despite this difference, both molecular 
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structures revealed that the imidazole plane (tethered or untethered to the N2S 
framework) favored a nearly perpendicular orientation with respect to the nickel square 
plane.  In contrast, a bis-imidazole N4Ni complex, in which both imidazole ligands were 
connected to the diazacycle backbone by a methylene linkage, was prepared.  In this 
case, the molecular structure found that the imidazole ligands were held roughly 
coplanar with the nickel square plane.  This series of NxSyNi imidazole complexes 
demonstrated the influence of the length of the carbon chain attached to the imidazole 
ligand; a chain with more flexibility allows the imidazole ligand to orient in an 
apparently preferred orthogonal position, whereas the shorter carbon chain restricted the 
imidazole ligand to a planar orientation.   Grapperhaus and coworkers synthesized an 
N3SNi complex, analogous to my complexes, which contained an amide donor in place 
of one of the amines (Figure VI-2f).201  As observed in our bis-imidazole nickel 
complex, the one carbon linker forces the imidazole plane to orient parallel to the nickel 
square plane.   
 Given that the imidazole ligand was not tethered in one of the imidazole 
N2N’SNi complexes, we pursued the unique opportunity to investigate the preferred 
orientation of this imidazole N2N’SNi complex utilizing VT 1H NMR spectroscopy.  The 
term “unique” refers to the asymmetry of the N2N’SNi complex due to the 
diazacycloheptane ligand which renders one face of the Ni-square plane different from 
the other.  Thus, variable temperature 1H NMR was used to examine the solution phase 
conformations and interconversions, and in correlation with these results, density 
functional theory computations related the orientation of the imidazole with respect to 
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the N2N’SNi square plane to the observed fluxionality and activation parameters.  
Furthermore, the computational studies indicated that the frontier molecular orbitals 
were predominately derived from the interactions between the S-thiolate and Ni center.  
While imidazole ligands have the potential to participate in π-donor interactions, the 
analysis of the ground and the DFT derived transition state computational results showed 
only σ-bonding orbitals with large contributions from Ni and the N-donor imidazole 
nitrogen.   
Based on this paradigm for imidazole binding in N2SNi planes, a series of 
monodentate heterocycles was used to cleave dimeric precursors to produce monomeric 
square planar [N2SNiL]n+ complexes in order to better understand factors that influence 
the orientation of imidazole ligands found within a flexible coordination environment.   
The targeted monomeric square planar [N2SNiL]n+ complexes were designed to 
encompass different electronic and steric properties.  The differences in electronic 
makeup were governed by the pKa of the monodentate donor atom’s conjugate acid in 
each ligand. The steric character was altered in two ways: (1) the steric bulk of the 
monodentate donor atom; and (2), the substituent on the N-donor from the 
diazacycloheptane frame.    
The isolation of the target monomeric square planar [N2SNiL]n+ complexes and 
characterization by X-ray diffraction analysis revealed that regardless of the electronic or 
steric makeup, the plane of the monodentate ligand had a preference to orient in a nearly 
orthogonal position to the nickel square plane.  This result suggested that the orientation 
of the monodentate ligand was dictated largely by minimization of steric interactions of 
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the monodentate ligand with the steric constraints of N2SNi binding site that allowed a 
maximum σ-bonding interaction.  Nevertheless, in the case of the imidazole ligands, a 
slight deviation from orthogonality was observed, and this tilt directed the imidazole C-2 
C-H toward the S-thiolate atom. Furthermore, DFT computations suggested a minor 
electronic contribution between the imidazole C-2 C-Hδ+ and the Sδ- influenced the 
stability of the ground state and in the imidazole rotation process, the transition state 
structures.  The interaction was interpreted as an intramolecular donor/acceptor 
interaction.  This hypothesis was confirmed by computational studies which found that 
this type of donor-acceptor interaction was magnified in O-analogues, where coplanar 
arrangements in the ground state of N2ONimidNi complexes were predicted.   
That imidazoles can be involved in intramolecular donor-acceptor interactions 
has been previously observed.133-141  As mentioned in Chapter IV, a survey of the 
Cambridge data base found ten square planar nickel complexes containing a 
monodentate imidazole donor, but within different nickel first coordination sphere 
environments.  These compounds were prepared due to their ability to self-assemble in 
extended arrays originating from intermolecular H-bonding interactions and π-π stacking 
interactions.   The molecular structures of the NiII-Schiff base complexes containing hard 
O-donors cis to the unsubstituted imidazole monodentate ligand found the imidazole in a 
nearly coplanar orientation, with the C2 oriented towards the O-donor, consistent with 
our computational findings.  
Overall, our simple [N2SNiL]n+ systems containing imidazole ligands have 
proved, that much like the protein coordination environment, many factors, such as 
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steric bulk and internal electrostatic interactions, can affect the imidazole ligand 
orientation without disturbing the σ-bond between the Ni and the N-imidazole. As 
described in Chapter I, the ground state binding orientation of the His-imidazole has 
profound effects on the function of biomolecules particularly well studied.  The studies 
presented in this dissertation have expanded our knowledge of the fundamental 
coordination chemistry of square planar NxSyNi complexes containing imidazole 
ligands.  It is expected that preferences in orientation due to cis-O or cis-S donor atoms 
could eventually be recognized as having profound effects in nickel 
biomolecules/proteins.   
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APPENDIX  
 
CRYSTALLOGRAPHIC DATA FOR STRUCTURES 
 
 
 
[(me-mdach)Ni]2(BF4)2 [(me-mdach)-NiCl]2 
[(mmp-mdach)Ni(Im)]Cl [Ni-1’(CH2-mIm)]Cl 
[(bmIme-dach)Ni](BF4)2
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py-[(mmp-mdach)Ni]2[BF4]2 mIm-[(mmp-mdach)Ni]2[BF4]2 
[(mmp-mdach)Ni(mIm)][BF4] [(mmp-mdach)Ni(ipIm)][BF4] 
[(mmp-mdach)Ni(me2NHC)][I] Im-[(mmp-dach)Ni]2[BF4]2 
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[(bme-dach)(V=O)] 
[(bme-daco)(V=O)] 
[Et4N]2[(V=O)(ema)]
 
 
 
 
 
 
 
 
 
 
 
 
 
Table A-1.  Crystal data and structure refinement for [(me-mdach)Ni]2(BF4)2. 
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Empirical formula  C16 H34 Cl2 N4 Ni2 S2 
Formula weight  534.91 
Temperature  110(2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group  P2(1)/c 
Unit cell dimensions a = 7.599(3) Å   α= 90°. 
 b = 8.361(3) Å β = 102.236(6)°. 
 c = 17.927(6) Å γ = 90°. 
Volume 1113.1(7) Å3 
Z 2 
Density (calculated) 1.596 Mg/m3 
Absorption coefficient 2.128 mm-1 
F(000) 560 
Crystal size 0.15 x 0.13 x 0.12 mm3 
Theta range for data collection 4.02 to 24.99°. 
Index ranges -9<=h<=9, -9<=k<=9, -21<=l<=21 
Reflections collected 8046 
Independent reflections 1899 [R(int) = 0.0549] 
Completeness to theta = 24.99° 97.0 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.7843 and 0.7408 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 1899 / 0 / 119 
Goodness-of-fit on F2 1.155 
Final R indices [I>2sigma(I)] R1 = 0.0597, wR2 = 0.1337 
R indices (all data) R1 = 0.0690, wR2 = 0.1369 
Largest diff. peak and hole 0.730 and -0.462 e.Å-3 
 
 
 
 
Table B2.   Bond lengths [Å] and angles [°] for [(me-mdach)Ni]2(BF4)2. 
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_____________________________________________________  
Ni(1)-N(1)  2.084(5) 
Ni(1)-N(2)  2.144(5) 
Ni(1)-Cl(1)  2.3315(17) 
Ni(1)-S(1)#1  2.3461(18) 
Ni(1)-S(1)  2.3693(17) 
S(1)-C(1)  1.829(6) 
S(1)-Ni(1)#1  2.3461(18) 
N(1)-C(2)  1.468(8) 
N(1)-C(6)  1.487(8) 
N(1)-C(3)  1.491(8) 
N(2)-C(8)  1.463(8) 
N(2)-C(7)  1.478(7) 
N(2)-C(5)  1.505(9) 
C(1)-C(2)  1.520(8) 
C(3)-C(4)  1.501(9) 
C(4)-C(5)  1.523(9) 
C(6)-C(7)  1.562(8) 
N(1)-Ni(1)-N(2) 77.3(2) 
N(1)-Ni(1)-Cl(1) 144.45(15) 
N(2)-Ni(1)-Cl(1) 92.91(14) 
N(1)-Ni(1)-S(1)#1 100.60(15) 
N(2)-Ni(1)-S(1)#1 96.77(15) 
Cl(1)-Ni(1)-S(1)#1 114.57(6) 
N(1)-Ni(1)-S(1) 86.66(14) 
N(2)-Ni(1)-S(1) 162.82(15) 
Cl(1)-Ni(1)-S(1) 96.61(6) 
S(1)#1-Ni(1)-S(1) 92.25(5) 
C(1)-S(1)-Ni(1)#1 104.6(2) 
C(1)-S(1)-Ni(1) 96.53(19) 
Ni(1)#1-S(1)-Ni(1) 87.75(5) 
C(2)-N(1)-C(6) 110.0(5) 
C(2)-N(1)-C(3) 111.7(5) 
 
Table B-2 (continuted) 
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C(6)-N(1)-C(3) 111.4(5) 
C(2)-N(1)-Ni(1) 111.6(3) 
C(6)-N(1)-Ni(1) 107.1(3) 
C(3)-N(1)-Ni(1) 104.7(4) 
C(8)-N(2)-C(7) 110.5(5) 
C(8)-N(2)-C(5) 109.2(5) 
C(7)-N(2)-C(5) 110.2(5) 
C(8)-N(2)-Ni(1) 114.0(4) 
C(7)-N(2)-Ni(1) 105.8(4) 
C(5)-N(2)-Ni(1) 107.0(4) 
C(2)-C(1)-S(1) 111.3(4) 
N(1)-C(2)-C(1) 111.8(5) 
N(1)-C(3)-C(4) 113.7(5) 
C(3)-C(4)-C(5) 114.7(5) 
N(2)-C(5)-C(4) 112.7(5) 
N(1)-C(6)-C(7) 111.6(5) 
N(2)-C(7)-C(6) 111.1(5) 
_____________________________________________________________  
Symmetry transformations used to generate equivalent atoms:  
#1 -x+1,-y+1,-z+1       
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Table B-3.  Crystal data and structure refinement for [(me-mdach)-NiCl]2. 
 
Empirical formula  C8 H17 B F4 N2 Ni S 
Formula weight  318.82 
Temperature  110(2) K 
Wavelength  1.54178 Å 
Crystal system  Orthorhombic 
Space group  P2(1)2(1)2 
Unit cell dimensions a = 10.1120(16) Å α= 90°. 
 b = 19.466(3) Å β= 90°. 
 c = 6.0785(9) Å γ = 90°. 
Volume 1196.5(3) Å3 
Z 4 
Density (calculated) 1.770 Mg/m3 
Absorption coefficient 4.293 mm-1 
F(000) 656 
Crystal size 0.20 x 0.20 x 0.01 mm3 
Theta range for data collection 4.54 to 59.96°. 
Index ranges -9<=h<=11, -20<=k<=21, -6<=l<=6 
Reflections collected 7385 
Independent reflections 1597 [R(int) = 0.1327] 
Completeness to theta = 59.96° 92.2 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.9583 and 0.4806 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 1597 / 268 / 238 
Goodness-of-fit on F2 1.024 
Final R indices [I>2sigma(I)] R1 = 0.0650, wR2 = 0.1469 
R indices (all data) R1 = 0.0927, wR2 = 0.1578 
Absolute structure parameter 0.0(3) 
Largest diff. peak and hole 1.550 and -0.431 e.Å-3 
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Table B-4.   Bond lengths [Å] and angles [°] for [(me-mdach)-NiCl]2. 
_____________________________________________________  
Ni(1)-N(2)  1.914(8) 
Ni(1)-N(1)  1.923(8) 
Ni(1)-S(1')  2.106(17) 
Ni(1)-S(1')#1  2.288(17) 
Ni(1)-S(1)  2.069(19) 
Ni(1)-S(1)#1  2.245(16) 
Ni(1)-Ni(1)#1  2.837(3) 
S(1)-C(1)  1.800(17) 
S(1)-Ni(1)#1  2.245(16) 
S(1')-C(1')  1.785(17) 
S(1')-Ni(1)#1  2.288(17) 
N(1)-C(8')  1.499(18) 
N(1)-C(3)  1.503(12) 
N(1)-C(6)  1.520(12) 
N(1)-C(2)  1.53(2) 
N(2)-C(5)  1.464(12) 
N(2)-C(8)  1.523(19) 
N(2)-C(7)  1.529(11) 
N(2)-C(2')  1.542(18) 
C(1)-C(2)  1.53(2) 
C(1')-C(2')  1.53(2) 
C(3)-C(4)  1.552(14) 
C(4)-C(5)  1.509(13) 
C(6)-C(7)  1.495(14) 
B13-F43  1.353(18) 
B13-F13  1.359(13) 
B13-F33  1.378(16) 
B13-F23  1.410(15) 
B14-F44  1.354(18) 
B14-F14  1.358(14) 
B14-F34  1.378(17) 
B14-F24  1.409(15) 
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Table B-4 (continued) 
 
N(2)-Ni(1)-N(1) 83.6(3) 
N(2)-Ni(1)-S(1') 95.7(4) 
N(1)-Ni(1)-S(1') 177.8(6) 
N(2)-Ni(1)-S(1')#1 176.4(5) 
N(1)-Ni(1)-S(1')#1 99.7(4) 
S(1')-Ni(1)-S(1')#1 81.1(6) 
N(2)-Ni(1)-S(1) 178.3(6) 
N(1)-Ni(1)-S(1) 96.4(5) 
S(1')-Ni(1)-S(1) 84.2(5) 
S(1')#1-Ni(1)-S(1) 4.6(8) 
N(2)-Ni(1)-S(1)#1 100.5(4) 
N(1)-Ni(1)-S(1)#1 175.4(5) 
S(1')-Ni(1)-S(1)#1 6.4(9) 
S(1')#1-Ni(1)-S(1)#1 76.2(5) 
S(1)-Ni(1)-S(1)#1 79.6(6) 
N(2)-Ni(1)-Ni(1)#1 129.5(2) 
N(1)-Ni(1)-Ni(1)#1 129.3(2) 
S(1')-Ni(1)-Ni(1)#1 52.7(5) 
S(1')#1-Ni(1)-Ni(1)#1 47.0(4) 
S(1)-Ni(1)-Ni(1)#1 51.6(4) 
S(1)#1-Ni(1)-Ni(1)#1 46.3(5) 
C(1)-S(1)-Ni(1) 96.2(10) 
C(1)-S(1)-Ni(1)#1 118.3(10) 
Ni(1)-S(1)-Ni(1)#1 82.1(6) 
C(1')-S(1')-Ni(1) 96.7(9) 
C(1')-S(1')-Ni(1)#1 118.1(11) 
Ni(1)-S(1')-Ni(1)#1 80.3(6) 
C(8')-N(1)-C(3) 108.1(11) 
C(8')-N(1)-C(6) 102.4(10) 
C(3)-N(1)-C(6) 112.1(8) 
C(8')-N(1)-C(2) 20.6(10) 
C(3)-N(1)-C(2) 111.4(14) 
C(6)-N(1)-C(2) 117.3(11) 
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Table B-4 (continued) 
 
C(8')-N(1)-Ni(1) 122.4(9) 
C(3)-N(1)-Ni(1) 108.6(6) 
C(6)-N(1)-Ni(1) 102.9(6) 
C(2)-N(1)-Ni(1) 103.4(10) 
C(5)-N(2)-C(8) 118.5(13) 
C(5)-N(2)-C(7) 109.6(7) 
C(8)-N(2)-C(7) 98.2(10) 
C(5)-N(2)-C(2') 107.9(12) 
C(8)-N(2)-C(2') 21.8(9) 
C(7)-N(2)-C(2') 120.0(10) 
C(5)-N(2)-Ni(1) 107.2(6) 
C(8)-N(2)-Ni(1) 116.9(12) 
C(7)-N(2)-Ni(1) 105.1(6) 
C(2')-N(2)-Ni(1) 106.4(9) 
C(2)-C(1)-S(1) 101.8(16) 
N(1)-C(2)-C(1) 113.2(15) 
C(2')-C(1')-S(1') 105.1(13) 
C(1')-C(2')-N(2) 114.3(14) 
N(1)-C(3)-C(4) 113.8(8) 
C(5)-C(4)-C(3) 112.1(9) 
N(2)-C(5)-C(4) 117.8(8) 
C(7)-C(6)-N(1) 111.5(8) 
C(6)-C(7)-N(2) 109.3(8) 
F43-B13-F13 112.1(13) 
F43-B13-F33 108.2(12) 
F13-B13-F33 110.2(12) 
F43-B13-F23 108.7(12) 
F13-B13-F23 110.0(10) 
F33-B13-F23 107.4(12) 
F44-B14-F14 111.6(14) 
F44-B14-F34 107.9(13) 
F14-B14-F34 110.3(13) 
F44-B14-F24 108.9(13) 
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Table B-4 (continued) 
 
F14-B14-F24 110.3(11) 
F34-B14-F24 107.8(13) 
_____________________________________________________________  
Symmetry transformations used to generate equivalent atoms:  
#1 -x,-y,z       
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Table B-5.  Crystal data and structure refinement for [(mmp-mdach)Ni(Im)]Cl. 
 
Empirical formula  C14 H29 Cl N4 Ni O S 
Formula weight  395.63 
Temperature  110(2) K 
Wavelength  0.71073 Å 
Crystal system  Orthorhombic 
Space group  Pna2(1) 
Unit cell dimensions a = 9.954(3) Å α= 90°. 
 b = 21.542(8) Å β = 90°. 
 c = 9.090(3) Å γ= 90°. 
Volume 1949.3(11) Å3 
Z 4 
Density (calculated) 1.348 Mg/m3 
Absorption coefficient 1.246 mm-1 
F(000) 840 
Crystal size 0.30 x 0.10 x 0.10 mm3 
Theta range for data collection 2.43 to 25.00°. 
Index ranges -11<=h<=7, -25<=k<=24, -6<=l<=10 
Reflections collected 4018 
Independent reflections 2350 [R(int) = 0.0956] 
Completeness to theta = 25.00° 93.6 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.8856 and 0.7063 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 2350 / 192 / 207 
Goodness-of-fit on F2 1.020 
Final R indices [I>2sigma(I)] R1 = 0.0634, wR2 = 0.1046 
R indices (all data) R1 = 0.1162, wR2 = 0.1205 
Absolute structure parameter 0.00(4) 
Largest diff. peak and hole 0.858 and -0.577 e.Å-3 
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Table B-6.   Bond lengths [Å] and angles [°] for [(mmp-mdach)Ni(Im)]Cl. 
_____________________________________________________  
Ni(1)-N(3)  1.888(9) 
Ni(1)-N(1)  1.897(10) 
Ni(1)-N(2)  1.949(10) 
Ni(1)-S(1)  2.149(3) 
N(1)-C(2)  1.489(15) 
N(1)-C(6)  1.517(17) 
N(1)-C(3)  1.577(14) 
C(1)-C(10)  1.390(17) 
C(1)-C(2)  1.528(15) 
C(1)-C(9)  1.607(16) 
C(1)-S(1)  1.852(12) 
N(2)-C(5)  1.337(16) 
N(2)-C(7)  1.468(17) 
N(2)-C(8)  1.623(17) 
N(3)-C(13)  1.342(12) 
N(3)-C(11)  1.372(13) 
C(3)-C(4)  1.541(5) 
N(4)-C(13)  1.326(13) 
N(4)-C(12)  1.413(13) 
C(4)-C(5)  1.550(5) 
C(6)-C(7)  1.611(17) 
C(11)-C(12)  1.316(14) 
O11-C11  1.679(19) 
O12-C12  1.684(19) 
N(3)-Ni(1)-N(1) 175.5(4) 
N(3)-Ni(1)-N(2) 97.1(4) 
N(1)-Ni(1)-N(2) 81.5(5) 
N(3)-Ni(1)-S(1) 91.4(3) 
N(1)-Ni(1)-S(1) 90.4(3) 
N(2)-Ni(1)-S(1) 170.6(4) 
C(2)-N(1)-C(6) 120.8(10) 
C(2)-N(1)-C(3) 105.6(9) 
C(6)-N(1)-C(3) 101.5(9) 
 186
Table B-6 (continuted) 
 
C(2)-N(1)-Ni(1) 114.5(7) 
C(6)-N(1)-Ni(1) 108.2(8) 
C(3)-N(1)-Ni(1) 103.9(7) 
C(10)-C(1)-C(2) 112.1(10) 
C(10)-C(1)-C(9) 111.0(10) 
C(2)-C(1)-C(9) 108.3(10) 
C(10)-C(1)-S(1) 114.4(10) 
C(2)-C(1)-S(1) 103.0(7) 
C(9)-C(1)-S(1) 107.6(8) 
C(1)-S(1)-Ni(1) 99.1(4) 
C(5)-N(2)-C(7) 123.0(11) 
C(5)-N(2)-C(8) 101.1(9) 
C(7)-N(2)-C(8) 95.3(10) 
C(5)-N(2)-Ni(1) 113.8(10) 
C(7)-N(2)-Ni(1) 107.3(8) 
C(8)-N(2)-Ni(1) 114.8(8) 
N(1)-C(2)-C(1) 115.0(10) 
C(13)-N(3)-C(11) 103.7(9) 
C(13)-N(3)-Ni(1) 125.1(7) 
C(11)-N(3)-Ni(1) 131.1(7) 
C(4)-C(3)-N(1) 112.0(10) 
C(13)-N(4)-C(12) 106.5(9) 
C(3)-C(4)-C(5) 120.0(10) 
N(2)-C(5)-C(4) 102.1(11) 
N(1)-C(6)-C(7) 111.1(11) 
N(2)-C(7)-C(6) 102.5(12) 
C(12)-C(11)-N(3) 112.5(10) 
C(11)-C(12)-N(4) 105.2(10) 
N(4)-C(13)-N(3) 112.0(9) 
_____________________________________________________________  
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Table B-7.  Crystal data and structure refinement for [Ni-1’(CH2-mIm)]Cl. 
 
Empirical formula  C14 H25 Cl N4 Ni S2 
Formula weight  407.66 
Temperature  110(2) K 
Wavelength  0.71073 Å 
Crystal system  Triclinic 
Space group  P-1 
Unit cell dimensions a = 7.409(4) Å α = 75.918(9)°. 
 b = 11.169(6) Å β= 71.534(9)°. 
 c = 11.640(6) Å γ = 71.494(9)°. 
Volume 855.4(8) Å3 
Z 2 
Density (calculated) 1.583 Mg/m3 
Absorption coefficient 1.535 mm-1 
F(000) 428 
Crystal size 0.16 x 0.08 x 0.02 mm3 
Theta range for data collection 1.87 to 27.49°. 
Index ranges -9<=h<=9, -14<=k<=14, -14<=l<=15 
Reflections collected 9125 
Independent reflections 3810 [R(int) = 0.3126] 
Completeness to theta = 27.49° 96.7 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.9670 and 0.7868 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 3810 / 12 / 194 
Goodness-of-fit on F2 0.907 
Final R indices [I>2sigma(I)] R1 = 0.0925, wR2 = 0.1609 
R indices (all data) R1 = 0.1648, wR2 = 0.1886 
Largest diff. peak and hole 1.411 and -1.082 e.Å-3 
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Table B-8.   Bond lengths [Å] and angles [°] for [Ni-1’(CH2-mIm)]Cl. 
_____________________________________________________          
Ni(1)-N(1)  1.906(7) 
Ni(1)-N(3)  1.908(7) 
Ni(1)-N(2)  1.995(5) 
Ni(1)-S(2)  2.168(2) 
S(2)-C(7)  1.837(9) 
S(1)-C(10)  1.815(7) 
S(1)-C(9)  1.821(7) 
N(3)-C(13)  1.322(8) 
N(3)-C(11)  1.378(10) 
N(4)-C(13)  1.336(10) 
N(4)-C(12)  1.381(9) 
N(1)-C(1)  1.500(8) 
N(1)-C(5)  1.501(7) 
N(1)-C(6)  1.507(10) 
C(11)-C(12)  1.324(11) 
C(11)-C(10)  1.499(9) 
C(8)-N(2)  1.469(10) 
C(8)-C(9)  1.528(9) 
C(7)-C(6)  1.513(9) 
N(2)-C(4)  1.488(9) 
N(2)-C(3)  1.498(9) 
C(1)-C(2)  1.523(10) 
C(5)-C(4)  1.536(11) 
C(14)-C(12)  1.485(12) 
C(3)-C(2)  1.510(12) 
N(1)-Ni(1)-N(3) 166.6(2) 
N(1)-Ni(1)-N(2) 82.3(3) 
N(3)-Ni(1)-N(2) 95.5(3) 
N(1)-Ni(1)-S(2) 90.27(19) 
N(3)-Ni(1)-S(2) 91.57(18) 
N(2)-Ni(1)-S(2) 172.6(2) 
C(7)-S(2)-Ni(1) 98.5(2) 
C(10)-S(1)-C(9) 101.9(4) 
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Table B-8 (continued) 
 
C(13)-N(3)-C(11) 106.7(7) 
C(13)-N(3)-Ni(1) 122.0(5) 
C(11)-N(3)-Ni(1) 131.0(4) 
C(13)-N(4)-C(12) 107.7(6) 
C(1)-N(1)-C(5) 110.7(5) 
C(1)-N(1)-C(6) 108.9(5) 
C(5)-N(1)-C(6) 110.7(6) 
C(1)-N(1)-Ni(1) 102.7(5) 
C(5)-N(1)-Ni(1) 109.4(5) 
C(6)-N(1)-Ni(1) 114.2(5) 
C(12)-C(11)-N(3) 109.2(6) 
C(12)-C(11)-C(10) 128.6(7) 
N(3)-C(11)-C(10) 122.2(7) 
N(2)-C(8)-C(9) 116.3(6) 
C(6)-C(7)-S(2) 107.2(5) 
C(8)-N(2)-C(4) 110.5(5) 
C(8)-N(2)-C(3) 107.8(6) 
C(4)-N(2)-C(3) 109.3(6) 
C(8)-N(2)-Ni(1) 117.2(5) 
C(4)-N(2)-Ni(1) 107.8(4) 
C(3)-N(2)-Ni(1) 103.9(4) 
N(1)-C(1)-C(2) 112.7(6) 
N(3)-C(13)-N(4) 109.7(6) 
N(1)-C(5)-C(4) 110.4(6) 
N(2)-C(4)-C(5) 110.0(5) 
C(11)-C(12)-N(4) 106.7(7) 
C(11)-C(12)-C(14) 131.8(6) 
N(4)-C(12)-C(14) 121.5(7) 
C(8)-C(9)-S(1) 116.2(5) 
N(1)-C(6)-C(7) 109.5(6) 
C(11)-C(10)-S(1) 114.8(5) 
N(2)-C(3)-C(2) 112.8(7) 
C(3)-C(2)-C(1) 115.3(7) 
_____________________________________________________________  
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Table B-9.  Crystal data and structure refinement for [(bmIme-dach)Ni](BF4)2. 
 
Empirical formula  C15 H22 B2 F8 N6 Ni 
Formula weight  518.72 
Temperature  110(2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group  P2(1)/n 
Unit cell dimensions a = 11.8350(19) Å α = 90°. 
 b = 13.9584(19) Å β= 104.383(7)°. 
 c = 13.0506(13) Å γ = 90°. 
Volume 2088.4(5) Å3 
Z 4 
Density (calculated) 1.650 Mg/m3 
Absorption coefficient 1.015 mm-1 
F(000) 1056 
Crystal size 0.20 x 0.20 x 0.20 mm3 
Theta range for data collection 2.17 to 25.00°. 
Index ranges -10<=h<=14, -15<=k<=6, -14<=l<=15 
Reflections collected 4777 
Independent reflections 3370 [R(int) = 0.0275] 
Completeness to theta = 25.00° 91.7 %  
Absorption correction None 
Max. and min. transmission 0.8228 and 0.8228 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 3370 / 20 / 347 
Goodness-of-fit on F2 1.063 
Final R indices [I>2sigma(I)] R1 = 0.0550, wR2 = 0.1463 
R indices (all data) R1 = 0.0640, wR2 = 0.1547 
Largest diff. peak and hole 1.177 and -0.553 e.Å-3 
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Table B-10.   Bond lengths [Å] and angles [°] for [(bmIme-dach)Ni](BF4)2. 
_____________________________________________________  
Ni(1)-N(3)  1.873(3) 
Ni(1)-N(4)  1.893(3) 
Ni(1)-N(2)  1.904(3) 
Ni(1)-N(1)  1.913(3) 
N(1)-C(5)  1.485(5) 
N(1)-C(12)  1.507(5) 
N(1)-C(13)  1.516(5) 
N(2)-C(10)  1.490(5) 
N(2)-C(14)  1.494(5) 
N(2)-C(9)  1.515(5) 
N(3)-C(2)  1.332(5) 
N(3)-C(1)  1.373(5) 
N(4)-C(16)  1.340(5) 
N(4)-C(8)  1.386(5) 
N(5)-C(2)  1.333(5) 
N(5)-C(3)  1.376(6) 
N(6)-C(16)  1.343(6) 
N(6)-C(7)  1.382(6) 
C(1)-C(3)  1.379(6) 
C(1)-C(5)  1.489(6) 
C(3)-C(4)  1.501(6) 
C(7)-C(8)  1.360(5) 
C(7)-C(15)  1.500(6) 
C(8)-C(9)  1.487(6) 
C(10)-C(11)  1.511(6) 
C(11)-C(12)  1.512(6) 
C(13)-C(14)  1.529(6) 
B(1A)-F(3A)  1.376(6) 
B(1A)-F(2A)  1.377(6) 
B(1A)-F(4A)  1.398(6) 
B(1A)-F(1A)  1.399(6) 
B(2A)-F(6A)  1.306(10) 
B(2A)-F(8A)  1.343(10) 
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Table B-10 (continued) 
 
B(2A)-F(7A)  1.352(10) 
B(2A)-F(5A)  1.410(9) 
N(3)-Ni(1)-N(4) 104.07(14) 
N(3)-Ni(1)-N(2) 169.62(13) 
N(4)-Ni(1)-N(2) 85.92(13) 
N(3)-Ni(1)-N(1) 86.48(13) 
N(4)-Ni(1)-N(1) 167.01(13) 
N(2)-Ni(1)-N(1) 83.25(13) 
C(5)-N(1)-C(12) 112.3(3) 
C(5)-N(1)-C(13) 111.4(3) 
C(12)-N(1)-C(13) 110.3(3) 
C(5)-N(1)-Ni(1) 110.6(2) 
C(12)-N(1)-Ni(1) 103.8(2) 
C(13)-N(1)-Ni(1) 108.1(2) 
C(10)-N(2)-C(14) 111.9(3) 
C(10)-N(2)-C(9) 111.2(3) 
C(14)-N(2)-C(9) 111.4(3) 
C(10)-N(2)-Ni(1) 104.3(2) 
C(14)-N(2)-Ni(1) 108.3(2) 
C(9)-N(2)-Ni(1) 109.4(2) 
C(2)-N(3)-C(1) 107.0(3) 
C(2)-N(3)-Ni(1) 139.8(3) 
C(1)-N(3)-Ni(1) 113.0(2) 
C(16)-N(4)-C(8) 106.3(3) 
C(16)-N(4)-Ni(1) 140.0(3) 
C(8)-N(4)-Ni(1) 112.9(2) 
C(2)-N(5)-C(3) 109.5(3) 
C(16)-N(6)-C(7) 109.9(3) 
N(3)-C(1)-C(3) 109.0(4) 
N(3)-C(1)-C(5) 116.2(3) 
C(3)-C(1)-C(5) 134.3(4) 
N(3)-C(2)-N(5) 109.6(4) 
N(5)-C(3)-C(1) 104.8(4) 
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Table B-10 (continued) 
 
N(5)-C(3)-C(4) 124.7(4) 
C(1)-C(3)-C(4) 130.4(4) 
N(1)-C(5)-C(1) 106.7(3) 
C(8)-C(7)-N(6) 104.6(4) 
C(8)-C(7)-C(15) 132.3(4) 
N(6)-C(7)-C(15) 123.2(4) 
C(7)-C(8)-N(4) 110.2(4) 
C(7)-C(8)-C(9) 134.5(4) 
N(4)-C(8)-C(9) 115.2(3) 
C(8)-C(9)-N(2) 105.6(3) 
N(2)-C(10)-C(11) 111.5(3) 
C(10)-C(11)-C(12) 116.3(3) 
N(1)-C(12)-C(11) 112.3(3) 
N(1)-C(13)-C(14) 108.9(3) 
N(2)-C(14)-C(13) 110.1(3) 
N(4)-C(16)-N(6) 109.1(4) 
F(3A)-B(1A)-F(2A) 109.4(6) 
F(3A)-B(1A)-F(4A) 110.7(5) 
F(2A)-B(1A)-F(4A) 110.4(5) 
F(3A)-B(1A)-F(1A) 108.5(5) 
F(2A)-B(1A)-F(1A) 110.0(6) 
F(4A)-B(1A)-F(1A) 107.7(5) 
F(6A)-B(2A)-F(8A) 109.9(11) 
F(6A)-B(2A)-F(7A) 107.8(12) 
F(8A)-B(2A)-F(7A) 114.3(12) 
F(6A)-B(2A)-F(5A) 101.8(10) 
F(8A)-B(2A)-F(5A) 108.8(7) 
F(7A)-B(2A)-F(5A) 113.4(10) 
_____________________________________________________________  
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Table B-11.  Crystal data and structure refinement for py-[(mmp-mdach)Ni]2[BF4]2. 
 
Empirical formula  C27 H50 B2 F8 N6 Ni2 S2 
Formula weight  813.89 
Temperature  110(2) K 
Wavelength  1.54178 Å 
Crystal system  Monoclinic 
Space group  C2/c 
Unit cell dimensions a = 24.647(9) Å α = 90°. 
 b = 10.904(3) Å β = 113.28(3)°. 
 c = 28.217(8) Å γ = 90°. 
Volume 6966(4) Å3 
Z 8 
Density (calculated) 1.552 Mg/m3 
Absorption coefficient 3.104 mm-1 
F(000) 3392 
Crystal size 0.10 x 0.01 x 0.01 mm3 
Theta range for data collection 4.50 to 60.00°. 
Index ranges -26<=h<=27, -12<=k<=12, -31<=l<=31 
Reflections collected 22435 
Independent reflections 4965 [R(int) = 0.1605] 
Completeness to theta = 60.00° 96.1 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.9696 and 0.7466 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 4965 / 382 / 452 
Goodness-of-fit on F2 1.244 
Final R indices [I>2sigma(I)] R1 = 0.0771, wR2 = 0.1534 
R indices (all data) R1 = 0.2058, wR2 = 0.1709 
Extinction coefficient 0.000033(7) 
Largest diff. peak and hole 0.708 and -0.481 e.Å-3 
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Table B-12.   Bond lengths [Å] and angles [°] for py-[(mmp-mdach)Ni]2[BF4]2. 
_____________________________________________________  
Ni(1)-N(1)  1.900(4) 
Ni(1)-N(3)  1.918(4) 
Ni(1)-N(2)  1.951(5) 
Ni(1)-S(1)  2.1514(19) 
Ni(2)-N(4)  1.930(6) 
Ni(2)-N(5)  1.944(5) 
Ni(2)-S(2)  2.1333(19) 
Ni(2)-S(1)  2.192(2) 
S(1)-C(1)  1.864(6) 
S(2)-C(16)  1.785(7) 
N(1)-C(5)  1.465(7) 
N(1)-C(3)  1.490(6) 
N(1)-C(2)  1.506(7) 
N(2)-C(4)  1.491(7) 
N(2)-C(8)  1.490(6) 
N(2)-C(7)  1.514(7) 
N(3)-C(11)  1.332(7) 
N(3)-C(15)  1.371(7) 
N(4)-C(17)  1.449(7) 
N(4)-C(18)  1.491(8) 
N(4)-C(21)  1.469(8) 
N(5)-C(20)  1.372(9) 
N(5)-C(22)  1.539(9) 
N(5)-C(23)  1.581(10) 
C(1)-C(2)  1.482(7) 
C(1)-C(10)  1.518(8) 
C(1)-C(9)  1.536(8) 
C(3)-C(4)  1.488(7) 
C(5)-C(6)  1.498(8) 
C(6)-C(7)  1.497(7) 
C(11)-C(12)  1.384(7) 
C(12)-C(13)  1.375(8) 
C(13)-C(14)  1.390(8) 
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Table B-12 (continued) 
 
C(14)-C(15)  1.349(7) 
C(16)-C(25)  1.511(8) 
C(16)-C(17)  1.511(8) 
C(16)-C(24)  1.554(8) 
C(18)-C(19)  1.416(8) 
C(19)-C(20)  1.413(10) 
C(21)-C(22)  1.656(9) 
N(1N)-C(1N)  1.1425(8) 
C(1N)-C(2N)  1.5020(7) 
B(1)-F(2)  1.316(3) 
B(1)-F(3)  1.414(3) 
B(1)-F(1)  1.298(4) 
B(1)-F(4)  1.444(3) 
B(2)-F(5)  1.298(4) 
B(2)-F(6)  1.311(4) 
B(2)-F(7)  1.425(4) 
B(2)-F(8)  1.447(4) 
N(1)-Ni(1)-N(3) 173.6(2) 
N(1)-Ni(1)-N(2) 82.64(19) 
N(3)-Ni(1)-N(2) 96.15(19) 
N(1)-Ni(1)-S(1) 92.33(15) 
N(3)-Ni(1)-S(1) 88.92(15) 
N(2)-Ni(1)-S(1) 174.94(14) 
N(4)-Ni(2)-N(5) 80.8(2) 
N(4)-Ni(2)-S(2) 89.87(15) 
N(5)-Ni(2)-S(2) 170.12(19) 
N(4)-Ni(2)-S(1) 177.49(16) 
N(5)-Ni(2)-S(1) 97.28(19) 
S(2)-Ni(2)-S(1) 91.92(8) 
C(1)-S(1)-Ni(1) 99.1(2) 
C(1)-S(1)-Ni(2) 111.2(2) 
Ni(1)-S(1)-Ni(2) 102.17(7) 
C(16)-S(2)-Ni(2) 98.4(2) 
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Table B-12 (continued) 
 
C(5)-N(1)-C(3) 109.6(4) 
C(5)-N(1)-C(2) 112.6(4) 
C(3)-N(1)-C(2) 109.8(4) 
C(5)-N(1)-Ni(1) 105.0(3) 
C(3)-N(1)-Ni(1) 107.4(3) 
C(2)-N(1)-Ni(1) 112.2(3) 
C(4)-N(2)-C(8) 107.2(4) 
C(4)-N(2)-C(7) 111.3(5) 
C(8)-N(2)-C(7) 109.6(4) 
C(4)-N(2)-Ni(1) 103.5(4) 
C(8)-N(2)-Ni(1) 118.1(4) 
C(7)-N(2)-Ni(1) 107.1(3) 
C(11)-N(3)-C(15) 120.8(5) 
C(11)-N(3)-Ni(1) 123.0(4) 
C(15)-N(3)-Ni(1) 116.2(4) 
C(17)-N(4)-C(18) 112.3(5) 
C(17)-N(4)-C(21) 111.4(5) 
C(18)-N(4)-C(21) 105.0(5) 
C(17)-N(4)-Ni(2) 114.6(4) 
C(18)-N(4)-Ni(2) 104.9(4) 
C(21)-N(4)-Ni(2) 107.9(4) 
C(20)-N(5)-C(22) 118.8(6) 
C(20)-N(5)-C(23) 97.5(6) 
C(22)-N(5)-C(23) 102.5(5) 
C(20)-N(5)-Ni(2) 112.8(5) 
C(22)-N(5)-Ni(2) 108.3(4) 
C(23)-N(5)-Ni(2) 116.5(5) 
C(2)-C(1)-C(10) 116.8(5) 
C(2)-C(1)-C(9) 108.8(5) 
C(10)-C(1)-C(9) 107.5(5) 
C(2)-C(1)-S(1) 107.9(4) 
C(10)-C(1)-S(1) 105.8(4) 
C(9)-C(1)-S(1) 109.9(4) 
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Table B-12 (continued) 
 
C(1)-C(2)-N(1) 115.5(4) 
N(1)-C(3)-C(4) 110.0(4) 
N(2)-C(4)-C(3) 111.3(4) 
N(1)-C(5)-C(6) 114.2(4) 
C(5)-C(6)-C(7) 113.7(5) 
C(6)-C(7)-N(2) 112.2(5) 
N(3)-C(11)-C(12) 122.5(6) 
C(11)-C(12)-C(13) 116.0(6) 
C(14)-C(13)-C(12) 121.8(6) 
C(15)-C(14)-C(13) 119.5(6) 
N(3)-C(15)-C(14) 119.4(6) 
C(25)-C(16)-C(17) 109.6(5) 
C(25)-C(16)-C(24) 106.5(5) 
C(17)-C(16)-C(24) 113.9(6) 
C(25)-C(16)-S(2) 108.9(5) 
C(17)-C(16)-S(2) 107.4(4) 
C(24)-C(16)-S(2) 110.5(4) 
N(4)-C(17)-C(16) 112.5(5) 
C(19)-C(18)-N(4) 115.2(6) 
C(18)-C(19)-C(20) 129.9(8) 
N(5)-C(20)-C(19) 99.0(6) 
N(4)-C(21)-C(22) 109.7(5) 
N(5)-C(22)-C(21) 103.4(5) 
N(1N)-C(1N)-C(2N) 171.74(12) 
F(2)-B(1)-F(3) 109.5(3) 
F(2)-B(1)-F(1) 120.0(3) 
F(3)-B(1)-F(1) 110.2(3) 
F(2)-B(1)-F(4) 109.4(3) 
F(3)-B(1)-F(4) 100.7(2) 
F(1)-B(1)-F(4) 105.3(3) 
F(5)-B(2)-F(6) 119.7(4) 
F(5)-B(2)-F(7) 109.5(3) 
F(6)-B(2)-F(7) 109.6(4) 
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Table B-12 (continued) 
 
F(5)-B(2)-F(8) 106.3(3) 
F(6)-B(2)-F(8) 111.9(3) 
F(7)-B(2)-F(8) 97.4(3) 
_____________________________________________________________  
Symmetry transformations used to generate equivalent atoms:  
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 Table B-13.  Crystal data and structure refinement for mIm-[(mmp-mdach)Ni]2[BF4]2. 
 
Empirical formula  C24 H48 B2 F8 N6 Ni2 S2 
Formula weight  775.84 
Temperature  293(2) K 
Wavelength  0.71073 Å 
Crystal system  Triclinic 
Space group  P-1 
Unit cell dimensions a = 9.967(3) Å α = 81.848(5)°. 
 b = 11.316(3) Å β = 76.059(5)°. 
 c = 16.490(5) Å γ = 68.849(5)°. 
Volume 1680.4(9) Å3 
Z 2 
Density (calculated) 1.533 Mg/m3 
Absorption coefficient 1.315 mm-1 
F(000) 808 
Crystal size 0.30 x 0.10 x 0.10 mm3 
Theta range for data collection 2.24 to 25.00°. 
Index ranges -11<=h<=11, -13<=k<=13, -19<=l<=19 
Reflections collected 15112 
Independent reflections 5713 [R(int) = 0.0553] 
Completeness to theta = 25.00° 96.4 %  
Max. and min. transmission 0.8797 and 0.6937 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 5713 / 332 / 443 
Goodness-of-fit on F2 1.041 
Final R indices [I>2sigma(I)] R1 = 0.0759, wR2 = 0.1761 
R indices (all data) R1 = 0.1044, wR2 = 0.1921 
Largest diff. peak and hole 1.507 and -1.039 e.Å-3 
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Table B-14.   Bond lengths [Å] and angles [°] for  mIm-[(mmp-mdach)Ni]2[BF4]2. 
_____________________________________________________  
Ni(1)-N(3)  1.905(5) 
Ni(1)-N(1)  1.922(5) 
Ni(1)-N(2)  1.961(6) 
Ni(1)-S(1)  2.1663(19) 
Ni(2)-N(4)  1.925(6) 
Ni(2)-N(5)  2.026(7) 
Ni(2)-S(2)  2.1403(19) 
Ni(2)-S(1)  2.2135(19) 
S(1)-C(8)  1.850(7) 
S(2)-C(22)  1.836(7) 
N(1)-C(5)  1.493(8) 
N(1)-C(7)  1.498(8) 
N(1)-C(1)  1.506(8) 
N(2)-C(2)  1.487(9) 
N(2)-C(3)  1.504(9) 
N(2)-C(6)  1.507(10) 
N(3)-C(13)  1.312(9) 
N(3)-C(11)  1.353(9) 
N(4)-C(15)  1.488(10) 
N(4)-C(21)  1.493(9) 
N(4)-C(19)  1.505(10) 
N(5)-C(17)  1.426(13) 
N(5)-C(20)  1.493(12) 
N(5)-C(16)  1.569(12) 
N(6)-C(13)  1.339(9) 
N(6)-C(12)  1.365(10) 
N(6)-C(14)  1.479(9) 
C(1)-C(2)  1.523(10) 
C(3)-C(4)  1.509(10) 
C(4)-C(5)  1.514(10) 
C(7)-C(8)  1.523(10) 
C(8)-C(9)  1.522(10) 
C(8)-C(10)  1.537(10) 
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Table B-14 (continued) 
 
C(11)-C(12)  1.357(10) 
C(15)-C(16)  1.522(11) 
C(17)-C(18)  1.404(14) 
C(18)-C(19)  1.476(12) 
C(21)-C(22)  1.524(10) 
C(22)-C(23)  1.507(11) 
C(22)-C(24)  1.508(11) 
B11-F11  1.363(9) 
B11-F31  1.371(10) 
B11-F21  1.382(10) 
B11-F41  1.382(9) 
B12-F12  1.363(9) 
B12-F32  1.371(10) 
B12-F22  1.382(10) 
B12-F42  1.382(9) 
B13-F13  1.363(9) 
B13-F33  1.371(10) 
B13-F23  1.382(10) 
B13-F43  1.382(9) 
N(3)-Ni(1)-N(1) 174.4(2) 
N(3)-Ni(1)-N(2) 97.4(2) 
N(1)-Ni(1)-N(2) 82.3(2) 
N(3)-Ni(1)-S(1) 89.10(18) 
N(1)-Ni(1)-S(1) 91.16(17) 
N(2)-Ni(1)-S(1) 173.46(18) 
N(4)-Ni(2)-N(5) 80.7(3) 
N(4)-Ni(2)-S(2) 89.95(18) 
N(5)-Ni(2)-S(2) 170.3(2) 
N(4)-Ni(2)-S(1) 174.35(18) 
N(5)-Ni(2)-S(1) 96.4(2) 
S(2)-Ni(2)-S(1) 92.66(7) 
C(8)-S(1)-Ni(1) 100.6(2) 
C(8)-S(1)-Ni(2) 115.1(2) 
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Table B-14 (continued) 
 
Ni(1)-S(1)-Ni(2) 99.34(7) 
C(22)-S(2)-Ni(2) 101.5(2) 
C(5)-N(1)-C(7) 112.0(5) 
C(5)-N(1)-C(1) 109.3(5) 
C(7)-N(1)-C(1) 109.4(5) 
C(5)-N(1)-Ni(1) 107.4(4) 
C(7)-N(1)-Ni(1) 112.6(4) 
C(1)-N(1)-Ni(1) 105.9(4) 
C(2)-N(2)-C(3) 111.0(5) 
C(2)-N(2)-C(6) 108.6(6) 
C(3)-N(2)-C(6) 108.0(6) 
C(2)-N(2)-Ni(1) 104.9(4) 
C(3)-N(2)-Ni(1) 108.2(4) 
C(6)-N(2)-Ni(1) 116.1(5) 
C(13)-N(3)-C(11) 106.2(6) 
C(13)-N(3)-Ni(1) 129.4(5) 
C(11)-N(3)-Ni(1) 124.0(5) 
C(15)-N(4)-C(21) 107.6(6) 
C(15)-N(4)-C(19) 109.2(6) 
C(21)-N(4)-C(19) 111.6(5) 
C(15)-N(4)-Ni(2) 108.6(4) 
C(21)-N(4)-Ni(2) 114.2(4) 
C(19)-N(4)-Ni(2) 105.6(5) 
C(17)-N(5)-C(20) 110.9(7) 
C(17)-N(5)-C(16) 111.6(7) 
C(20)-N(5)-C(16) 105.8(7) 
C(17)-N(5)-Ni(2) 102.9(6) 
C(20)-N(5)-Ni(2) 118.8(6) 
C(16)-N(5)-Ni(2) 107.0(5) 
C(13)-N(6)-C(12) 107.2(6) 
C(13)-N(6)-C(14) 126.6(6) 
C(12)-N(6)-C(14) 126.2(6) 
N(1)-C(1)-C(2) 110.8(5) 
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Table B-14 (continued) 
 
N(2)-C(2)-C(1) 109.4(5) 
N(2)-C(3)-C(4) 112.1(5) 
C(3)-C(4)-C(5) 114.9(6) 
N(1)-C(5)-C(4) 112.3(6) 
N(1)-C(7)-C(8) 115.3(5) 
C(9)-C(8)-C(7) 107.9(6) 
C(9)-C(8)-C(10) 109.4(6) 
C(7)-C(8)-C(10) 114.6(6) 
C(9)-C(8)-S(1) 111.4(5) 
C(7)-C(8)-S(1) 106.5(5) 
C(10)-C(8)-S(1) 107.0(5) 
N(3)-C(11)-C(12) 109.7(7) 
C(11)-C(12)-N(6) 105.8(6) 
N(3)-C(13)-N(6) 111.1(6) 
N(4)-C(15)-C(16) 112.0(6) 
C(15)-C(16)-N(5) 107.6(6) 
C(18)-C(17)-N(5) 114.9(8) 
C(17)-C(18)-C(19) 118.5(8) 
C(18)-C(19)-N(4) 114.6(7) 
N(4)-C(21)-C(22) 113.5(6) 
C(23)-C(22)-C(24) 107.0(7) 
C(23)-C(22)-C(21) 114.1(6) 
C(24)-C(22)-C(21) 109.3(6) 
C(23)-C(22)-S(2) 112.1(6) 
C(24)-C(22)-S(2) 108.7(5) 
C(21)-C(22)-S(2) 105.5(4) 
F11-B11-F31 110.1(7) 
F11-B11-F21 108.9(6) 
F31-B11-F21 109.2(6) 
F11-B11-F41 111.5(6) 
F31-B11-F41 109.5(6) 
F21-B11-F41 107.6(7) 
F12-B12-F32 110.0(7) 
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Table B-14 (continued) 
 
F12-B12-F22 108.9(6) 
F32-B12-F22 109.2(6) 
F12-B12-F42 111.5(7) 
F32-B12-F42 109.5(6) 
F22-B12-F42 107.6(7) 
F13-B13-F33 110.1(7) 
F13-B13-F23 108.9(6) 
F33-B13-F23 109.2(7) 
F13-B13-F43 111.5(7) 
F33-B13-F43 109.5(6) 
F23-B13-F43 107.6(7) 
_____________________________________________________________  
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Table B-15.  Crystal data and structure refinement for [(mmp-mdach)Ni(mIm)][BF4]. 
 
Empirical formula  C14 H27 B F4 N4 Ni S 
Formula weight  428.97 
Temperature  110(2) K 
Wavelength  1.54178 Å 
Crystal system  Monoclinic 
Space group  P2(1)/n 
Unit cell dimensions a = 11.449(4) Å α = 90°. 
 b = 7.126(3) Å β = 93.930(14)°. 
 c = 22.881(8) Å γ = 90°. 
Volume 1862.3(11) Å3 
Z 4 
Density (calculated) 1.530 Mg/m3 
Absorption coefficient 2.949 mm-1 
F(000) 896 
Crystal size 0.20 x 0.10 x 0.10 mm3 
Theta range for data collection 3.87 to 60.00°. 
Index ranges -12<=h<=12, -7<=k<=7, -25<=l<=25 
Reflections collected 12424 
Independent reflections 2395 [R(int) = 0.2384] 
Completeness to theta = 60.00° 87.0 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.7569 and 0.5900 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 2395 / 0 / 230 
Goodness-of-fit on F2 1.000 
Final R indices [I>2sigma(I)] R1 = 0.0603, wR2 = 0.1181 
R indices (all data) R1 = 0.1733, wR2 = 0.1608 
Largest diff. peak and hole 0.363 and -0.403 e.Å-3 
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Table B-16.   Bond lengths [Å] and angles [°] for [(mmp-mdach)Ni(mIm)][BF4]. 
_____________________________________________________  
Ni(1)-N(3)  1.888(7) 
Ni(1)-N(1)  1.890(7) 
Ni(1)-N(2)  1.956(7) 
Ni(1)-S(1)  2.136(3) 
S(1)-C(1)  1.854(8) 
F(4)-B(1)  1.380(12) 
F(3)-B(1)  1.376(10) 
F(2)-B(1)  1.365(11) 
F(1)-B(1)  1.379(13) 
N(1)-C(6)  1.486(10) 
N(1)-C(2)  1.498(9) 
N(1)-C(3)  1.532(9) 
N(2)-C(8)  1.464(10) 
N(2)-C(7)  1.501(11) 
N(2)-C(5)  1.507(9) 
N(3)-C(13)  1.318(10) 
N(3)-C(11)  1.396(10) 
N(4)-C(12)  1.360(10) 
N(4)-C(13)  1.358(11) 
N(4)-C(14)  1.463(10) 
C(1)-C(2)  1.474(12) 
C(1)-C(9)  1.519(12) 
C(1)-C(10)  1.531(10) 
C(3)-C(4)  1.534(10) 
C(4)-C(5)  1.501(11) 
C(6)-C(7)  1.527(12) 
C(11)-C(12)  1.362(11) 
N(3)-Ni(1)-N(1) 176.3(3) 
N(3)-Ni(1)-N(2) 97.1(3) 
N(1)-Ni(1)-N(2) 82.7(3) 
N(3)-Ni(1)-S(1) 89.2(2) 
N(1)-Ni(1)-S(1) 90.9(2) 
N(2)-Ni(1)-S(1) 173.3(2) 
 208
Table B-16 (continued) 
 
C(1)-S(1)-Ni(1) 100.7(3) 
F(2)-B(1)-F(3) 107.4(8) 
F(2)-B(1)-F(1) 109.4(9) 
F(3)-B(1)-F(1) 109.2(9) 
F(2)-B(1)-F(4) 111.2(9) 
F(3)-B(1)-F(4) 109.8(8) 
F(1)-B(1)-F(4) 109.9(8) 
C(6)-N(1)-C(2) 109.5(7) 
C(6)-N(1)-C(3) 110.1(6) 
C(2)-N(1)-C(3) 110.6(6) 
C(6)-N(1)-Ni(1) 108.8(5) 
C(2)-N(1)-Ni(1) 113.6(5) 
C(3)-N(1)-Ni(1) 104.1(5) 
C(8)-N(2)-C(7) 107.8(7) 
C(8)-N(2)-C(5) 108.1(6) 
C(7)-N(2)-C(5) 110.7(6) 
C(8)-N(2)-Ni(1) 116.9(5) 
C(7)-N(2)-Ni(1) 106.3(5) 
C(5)-N(2)-Ni(1) 106.9(5) 
C(13)-N(3)-C(11) 106.4(7) 
C(13)-N(3)-Ni(1) 129.4(6) 
C(11)-N(3)-Ni(1) 124.0(5) 
C(12)-N(4)-C(13) 108.6(7) 
C(12)-N(4)-C(14) 125.3(8) 
C(13)-N(4)-C(14) 125.9(7) 
C(2)-C(1)-C(9) 116.3(7) 
C(2)-C(1)-C(10) 108.6(7) 
C(9)-C(1)-C(10) 106.1(8) 
C(2)-C(1)-S(1) 107.3(6) 
C(9)-C(1)-S(1) 109.4(6) 
C(10)-C(1)-S(1) 108.9(6) 
C(1)-C(2)-N(1) 115.3(7) 
N(1)-C(3)-C(4) 111.8(6) 
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Table B-16 (continued) 
 
C(5)-C(4)-C(3) 115.7(6) 
C(4)-C(5)-N(2) 110.6(6) 
N(1)-C(6)-C(7) 109.8(7) 
N(2)-C(7)-C(6) 109.9(7) 
C(12)-C(11)-N(3) 108.9(7) 
N(4)-C(12)-C(11) 106.1(7) 
N(3)-C(13)-N(4) 110.0(8) 
_____________________________________________________________  
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Table B-17.  Crystal data and structure refinement for [(mmp-mdach)Ni(ipIm)][BF4]. 
 
Empirical formula  C15 H28 B F4 N4 Ni S 
Formula weight  441.99 
Temperature  110(2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group  P2(1)/n 
Unit cell dimensions a = 7.849(2) Å α = 90°. 
 b = 11.715(4) Å β = 99.02(3)°. 
 c = 23.118(9) Å γ = 90°. 
Volume 2099.4(12) Å3 
Z 4 
Density (calculated) 1.398 Mg/m3 
Absorption coefficient 1.064 mm-1 
F(000) 924 
Crystal size 0.15 x 0.12 x 0.14 mm3 
Theta range for data collection 1.78 to 25.00°. 
Index ranges -4<=h<=6, -13<=k<=5, -25<=l<=27 
Reflections collected 4696 
Independent reflections 2738 [R(int) = 0.0626] 
Completeness to theta = 25.00° 74.0 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.8154 and 0.8154 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 2738 / 222 / 253 
Goodness-of-fit on F2 1.002 
Final R indices [I>2sigma(I)] R1 = 0.0713, wR2 = 0.1540 
R indices (all data) R1 = 0.1145, wR2 = 0.1693 
Largest diff. peak and hole 0.782 and -0.480 e.Å-3 
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Table B-18.   Bond lengths [Å] and angles [°] for [(mmp-mdach)Ni(ipIm)][BF4].. 
_____________________________________________________  
Ni(1)-N(3)  1.906(6) 
Ni(1)-N(1)  1.921(6) 
Ni(1)-N(2)  1.971(6) 
Ni(1)-S(1)  2.151(3) 
S(1)-C(8)  1.847(7) 
F(1)-B(1)  1.388(10) 
N(1)-C(5)  1.476(9) 
N(1)-C(7)  1.491(9) 
N(1)-C(1)  1.536(10) 
N(3)-C(13)  1.318(8) 
N(3)-C(11)  1.388(9) 
F(4)-B(1)  1.381(10) 
F(2)-B(1)  1.376(11) 
F(3)-B(1)  1.407(12) 
C(13)-N(4)  1.342(9) 
C(13)-C(14)  1.497(10) 
C(12)-C(11)  1.341(10) 
C(12)-N(4)  1.353(9) 
C(5)-C(4)  1.496(10) 
C(14)-C(16)  1.528(11) 
C(14)-C(15)  1.544(10) 
C(8)-C(9)  1.489(11) 
C(8)-C(10)  1.527(10) 
C(8)-C(7)  1.545(11) 
N(2)-C(3)  1.464(9) 
N(2)-C(6)  1.494(9) 
N(2)-C(2)  1.496(10) 
C(3)-C(4)  1.461(10) 
C(1)-C(2)  1.531(10) 
N(3)-Ni(1)-N(1) 173.1(2) 
N(3)-Ni(1)-N(2) 96.0(3) 
N(1)-Ni(1)-N(2) 82.4(3) 
N(3)-Ni(1)-S(1) 90.9(2) 
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Table B-18 (continued) 
 
N(1)-Ni(1)-S(1) 90.9(2) 
N(2)-Ni(1)-S(1) 173.16(19) 
C(8)-S(1)-Ni(1) 101.3(3) 
C(5)-N(1)-C(7) 114.9(6) 
C(5)-N(1)-C(1) 108.9(6) 
C(7)-N(1)-C(1) 108.5(5) 
C(5)-N(1)-Ni(1) 104.3(4) 
C(7)-N(1)-Ni(1) 113.2(5) 
C(1)-N(1)-Ni(1) 106.5(4) 
C(13)-N(3)-C(11) 107.5(6) 
C(13)-N(3)-Ni(1) 129.7(5) 
C(11)-N(3)-Ni(1) 122.8(5) 
N(3)-C(13)-N(4) 108.5(6) 
N(3)-C(13)-C(14) 127.1(7) 
N(4)-C(13)-C(14) 124.4(7) 
C(11)-C(12)-N(4) 106.7(7) 
C(12)-C(11)-N(3) 108.0(6) 
C(13)-N(4)-C(12) 109.3(6) 
N(1)-C(5)-C(4) 115.3(6) 
C(13)-C(14)-C(16) 111.2(7) 
C(13)-C(14)-C(15) 110.4(6) 
C(16)-C(14)-C(15) 110.3(6) 
C(9)-C(8)-C(10) 108.7(7) 
C(9)-C(8)-C(7) 115.8(7) 
C(10)-C(8)-C(7) 105.9(7) 
C(9)-C(8)-S(1) 111.6(6) 
C(10)-C(8)-S(1) 108.9(5) 
C(7)-C(8)-S(1) 105.6(5) 
C(3)-N(2)-C(6) 109.1(6) 
C(3)-N(2)-C(2) 109.7(6) 
C(6)-N(2)-C(2) 107.5(6) 
C(3)-N(2)-Ni(1) 106.8(5) 
C(6)-N(2)-Ni(1) 116.8(5) 
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Table B-18 (continued) 
 
C(2)-N(2)-Ni(1) 106.8(4) 
C(4)-C(3)-N(2) 114.4(6) 
C(3)-C(4)-C(5) 114.2(7) 
C(2)-C(1)-N(1) 110.4(6) 
F(2)-B(1)-F(4) 110.4(8) 
F(2)-B(1)-F(1) 109.2(7) 
F(4)-B(1)-F(1) 110.0(7) 
F(2)-B(1)-F(3) 108.6(8) 
F(4)-B(1)-F(3) 109.3(7) 
F(1)-B(1)-F(3) 109.2(8) 
N(1)-C(7)-C(8) 114.1(6) 
N(2)-C(2)-C(1) 109.4(6) 
_____________________________________________________________  
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Table B-19.  Crystal data and structure refinement for [(mmp-mdach)Ni(me2NHC)][I]. 
 
Empirical formula  C15 H29 I N4 Ni S 
Formula weight  483.09 
Temperature  110(2) K 
Wavelength  0.71069 Å 
Crystal system  Monoclinic 
Space group  P2(1)/c 
Unit cell dimensions a = 13.963(5) Å α = 90.000(5)°. 
 b = 12.042(5) Å β = 110.946(5)°. 
 c = 12.364(5) Å γ = 90.000(5)°. 
Volume 1941.5(13) Å3 
Z 4 
Density (calculated) 1.653 Mg/m3 
Absorption coefficient 2.699 mm-1 
F(000) 976 
Crystal size 0.17 x 0.05 x 0.05 mm3 
Theta range for data collection 2.54 to 25.00°. 
Index ranges -16<=h<=15, -14<=k<=13, -14<=l<=14 
Reflections collected 15834 
Independent reflections 3140 [R(int) = 0.1086] 
Completeness to theta = 25.00° 91.6 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.8769 and 0.6569 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 3140 / 0 / 200 
Goodness-of-fit on F2 0.994 
Final R indices [I>2sigma(I)] R1 = 0.0472, wR2 = 0.0963 
R indices (all data) R1 = 0.1030, wR2 = 0.1154 
Extinction coefficient 0.0053(7) 
Largest diff. peak and hole 0.754 and -0.572 e.Å-3 
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Table B-20.   Bond lengths [Å] and angles [°] for [(mmp-mdach)Ni(me2NHC)][I]. 
_____________________________________________________  
Ni(1)-C(11)  1.891(8) 
Ni(1)-N(1)  1.947(6) 
Ni(1)-N(2)  1.972(7) 
Ni(1)-S(1)  2.142(2) 
S(1)-C(1)  1.837(8) 
N(1)-C(6)  1.490(10) 
N(1)-C(2)  1.495(11) 
N(1)-C(3)  1.499(12) 
N(2)-C(8)  1.476(11) 
N(2)-C(7)  1.490(10) 
N(2)-C(5)  1.504(11) 
N(3)-C(11)  1.354(10) 
N(3)-C(12)  1.389(11) 
N(3)-C(14)  1.458(11) 
N(4)-C(11)  1.334(10) 
N(4)-C(13)  1.383(10) 
N(4)-C(15)  1.473(11) 
C(1)-C(10)  1.492(14) 
C(1)-C(2)  1.530(12) 
C(1)-C(9)  1.536(13) 
C(3)-C(4)  1.501(13) 
C(4)-C(5)  1.464(12) 
C(6)-C(7)  1.512(13) 
C(12)-C(13)  1.340(13) 
C(11)-Ni(1)-N(1) 176.5(3) 
C(11)-Ni(1)-N(2) 97.5(3) 
N(1)-Ni(1)-N(2) 82.0(3) 
C(11)-Ni(1)-S(1) 89.6(2) 
N(1)-Ni(1)-S(1) 90.7(2) 
N(2)-Ni(1)-S(1) 171.97(19) 
C(1)-S(1)-Ni(1) 96.9(3) 
C(6)-N(1)-C(2) 113.5(6) 
C(6)-N(1)-C(3) 109.4(7) 
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Table B-20 (continued) 
 
C(2)-N(1)-C(3) 106.4(7) 
C(6)-N(1)-Ni(1) 104.4(5) 
C(2)-N(1)-Ni(1) 113.5(5) 
C(3)-N(1)-Ni(1) 109.6(5) 
C(8)-N(2)-C(7) 108.8(6) 
C(8)-N(2)-C(5) 108.0(6) 
C(7)-N(2)-C(5) 110.5(6) 
C(8)-N(2)-Ni(1) 117.8(5) 
C(7)-N(2)-Ni(1) 101.7(5) 
C(5)-N(2)-Ni(1) 109.8(5) 
C(11)-N(3)-C(12) 109.5(7) 
C(11)-N(3)-C(14) 124.7(7) 
C(12)-N(3)-C(14) 125.9(7) 
C(11)-N(4)-C(13) 111.8(7) 
C(11)-N(4)-C(15) 125.4(7) 
C(13)-N(4)-C(15) 122.7(7) 
C(10)-C(1)-C(2) 112.1(8) 
C(10)-C(1)-C(9) 109.8(8) 
C(2)-C(1)-C(9) 109.3(7) 
C(10)-C(1)-S(1) 111.7(6) 
C(2)-C(1)-S(1) 105.6(5) 
C(9)-C(1)-S(1) 108.3(6) 
N(1)-C(2)-C(1) 114.1(7) 
N(1)-C(3)-C(4) 112.9(8) 
C(5)-C(4)-C(3) 116.4(7) 
C(4)-C(5)-N(2) 113.8(7) 
N(1)-C(6)-C(7) 109.9(6) 
N(2)-C(7)-C(6) 111.6(7) 
N(4)-C(11)-N(3) 105.3(6) 
N(4)-C(11)-Ni(1) 129.4(6) 
N(3)-C(11)-Ni(1) 125.3(6) 
C(13)-C(12)-N(3) 107.8(7) 
C(12)-C(13)-N(4) 105.6(7) 
_____________________________________________________________  
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Table B-21.  Crystal data and structure refinement for Im-[(mmp-dach)Ni]2[BF4]2. 
 
Empirical formula  C21 H42 B2 F8 N6 Ni2 S2 
Formula weight  733.77 
Temperature  293(2) K 
Wavelength  1.54178 Å 
Crystal system  monoclinic 
Space group  P2(1)/n 
Unit cell dimensions a = 10.805(5) Å α= 90°. 
 b = 14.125(7) Å β= 100.339(19)°. 
 c = 20.169(10) Å γ = 90°. 
Volume 3028(3) Å3 
Z 4 
Density (calculated) 1.609 Mg/m3 
Absorption coefficient 3.498 mm-1 
F(000) 1520 
Crystal size 0.30 x 0.01 x 0.01 mm3 
Theta range for data collection 5.36 to 58.82°. 
Index ranges -11<=h<=11, -15<=k<=14, -22<=l<=22 
Reflections collected 19669 
Independent reflections 3867 [R(int) = 0.4928] 
Completeness to theta = 58.82° 89.2 %  
Max. and min. transmission 0.9659 and 0.4201 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 3867 / 210 / 416 
Goodness-of-fit on F2 1.000 
Final R indices [I>2sigma(I)] R1 = 0.0752, wR2 = 0.0905 
R indices (all data) R1 = 0.3079, wR2 = 0.1568 
Largest diff. peak and hole 0.361 and -0.294 e.Å-3 
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Table B-22.   Bond lengths [Å] and angles [°] for  Im-[(mmp-dach)Ni]2[BF4]2. 
_____________________________________________________  
Ni(1)-N(1)  1.884(11) 
Ni(1)-N(1A)  1.893(12) 
Ni(1)-N(2)  1.929(11) 
Ni(1)-S(1)  2.187(4) 
Ni(2)-N(4)  1.918(12) 
Ni(2)-N(3)  1.971(13) 
Ni(2)-S(2)  2.128(4) 
Ni(2)-S(1)  2.178(4) 
S(1)-C(7)  1.924(15) 
S(2)-C(16)  1.824(18) 
N(1)-C(1)  1.510(15) 
N(1)-C(4)  1.598(15) 
N(1)-H(1C)  0.9100 
N(2)-C(6)  1.500(15) 
N(2)-C(3)  1.533(15) 
N(2)-C(5)  1.551(15) 
N(3)-C(13)  1.436(15) 
N(3)-C(10)  1.473(17) 
N(3)-H(3C)  0.9100 
N(4)-C(15)  1.497(17) 
N(4)-C(14)  1.514(18) 
N(4)-C(12)  1.524(18) 
C(1)-C(2)  1.486(16) 
C(1)-H(1A)  0.9700 
C(1)-H(1B)  0.9700 
C(2)-C(3)  1.419(17) 
C(2)-H(2A)  0.9700 
C(2)-H(2B)  0.9700 
C(3)-H(3A)  0.9700 
C(3)-H(3B)  0.9700 
C(4)-C(5)  1.504(16) 
C(4)-H(4A)  0.9700 
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Table B-22 (continued) 
 
C(6)-C(7)  1.543(18) 
C(7)-C(9)  1.486(16) 
C(7)-C(8)  1.488(17) 
C(10)-C(11)  1.365(18) 
C(11)-C(12)  1.491(19) 
C(13)-C(14)  1.51(2) 
C(15)-C(16)  1.40(2) 
C(16)-C(17)  1.370(19) 
C(16)-C(18)  1.55(2) 
N(1A)-C(1A)  1.349(15) 
N(1A)-C(3A)  1.360(16) 
N(2A)-C(1A)  1.293(15) 
N(2A)-C(2A)  1.314(16) 
C(2A)-C(3A)  1.383(18) 
B11-F11  1.308(19) 
B11-F21  1.349(18) 
B11-F41  1.357(18) 
B11-F31  1.426(19) 
B12-F12  1.308(19) 
B12-F22  1.351(18) 
B12-F42  1.357(18) 
B12-F32  1.427(19) 
B13-F13  1.308(19) 
B13-F23  1.350(18) 
B13-F43  1.357(18) 
B13-F33  1.43(2) 
N(1)-Ni(1)-N(1A) 93.6(5) 
N(1)-Ni(1)-N(2) 82.6(5) 
N(1A)-Ni(1)-N(2) 175.8(5) 
N(1)-Ni(1)-S(1) 173.2(4) 
N(1A)-Ni(1)-S(1) 93.2(3) 
N(2)-Ni(1)-S(1) 90.6(4) 
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Table B-22 (continued) 
 
N(4)-Ni(2)-N(3) 79.6(5) 
N(4)-Ni(2)-S(2) 91.6(4) 
N(3)-Ni(2)-S(2) 171.2(4) 
N(4)-Ni(2)-S(1) 174.4(4) 
N(3)-Ni(2)-S(1) 95.1(4) 
S(2)-Ni(2)-S(1) 93.73(15) 
C(7)-S(1)-Ni(2) 105.4(5) 
C(7)-S(1)-Ni(1) 99.7(5) 
Ni(2)-S(1)-Ni(1) 108.07(17) 
C(16)-S(2)-Ni(2) 99.8(7) 
C(1)-N(1)-C(4) 108.6(10) 
C(1)-N(1)-Ni(1) 113.0(9) 
C(4)-N(1)-Ni(1) 107.2(7) 
C(6)-N(2)-C(3) 114.8(10) 
C(6)-N(2)-C(5) 109.1(10) 
C(3)-N(2)-C(5) 107.8(11) 
C(6)-N(2)-Ni(1) 113.6(9) 
C(3)-N(2)-Ni(1) 106.8(8) 
C(5)-N(2)-Ni(1) 103.9(8) 
C(13)-N(3)-C(10) 112.9(13) 
C(13)-N(3)-Ni(2) 107.6(10) 
C(10)-N(3)-Ni(2) 106.9(10) 
C(15)-N(4)-C(14) 108.3(13) 
C(15)-N(4)-C(12) 116.0(14) 
C(14)-N(4)-C(12) 108.9(12) 
C(15)-N(4)-Ni(2) 110.7(9) 
C(14)-N(4)-Ni(2) 107.5(10) 
C(12)-N(4)-Ni(2) 105.2(10) 
C(2)-C(1)-N(1) 108.4(11) 
C(3)-C(2)-C(1) 117.1(13) 
C(2)-C(3)-N(2) 115.8(12) 
C(5)-C(4)-N(1) 105.9(10) 
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Table B-22 (continued) 
 
C(4)-C(5)-N(2) 111.6(10) 
N(2)-C(6)-C(7) 114.0(12) 
C(9)-C(7)-C(8) 110.1(12) 
C(9)-C(7)-C(6) 109.0(12) 
C(8)-C(7)-C(6) 119.2(12) 
C(9)-C(7)-S(1) 108.9(9) 
C(8)-C(7)-S(1) 106.4(10) 
C(6)-C(7)-S(1) 102.7(10) 
C(11)-C(10)-N(3) 113.6(15) 
C(10)-C(11)-C(12) 117.8(15) 
C(11)-C(12)-N(4) 118.2(14) 
N(3)-C(13)-C(14) 112.4(14) 
C(13)-C(14)-N(4) 106.5(11) 
C(16)-C(15)-N(4) 118.8(15) 
C(17)-C(16)-C(15) 115.1(18) 
C(17)-C(16)-C(18) 101.6(16) 
C(15)-C(16)-C(18) 108.9(18) 
C(17)-C(16)-S(2) 111.4(14) 
C(15)-C(16)-S(2) 110.1(14) 
C(18)-C(16)-S(2) 109.3(13) 
C(1A)-N(1A)-C(3A) 104.2(12) 
C(1A)-N(1A)-Ni(1) 129.0(10) 
C(3A)-N(1A)-Ni(1) 126.4(11) 
C(1A)-N(2A)-C(2A) 113.2(14) 
N(2A)-C(1A)-N(1A) 109.1(12) 
N(2A)-C(2A)-C(3A) 102.8(15) 
N(1A)-C(3A)-C(2A) 110.5(14) 
F11-B11-F21 108.0(15) 
F11-B11-F41 116.5(16) 
F21-B11-F41 109.1(15) 
F11-B11-F31 109.7(15) 
F21-B11-F31 105.7(14) 
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Table B-22 (continued) 
 
F41-B11-F31 107.4(14) 
F12-B12-F22 107.8(15) 
F12-B12-F42 116.6(17) 
F22-B12-F42 108.8(16) 
F12-B12-F32 110.1(16) 
F22-B12-F32 106.3(15) 
F42-B12-F32 106.8(15) 
F13-B13-F23 107.9(16) 
F13-B13-F43 116.6(17) 
F23-B13-F43 109.0(16) 
F13-B13-F33 109.8(17) 
F23-B13-F33 106.1(16) 
F43-B13-F33 107.1(15) 
_____________________________________________________________  
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Table B-23.  Crystal data and structure refinement for [(bme-daco)(V=O)]. 
 
Empirical formula  C10 H20 N2 O S2 V 
Formula weight  299.34 
Temperature  110(2) K 
Wavelength  0.71073 Å 
Crystal system  monoclinic 
Space group  P21/n 
Unit cell dimensions a = 7.590(3) Å α = 90°. 
 b = 20.689(9) Å β = 109.55(4)°. 
 c = 8.565(3) Å γ = 90°. 
Volume 1267.4(9) Å3 
Z 4 
Density (calculated) 1.569 Mg/m3 
Absorption coefficient 1.093 mm-1 
F(000) 628 
Crystal size 2.00 x 0.20 x 0.20 mm3 
Theta range for data collection 1.97 to 25.00°. 
Index ranges -9<=h<=8, -24<=k<=24, -10<=l<=9 
Reflections collected 11094 
Independent reflections 2159 [R(int) = 0.0584] 
Completeness to theta = 25.00° 96.9 %  
Max. and min. transmission 0.8110 and 0.2185 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 2159 / 0 / 145 
Goodness-of-fit on F2 1.016 
Final R indices [I>2sigma(I)] R1 = 0.0513, wR2 = 0.1066 
R indices (all data) R1 = 0.0637, wR2 = 0.1113 
Largest diff. peak and hole 0.432 and -0.604 e.Å-3 
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Table B-24.   Bond lengths [Å] and angles [°] for [(bme-daco)(V=O)]. 
_____________________________________________________  
V(1)-O(1)  1.599(3) 
V(1)-N(2)  2.154(3) 
V(1)-N(1)  2.159(3) 
V(1)-S(1)  2.3482(14) 
V(1)-S(2)  2.3617(18) 
S(1)-C(1)  1.825(4) 
S(2)-C(3)  1.837(4) 
N(2)-C(7)  1.499(5) 
N(2)-C(4)  1.506(5) 
N(2)-C(10)  1.511(5) 
N(1)-C(2)  1.493(5) 
N(1)-C(5)  1.504(5) 
N(1)-C(8)  1.519(5) 
C(1)-C(2)  1.519(6) 
C(8)-C(9)  1.528(5) 
C(3)-C(4)  1.510(6) 
C(5)-C(6)  1.507(6) 
C(6)-C(7)  1.525(6) 
C(9)-C(10)  1.513(5) 
O(1)-V(1)-N(2) 102.94(14) 
O(1)-V(1)-N(1) 101.26(14) 
N(2)-V(1)-N(1) 84.11(13) 
O(1)-V(1)-S(1) 112.27(11) 
N(2)-V(1)-S(1) 144.33(9) 
N(1)-V(1)-S(1) 83.65(10) 
O(1)-V(1)-S(2) 110.26(11) 
N(2)-V(1)-S(2) 84.23(10) 
N(1)-V(1)-S(2) 148.11(9) 
S(1)-V(1)-S(2) 88.80(5) 
C(1)-S(1)-V(1) 100.53(14) 
C(3)-S(2)-V(1) 100.55(13) 
C(7)-N(2)-C(4) 106.3(3) 
C(7)-N(2)-C(10) 110.7(3) 
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Table B-24 (continued) 
 
C(4)-N(2)-C(10) 110.8(3) 
C(7)-N(2)-V(1) 110.7(2) 
C(4)-N(2)-V(1) 108.7(2) 
C(10)-N(2)-V(1) 109.6(2) 
C(2)-N(1)-C(5) 106.7(3) 
C(2)-N(1)-C(8) 110.7(3) 
C(5)-N(1)-C(8) 109.9(3) 
C(2)-N(1)-V(1) 107.7(2) 
C(5)-N(1)-V(1) 110.9(2) 
C(8)-N(1)-V(1) 110.8(2) 
C(2)-C(1)-S(1) 111.4(3) 
N(1)-C(8)-C(9) 111.5(3) 
C(4)-C(3)-S(2) 111.4(3) 
N(2)-C(4)-C(3) 113.9(3) 
N(1)-C(5)-C(6) 114.5(3) 
C(5)-C(6)-C(7) 116.6(3) 
N(2)-C(7)-C(6) 114.9(3) 
C(10)-C(9)-C(8) 117.0(3) 
N(2)-C(10)-C(9) 113.3(3) 
N(1)-C(2)-C(1) 112.3(3) 
_____________________________________________________________  
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Table B-25.  Crystal data and structure refinement for [(bme-dach)(V=O)]. 
 
Empirical formula  C9 H18 N2 O S2 V 
Formula weight  285.31 
Temperature  293(2) K 
Wavelength  0.71073 Å 
Crystal system  orthorhombic 
Space group  P212121 
Unit cell dimensions a = 7.2514(18) Å α = 90°. 
 b = 9.816(2) Å β = 90°. 
 c = 16.378(5) Å γ = 90°. 
Volume 1165.8(5) Å3 
Z 4 
Density (calculated) 1.626 Mg/m3 
Absorption coefficient 1.184 mm-1 
F(000) 596 
Crystal size 0.10 x 0.10 x 0.02 mm3 
Theta range for data collection 2.49 to 25.00°. 
Index ranges -8<=h<=8, -6<=k<=11, -19<=l<=13 
Reflections collected 2642 
Independent reflections 1917 [R(int) = 0.0354] 
Completeness to theta = 25.00° 96.5 %  
Max. and min. transmission 0.9767 and 0.8908 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 1917 / 0 / 137 
Goodness-of-fit on F2 1.004 
Final R indices [I>2sigma(I)] R1 = 0.0363, wR2 = 0.0582 
R indices (all data) R1 = 0.0476, wR2 = 0.0619 
Absolute structure parameter 0.00(6) 
Largest diff. peak and hole 0.365 and -0.307 e.Å-3 
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Table B-26.   Bond lengths [Å] and angles [°] for [(bme-dach)(V=O)]. 
_____________________________________________________  
V(1)-O(1)  1.605(3) 
V(1)-N(2)  2.111(3) 
V(1)-N(1)  2.122(3) 
V(1)-S(1)  2.3407(12) 
V(1)-S(2)  2.3455(12) 
S(1)-C(1)  1.841(4) 
S(2)-C(3)  1.840(4) 
N(1)-C(8)  1.489(4) 
N(1)-C(5)  1.489(5) 
N(1)-C(2)  1.491(4) 
N(2)-C(9)  1.487(4) 
N(2)-C(4)  1.490(5) 
N(2)-C(7)  1.499(5) 
C(1)-C(2)  1.523(5) 
C(3)-C(4)  1.513(5) 
C(5)-C(6)  1.512(5) 
C(6)-C(7)  1.511(5) 
C(8)-C(9)  1.553(5) 
O(1)-V(1)-N(2) 102.17(13) 
O(1)-V(1)-N(1) 105.02(13) 
N(2)-V(1)-N(1) 74.35(11) 
O(1)-V(1)-S(1) 108.46(10) 
N(2)-V(1)-S(1) 146.39(9) 
N(1)-V(1)-S(1) 84.50(8) 
O(1)-V(1)-S(2) 110.66(10) 
N(2)-V(1)-S(2) 83.34(9) 
N(1)-V(1)-S(2) 141.09(9) 
S(1)-V(1)-S(2) 98.20(5) 
C(1)-S(1)-V(1) 99.17(12) 
C(3)-S(2)-V(1) 98.23(13) 
C(8)-N(1)-C(5) 111.0(3) 
C(8)-N(1)-C(2) 111.3(3) 
C(5)-N(1)-C(2) 109.8(3) 
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Table B-26 (continued) 
 
C(8)-N(1)-V(1) 104.8(2) 
C(5)-N(1)-V(1) 112.3(2) 
C(2)-N(1)-V(1) 107.6(2) 
C(9)-N(2)-C(4) 110.9(3) 
C(9)-N(2)-C(7) 110.7(3) 
C(4)-N(2)-C(7) 109.4(3) 
C(9)-N(2)-V(1) 104.8(2) 
C(4)-N(2)-V(1) 106.6(2) 
C(7)-N(2)-V(1) 114.3(2) 
C(2)-C(1)-S(1) 111.2(2) 
N(1)-C(2)-C(1) 110.8(3) 
C(4)-C(3)-S(2) 112.4(2) 
N(2)-C(4)-C(3) 110.1(3) 
N(1)-C(5)-C(6) 113.2(3) 
C(7)-C(6)-C(5) 114.8(3) 
N(2)-C(7)-C(6) 112.4(3) 
N(1)-C(8)-C(9) 109.9(3) 
N(2)-C(9)-C(8) 109.5(3) 
_____________________________________________________________  
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Table B-27.  Crystal data and structure refinement for [Et4N]2[(V=O)(ema)]. 
 
Empirical formula  C22 H50 N4 O4 S2 V 
Formula weight  549.72 
Temperature  293(2) K 
Wavelength  0.71073 Å 
Crystal system  triclinic 
Space group  P-1 
Unit cell dimensions a = 8.894(5) Å α = 72.63(5)°. 
 b = 12.219(7) Å β = 79.92(4)°. 
 c = 13.832(7) Å γ = 80.36(5)°. 
Volume 1401.9(13) Å3 
Z 2 
Density (calculated) 1.302 Mg/m3 
Absorption coefficient 0.536 mm-1 
F(000) 594 
Crystal size 0.10 x 0.10 x 0.01 mm3 
Theta range for data collection 2.00 to 25.00°. 
Index ranges -10<=h<=10, -14<=k<=14, -16<=l<=16 
Reflections collected 19908 
Independent reflections 4891 [R(int) = 0.0457] 
Completeness to theta = 25.00° 98.9 %  
Max. and min. transmission 0.9947 and 0.9484 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 4891 / 0 / 298 
Goodness-of-fit on F2 1.014 
Final R indices [I>2sigma(I)] R1 = 0.0397, wR2 = 0.0899 
R indices (all data) R1 = 0.0561, wR2 = 0.0983 
Largest diff. peak and hole 0.432 and -0.309 e.Å-3 
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Table B-28.   Bond lengths [Å] and angles [°] for  [Et4N]2[(V=O)(ema)]. 
_____________________________________________________  
V(1)-O(1)  1.6229(19) 
V(1)-N(1)  2.028(2) 
V(1)-N(2)  2.028(2) 
V(1)-S(2)  2.3632(15) 
V(1)-S(3)  2.3688(17) 
S(2)-C(1)  1.828(3) 
S(3)-C(6)  1.830(3) 
O(2)-C(2)  1.260(3) 
O(3)-C(5)  1.256(3) 
N(1)-C(2)  1.328(3) 
N(1)-C(3)  1.457(3) 
N(2)-C(5)  1.333(3) 
N(2)-C(4)  1.465(3) 
C(1)-C(2)  1.507(4) 
C(3)-C(4)  1.531(4) 
C(5)-C(6)  1.511(4) 
N(3)-C(10)  1.511(3) 
N(3)-C(8)  1.520(3) 
N(3)-C(11)  1.525(3) 
N(3)-C(13)  1.527(3) 
C(7)-C(8)  1.509(4) 
C(9)-C(10)  1.507(4) 
C(11)-C(12)  1.513(4) 
C(13)-C(14)  1.505(4) 
N(4)-C(19)  1.517(3) 
N(4)-C(15)  1.518(3) 
N(4)-C(17)  1.521(3) 
N(4)-C(21)  1.523(3) 
C(15)-C(16)  1.503(4) 
C(17)-C(18)  1.513(4) 
C(19)-C(20)  1.506(4) 
C(21)-C(22)  1.500(4) 
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Table B-28 (continued) 
 
O(1)-V(1)-N(1) 105.62(10) 
O(1)-V(1)-N(2) 109.72(10) 
N(1)-V(1)-N(2) 78.41(10) 
O(1)-V(1)-S(2) 111.79(8) 
N(1)-V(1)-S(2) 81.27(8) 
N(2)-V(1)-S(2) 137.28(7) 
O(1)-V(1)-S(3) 108.27(8) 
N(1)-V(1)-S(3) 145.03(7) 
N(2)-V(1)-S(3) 82.32(8) 
S(2)-V(1)-S(3) 93.91(6) 
C(1)-S(2)-V(1) 98.83(10) 
C(6)-S(3)-V(1) 97.51(10) 
C(2)-N(1)-C(3) 120.1(2) 
C(2)-N(1)-V(1) 126.01(17) 
C(3)-N(1)-V(1) 112.86(16) 
C(5)-N(2)-C(4) 117.0(2) 
C(5)-N(2)-V(1) 125.28(17) 
C(4)-N(2)-V(1) 117.59(16) 
C(2)-C(1)-S(2) 114.39(18) 
O(2)-C(2)-N(1) 125.8(2) 
O(2)-C(2)-C(1) 118.8(2) 
N(1)-C(2)-C(1) 115.4(2) 
N(1)-C(3)-C(4) 107.9(2) 
N(2)-C(4)-C(3) 108.3(2) 
O(3)-C(5)-N(2) 125.1(2) 
O(3)-C(5)-C(6) 119.1(2) 
N(2)-C(5)-C(6) 115.8(2) 
C(5)-C(6)-S(3) 114.24(18) 
C(10)-N(3)-C(8) 112.2(2) 
C(10)-N(3)-C(11) 108.1(2) 
C(8)-N(3)-C(11) 109.1(2) 
C(10)-N(3)-C(13) 107.8(2) 
C(8)-N(3)-C(13) 107.7(2) 
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Table B-28 (continued) 
 
C(11)-N(3)-C(13) 111.8(2) 
C(7)-C(8)-N(3) 115.4(2) 
C(9)-C(10)-N(3) 115.0(2) 
C(12)-C(11)-N(3) 114.4(2) 
C(14)-C(13)-N(3) 115.2(2) 
C(19)-N(4)-C(15) 106.0(2) 
C(19)-N(4)-C(17) 111.2(2) 
C(15)-N(4)-C(17) 111.7(2) 
C(19)-N(4)-C(21) 111.5(2) 
C(15)-N(4)-C(21) 111.0(2) 
C(17)-N(4)-C(21) 105.52(19) 
C(16)-C(15)-N(4) 115.0(2) 
C(18)-C(17)-N(4) 115.5(2) 
C(20)-C(19)-N(4) 115.9(2) 
C(22)-C(21)-N(4) 115.2(2) 
_____________________________________________________________  
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